[
    {
        "user_input":"Consider the Marketing Affiliate Agreement between Birch First Global Investments Inc. and Mount Knowledge Holdings Inc.; What is the expiration date of this contract?",
        "response":"The retrieved chunk does not provide an expiration date for the Marketing Affiliate Agreement between Birch First Global Investments Inc. and Mount Knowledge Holdings Inc. It only states the date the agreement was executed, which is May 8, 2014. There are no terms or conditions mentioned regarding the duration or expiration of the contract. Therefore, based on the provided information, I cannot determine the expiration date of this contract.",
        "retrieved_contexts":[
            "Exhibit 10.27\n\nMARKETING AFFILIATE AGREEMENT\n\nBetween:\n\nBirch First Global Investments Inc.\n\nAnd\n\nMount Knowledge Holdings Inc.\n\nDated: May 8, 2014\n\n1\n\nSource: CYBERGY HOLDINGS, INC., 10-Q, 5\/20\/2014\n\n\n\n\n\n1.\n\n2.\n\n2.1\n\n2.2",
            "This Marketing Affiliate Agreement (the \"Agreement\") is entered into this 8th day of May 2014, by and between BIRCH FIRST GLOBAL INVESTMENTS INC., a corporation incorporated in the U.S. Virgin Islands, with its main place of business located 9100 Havensight, Port of Sale, Ste. 15\/16, St. Thomas, VI 0080 (referred to as \"Company\") and MOUNT KNOWLEDGE HOLDINGS INC. and\/or assigns, a corporation incorporated in the State of Nevada, with its main place of business located at 228 Park Avenue S",
            "COMPANY\n\nBIRCH FIRST INVESTMENTS INC. A US Virgin Islands corporation\n\nBy: \/s\/ Pier S. Bjorklund Pier S. Bjorklund, President\n\nThis Agreement was executed as of the date set forth above.\n\nMA\n\nMOUNT KNOWLEDGE HOLDINGS INC. A Nevada corporation\n\nBy: \/s\/ James D. Beatty  James D. Beatty, CEO and President\n\n14\n\nSource: CYBERGY HOLDINGS, INC., 10-Q, 5\/20\/2014\n\n\n\n\n\n1.\n\nNote 1:\n\nNote 2:\n\nNote 3:\n\nNote 4:\n\nNote 5:\n\nNote 6:\n\n2.\n\n(a)\n\nSCHEDULE A\n\nMARKETING AFFILIATE Technology PRICING AND TERMS"
        ]
    },
    {
        "user_input":"Consider the Marketing Affiliate Agreement between Birch First Global Investments Inc. and Mount Knowledge Holdings Inc.; What is the renewal term for this contract?",
        "response":"The renewal term for the Marketing Affiliate Agreement is one (1) additional three (3) year period. This renewal occurs automatically unless either party provides written notice of non-renewal at least ninety (90) days before the expiration of the Initial Term.",
        "retrieved_contexts":[
            "Exhibit 10.27\n\nMARKETING AFFILIATE AGREEMENT\n\nBetween:\n\nBirch First Global Investments Inc.\n\nAnd\n\nMount Knowledge Holdings Inc.\n\nDated: May 8, 2014\n\n1\n\nSource: CYBERGY HOLDINGS, INC., 10-Q, 5\/20\/2014\n\n\n\n\n\n1.\n\n2.\n\n2.1\n\n2.2",
            "This Marketing Affiliate Agreement (the \"Agreement\") is entered into this 8th day of May 2014, by and between BIRCH FIRST GLOBAL INVESTMENTS INC., a corporation incorporated in the U.S. Virgin Islands, with its main place of business located 9100 Havensight, Port of Sale, Ste. 15\/16, St. Thomas, VI 0080 (referred to as \"Company\") and MOUNT KNOWLEDGE HOLDINGS INC. and\/or assigns, a corporation incorporated in the State of Nevada, with its main place of business located at 228 Park Avenue S",
            ". Thereafter, this Agreement shall renew automatically for one (1) additional three (3) year period (the \"Renewal Term\" and collectively, together with the Initial Term, the \"Term\") unless either party provides the other with written notice of non-renewal at least ninety (90) days before the expiration of the Initial Term].   6.2 Termination"
        ]
    },
    {
        "user_input":"Consider the Marketing Affiliate Agreement between Birch First Global Investments Inc. and Mount Knowledge Holdings Inc.; What is the notice period required to terminate the renewal?",
        "response":"The Marketing Affiliate Agreement specifies that the Distributor (Mount Knowledge Holdings Inc.) must provide prior written notice to the Company (Birch First Global Investments Inc.) within Ninety (90) days of the end of the initial period to renew the Agreement. However, the clause does not explicitly mention a notice period required for termination of the renewal itself. Therefore, based on the provided clause, there is no stated notice period required to terminate the renewal.",
        "retrieved_contexts":[
            "Exhibit 10.27\n\nMARKETING AFFILIATE AGREEMENT\n\nBetween:\n\nBirch First Global Investments Inc.\n\nAnd\n\nMount Knowledge Holdings Inc.\n\nDated: May 8, 2014\n\n1\n\nSource: CYBERGY HOLDINGS, INC., 10-Q, 5\/20\/2014\n\n\n\n\n\n1.\n\n2.\n\n2.1\n\n2.2",
            "This Marketing Affiliate Agreement (the \"Agreement\") is entered into this 8th day of May 2014, by and between BIRCH FIRST GLOBAL INVESTMENTS INC., a corporation incorporated in the U.S. Virgin Islands, with its main place of business located 9100 Havensight, Port of Sale, Ste. 15\/16, St. Thomas, VI 0080 (referred to as \"Company\") and MOUNT KNOWLEDGE HOLDINGS INC. and\/or assigns, a corporation incorporated in the State of Nevada, with its main place of business located at 228 Park Avenue S",
            "7. DURATION & TERMINATION. (a) Effective Date and Duration. This Agreement shall become effective on the date first written above and shall continue in effect for a period of Three (3) years. (b) Distributor Option to Renew. Distributor shall have the option to renew this Agreement for an additional Three (3) year period by providing prior written notice to Company within Ninety (90) days of the end of the initial period of this Agreement. (c) Termination"
        ]
    },
    {
        "user_input":"Consider the Marketing Affiliate Agreement between Birch First Global Investments Inc. and Mount Knowledge Holdings Inc.; What is the governing law for this contract?",
        "response":"The retrieved chunk does not specify the governing law for the Marketing Affiliate Agreement between Birch First Global Investments Inc. and Mount Knowledge Holdings Inc. Therefore, I cannot provide an answer regarding the governing law based on the information available in the clause.",
        "retrieved_contexts":[
            "This Marketing Affiliate Agreement (the \"Agreement\") is entered into this 8th day of May 2014, by and between BIRCH FIRST GLOBAL INVESTMENTS INC., a corporation incorporated in the U.S. Virgin Islands, with its main place of business located 9100 Havensight, Port of Sale, Ste. 15\/16, St. Thomas, VI 0080 (referred to as \"Company\") and MOUNT KNOWLEDGE HOLDINGS INC. and\/or assigns, a corporation incorporated in the State of Nevada, with its main place of business located at 228 Park Avenue S",
            "Exhibit 10.27\n\nMARKETING AFFILIATE AGREEMENT\n\nBetween:\n\nBirch First Global Investments Inc.\n\nAnd\n\nMount Knowledge Holdings Inc.\n\nDated: May 8, 2014\n\n1\n\nSource: CYBERGY HOLDINGS, INC., 10-Q, 5\/20\/2014\n\n\n\n\n\n1.\n\n2.\n\n2.1\n\n2.2",
            "; except that, either Party shall be permitted, without any need for the other Party's   consent, to assign this Agreement (a) in whole or in part to an Affiliate (provided, however, that once such Person is no longer an   Affiliate of the assigning Party, such former Affiliate shall assign this Agreement back to the assigning Party)"
        ]
    },
    {
        "user_input":"Consider the Marketing Affiliate Agreement between Birch First Global Investments Inc. and Mount Knowledge Holdings Inc.; Is there an anti-assignment clause in this contract?",
        "response":"The Marketing Affiliate Agreement does not contain a traditional anti-assignment clause. Instead, it allows for assignment under specific conditions. According to the clause, \"either Party shall be permitted, without any need for the other Party's consent, to assign this Agreement (a) in whole or in part to an Affiliate.\" However, it also states that if the assignee is no longer an Affiliate of the assigning Party, that former Affiliate must assign the Agreement back to the assigning Party.\n\nThis means that while assignments are generally permitted, they are restricted to Affiliates, and there is a requirement for the Agreement to be reassigned if the Affiliate status changes. Thus, while there is no outright prohibition on assignment, there are conditions that govern it.",
        "retrieved_contexts":[
            "Exhibit 10.27\n\nMARKETING AFFILIATE AGREEMENT\n\nBetween:\n\nBirch First Global Investments Inc.\n\nAnd\n\nMount Knowledge Holdings Inc.\n\nDated: May 8, 2014\n\n1\n\nSource: CYBERGY HOLDINGS, INC., 10-Q, 5\/20\/2014\n\n\n\n\n\n1.\n\n2.\n\n2.1\n\n2.2",
            "This Marketing Affiliate Agreement (the \"Agreement\") is entered into this 8th day of May 2014, by and between BIRCH FIRST GLOBAL INVESTMENTS INC., a corporation incorporated in the U.S. Virgin Islands, with its main place of business located 9100 Havensight, Port of Sale, Ste. 15\/16, St. Thomas, VI 0080 (referred to as \"Company\") and MOUNT KNOWLEDGE HOLDINGS INC. and\/or assigns, a corporation incorporated in the State of Nevada, with its main place of business located at 228 Park Avenue S",
            "; except that, either Party shall be permitted, without any need for the other Party's   consent, to assign this Agreement (a) in whole or in part to an Affiliate (provided, however, that once such Person is no longer an   Affiliate of the assigning Party, such former Affiliate shall assign this Agreement back to the assigning Party)"
        ]
    },
    {
        "user_input":"Consider the Marketing Affiliate Agreement between Birch First Global Investments Inc. and Mount Knowledge Holdings Inc.; Is there a minimum commitment required under this contract?",
        "response":"The provided clause does not specify any minimum commitment required under the Marketing Affiliate Agreement between Birch First Global Investments Inc. and Mount Knowledge Holdings Inc. It primarily discusses the assignment of the Agreement between the parties and their affiliates. Therefore, based on the information in the clause, there is no mention of a minimum commitment requirement.",
        "retrieved_contexts":[
            "This Marketing Affiliate Agreement (the \"Agreement\") is entered into this 8th day of May 2014, by and between BIRCH FIRST GLOBAL INVESTMENTS INC., a corporation incorporated in the U.S. Virgin Islands, with its main place of business located 9100 Havensight, Port of Sale, Ste. 15\/16, St. Thomas, VI 0080 (referred to as \"Company\") and MOUNT KNOWLEDGE HOLDINGS INC. and\/or assigns, a corporation incorporated in the State of Nevada, with its main place of business located at 228 Park Avenue S",
            "Exhibit 10.27\n\nMARKETING AFFILIATE AGREEMENT\n\nBetween:\n\nBirch First Global Investments Inc.\n\nAnd\n\nMount Knowledge Holdings Inc.\n\nDated: May 8, 2014\n\n1\n\nSource: CYBERGY HOLDINGS, INC., 10-Q, 5\/20\/2014\n\n\n\n\n\n1.\n\n2.\n\n2.1\n\n2.2",
            "; except that, either Party shall be permitted, without any need for the other Party's   consent, to assign this Agreement (a) in whole or in part to an Affiliate (provided, however, that once such Person is no longer an   Affiliate of the assigning Party, such former Affiliate shall assign this Agreement back to the assigning Party)"
        ]
    },
    {
        "user_input":"Consider the Marketing Affiliate Agreement between Birch First Global Investments Inc. and Mount Knowledge Holdings Inc.; What licenses are granted under this contract?",
        "response":"The provided excerpt from the Marketing Affiliate Agreement does not specify any licenses granted under the contract. The section that would typically contain information about licenses, such as rights to use intellectual property or marketing materials, is not included in the retrieved chunk. Therefore, based on the information available, I cannot provide details about any licenses granted under this contract.",
        "retrieved_contexts":[
            "Exhibit 10.27\n\nMARKETING AFFILIATE AGREEMENT\n\nBetween:\n\nBirch First Global Investments Inc.\n\nAnd\n\nMount Knowledge Holdings Inc.\n\nDated: May 8, 2014\n\n1\n\nSource: CYBERGY HOLDINGS, INC., 10-Q, 5\/20\/2014\n\n\n\n\n\n1.\n\n2.\n\n2.1\n\n2.2",
            "This Marketing Affiliate Agreement (the \"Agreement\") is entered into this 8th day of May 2014, by and between BIRCH FIRST GLOBAL INVESTMENTS INC., a corporation incorporated in the U.S. Virgin Islands, with its main place of business located 9100 Havensight, Port of Sale, Ste. 15\/16, St. Thomas, VI 0080 (referred to as \"Company\") and MOUNT KNOWLEDGE HOLDINGS INC. and\/or assigns, a corporation incorporated in the State of Nevada, with its main place of business located at 228 Park Avenue S",
            "COMPANY\n\nBIRCH FIRST INVESTMENTS INC. A US Virgin Islands corporation\n\nBy: \/s\/ Pier S. Bjorklund Pier S. Bjorklund, President\n\nThis Agreement was executed as of the date set forth above.\n\nMA\n\nMOUNT KNOWLEDGE HOLDINGS INC. A Nevada corporation\n\nBy: \/s\/ James D. Beatty  James D. Beatty, CEO and President\n\n14\n\nSource: CYBERGY HOLDINGS, INC., 10-Q, 5\/20\/2014\n\n\n\n\n\n1.\n\nNote 1:\n\nNote 2:\n\nNote 3:\n\nNote 4:\n\nNote 5:\n\nNote 6:\n\n2.\n\n(a)\n\nSCHEDULE A\n\nMARKETING AFFILIATE Technology PRICING AND TERMS"
        ]
    },
    {
        "user_input":"Consider the Marketing Affiliate Agreement between Birch First Global Investments Inc. and Mount Knowledge Holdings Inc.; What are the audit rights under this contract?",
        "response":"The provided clause does not contain any information regarding audit rights under the Marketing Affiliate Agreement between Birch First Global Investments Inc. and Mount Knowledge Holdings Inc. There are no terms, conditions, or restrictions related to audit rights mentioned in the retrieved chunk. Therefore, I cannot provide an answer regarding audit rights based on the information available.",
        "retrieved_contexts":[
            "This Marketing Affiliate Agreement (the \"Agreement\") is entered into this 8th day of May 2014, by and between BIRCH FIRST GLOBAL INVESTMENTS INC., a corporation incorporated in the U.S. Virgin Islands, with its main place of business located 9100 Havensight, Port of Sale, Ste. 15\/16, St. Thomas, VI 0080 (referred to as \"Company\") and MOUNT KNOWLEDGE HOLDINGS INC. and\/or assigns, a corporation incorporated in the State of Nevada, with its main place of business located at 228 Park Avenue S",
            "Exhibit 10.27\n\nMARKETING AFFILIATE AGREEMENT\n\nBetween:\n\nBirch First Global Investments Inc.\n\nAnd\n\nMount Knowledge Holdings Inc.\n\nDated: May 8, 2014\n\n1\n\nSource: CYBERGY HOLDINGS, INC., 10-Q, 5\/20\/2014\n\n\n\n\n\n1.\n\n2.\n\n2.1\n\n2.2",
            "(c) \"Affiliate(s)\" shall mean an entity controlling, controlled by or under common control with a party. \"Control,\" for purposes of this definition, means direct or indirect ownership or control of more than 50% of the voting interests of the subject entity.\n\n(d) \"Confidential Information\" shall have the meaning specified in Section 14(a) [Confidential Information].\n\n(e) \"Indemnified Party\" shall have the meaning specified in Section 13."
        ]
    },
    {
        "user_input":"Consider the Marketing Affiliate Agreement between Birch First Global Investments Inc. and Mount Knowledge Holdings Inc.; Is there a cap on liability under this contract?",
        "response":"The provided clause does not contain any information regarding a cap on liability under the Marketing Affiliate Agreement between Birch First Global Investments Inc. and Mount Knowledge Holdings Inc. Therefore, based on the retrieved chunk, there is no mention of any limitations or caps on liability in this contract.",
        "retrieved_contexts":[
            "This Marketing Affiliate Agreement (the \"Agreement\") is entered into this 8th day of May 2014, by and between BIRCH FIRST GLOBAL INVESTMENTS INC., a corporation incorporated in the U.S. Virgin Islands, with its main place of business located 9100 Havensight, Port of Sale, Ste. 15\/16, St. Thomas, VI 0080 (referred to as \"Company\") and MOUNT KNOWLEDGE HOLDINGS INC. and\/or assigns, a corporation incorporated in the State of Nevada, with its main place of business located at 228 Park Avenue S",
            "Exhibit 10.27\n\nMARKETING AFFILIATE AGREEMENT\n\nBetween:\n\nBirch First Global Investments Inc.\n\nAnd\n\nMount Knowledge Holdings Inc.\n\nDated: May 8, 2014\n\n1\n\nSource: CYBERGY HOLDINGS, INC., 10-Q, 5\/20\/2014\n\n\n\n\n\n1.\n\n2.\n\n2.1\n\n2.2",
            "COMPANY\n\nBIRCH FIRST INVESTMENTS INC. A US Virgin Islands corporation\n\nBy: \/s\/ Pier S. Bjorklund Pier S. Bjorklund, President\n\nThis Agreement was executed as of the date set forth above.\n\nMA\n\nMOUNT KNOWLEDGE HOLDINGS INC. A Nevada corporation\n\nBy: \/s\/ James D. Beatty  James D. Beatty, CEO and President\n\n14\n\nSource: CYBERGY HOLDINGS, INC., 10-Q, 5\/20\/2014\n\n\n\n\n\n1.\n\nNote 1:\n\nNote 2:\n\nNote 3:\n\nNote 4:\n\nNote 5:\n\nNote 6:\n\n2.\n\n(a)\n\nSCHEDULE A\n\nMARKETING AFFILIATE Technology PRICING AND TERMS"
        ]
    },
    {
        "user_input":"Consider the Marketing Affiliate Agreement between Birch First Global Investments Inc. and Mount Knowledge Holdings Inc.; What is the duration of any warranties provided in this contract?",
        "response":"The retrieved chunk does not provide any information regarding the duration of warranties in the Marketing Affiliate Agreement between Birch First Global Investments Inc. and Mount Knowledge Holdings Inc. There are no clauses or sections that specifically address warranties or their duration. Therefore, I cannot provide an answer to your question based on the provided text.",
        "retrieved_contexts":[
            "Exhibit 10.27\n\nMARKETING AFFILIATE AGREEMENT\n\nBetween:\n\nBirch First Global Investments Inc.\n\nAnd\n\nMount Knowledge Holdings Inc.\n\nDated: May 8, 2014\n\n1\n\nSource: CYBERGY HOLDINGS, INC., 10-Q, 5\/20\/2014\n\n\n\n\n\n1.\n\n2.\n\n2.1\n\n2.2",
            "This Marketing Affiliate Agreement (the \"Agreement\") is entered into this 8th day of May 2014, by and between BIRCH FIRST GLOBAL INVESTMENTS INC., a corporation incorporated in the U.S. Virgin Islands, with its main place of business located 9100 Havensight, Port of Sale, Ste. 15\/16, St. Thomas, VI 0080 (referred to as \"Company\") and MOUNT KNOWLEDGE HOLDINGS INC. and\/or assigns, a corporation incorporated in the State of Nevada, with its main place of business located at 228 Park Avenue S",
            "COMPANY\n\nBIRCH FIRST INVESTMENTS INC. A US Virgin Islands corporation\n\nBy: \/s\/ Pier S. Bjorklund Pier S. Bjorklund, President\n\nThis Agreement was executed as of the date set forth above.\n\nMA\n\nMOUNT KNOWLEDGE HOLDINGS INC. A Nevada corporation\n\nBy: \/s\/ James D. Beatty  James D. Beatty, CEO and President\n\n14\n\nSource: CYBERGY HOLDINGS, INC., 10-Q, 5\/20\/2014\n\n\n\n\n\n1.\n\nNote 1:\n\nNote 2:\n\nNote 3:\n\nNote 4:\n\nNote 5:\n\nNote 6:\n\n2.\n\n(a)\n\nSCHEDULE A\n\nMARKETING AFFILIATE Technology PRICING AND TERMS"
        ]
    },
    {
        "user_input":"Consider the Video-on-Demand Content License Agreement between Rogers Cable Communications Inc. and EuroMedia Holdings Corp.; What is the expiration date of this contract?",
        "response":"The expiration date of the Video-on-Demand Content License Agreement is not explicitly stated in the provided clause. The clause mentions an \"Effective Date\" of July 11, 2006, and refers to an \"Initial Term\" and a \"Renewal Term,\" but it does not specify the length of these terms or the exact expiration date of the contract. Therefore, without additional information regarding the duration of the Initial Term or any Renewal Term, the expiration date cannot be determined from the provided text.",
        "retrieved_contexts":[
            "Exhibit 10.B.01 EXECUTION COPY\n\nVIDEO-ON-DEMAND CONTENT LICENSE AGREEMENT between Rogers Cable Communications Inc. (\"Rogers\") and EuroMedia Holdings Corp. (\"Licensor\") offering EurocinemaSM Video-on-Demand service made as of July 11 , 2006 (the \"Effective Date\") (the \"Agreement\")",
            ".   If either party terminates this Agreement prior to its expiration, Rogers shall be entitled to continue to distribute and exhibit all Licensed Programs then being distributed and exhibited on the ROD Service, in each case, for a period of sixty (60) days from the effective date of termination or the expiry of the relevant License Period, whichever is earlier, and, in such event, Rogers shall continue to be bound by its payment obligations set forth herein in respect of such Licensed Programs",
            ". Notwithstanding the foregoing, if, at the expiry of this Agreement following the Initial Term or the Renewal Term (if any), as applicable, Licensor and Rogers have not executed a new agreement governing the VOD distribution and exhibition of Licensed Programs and Rogers (or its permitted assigns) continues to distribute and exhibit Licensed Programs on the ROD Service following such expiry"
        ]
    },
    {
        "user_input":"Consider the Video-on-Demand Content License Agreement between Rogers Cable Communications Inc. and EuroMedia Holdings Corp.; What is the renewal term for this contract?",
        "response":"The retrieved chunk does not specify a defined renewal term for the Video-on-Demand Content License Agreement between Rogers Cable Communications Inc. and EuroMedia Holdings Corp. It mentions a \"Renewal Term (if any),\" indicating that there may be a renewal option, but it does not provide details on the duration or conditions of such a renewal. Therefore, the clause does not provide a direct answer regarding the renewal term.",
        "retrieved_contexts":[
            "Exhibit 10.B.01 EXECUTION COPY\n\nVIDEO-ON-DEMAND CONTENT LICENSE AGREEMENT between Rogers Cable Communications Inc. (\"Rogers\") and EuroMedia Holdings Corp. (\"Licensor\") offering EurocinemaSM Video-on-Demand service made as of July 11 , 2006 (the \"Effective Date\") (the \"Agreement\")",
            ". Notwithstanding the foregoing, if, at the expiry of this Agreement following the Initial Term or the Renewal Term (if any), as applicable, Licensor and Rogers have not executed a new agreement governing the VOD distribution and exhibition of Licensed Programs and Rogers (or its permitted assigns) continues to distribute and exhibit Licensed Programs on the ROD Service following such expiry",
            ".   If either party terminates this Agreement prior to its expiration, Rogers shall be entitled to continue to distribute and exhibit all Licensed Programs then being distributed and exhibited on the ROD Service, in each case, for a period of sixty (60) days from the effective date of termination or the expiry of the relevant License Period, whichever is earlier, and, in such event, Rogers shall continue to be bound by its payment obligations set forth herein in respect of such Licensed Programs"
        ]
    },
    {
        "user_input":"Consider the Video-on-Demand Content License Agreement between Rogers Cable Communications Inc. and EuroMedia Holdings Corp.; What is the notice period required to terminate the renewal?",
        "response":"The notice period required to terminate the renewal of the Video-on-Demand Content License Agreement is sixty (60) days. This is specified in the clause, which states that \"each of Licensor and Rogers shall have the right, on sixty (60) days' prior written notice, to terminate this Agreement.\"",
        "retrieved_contexts":[
            ", such continued distribution and exhibition shall be governed by the terms of this Agreement in effect at the time of expiry, except that each of Licensor and Rogers shall have the right, on sixty (60) days' prior written notice, to terminate this Agreement, as so extended",
            "Exhibit 10.B.01 EXECUTION COPY\n\nVIDEO-ON-DEMAND CONTENT LICENSE AGREEMENT between Rogers Cable Communications Inc. (\"Rogers\") and EuroMedia Holdings Corp. (\"Licensor\") offering EurocinemaSM Video-on-Demand service made as of July 11 , 2006 (the \"Effective Date\") (the \"Agreement\")",
            ". Notwithstanding the foregoing, if, at the expiry of this Agreement following the Initial Term or the Renewal Term (if any), as applicable, Licensor and Rogers have not executed a new agreement governing the VOD distribution and exhibition of Licensed Programs and Rogers (or its permitted assigns) continues to distribute and exhibit Licensed Programs on the ROD Service following such expiry"
        ]
    },
    {
        "user_input":"Consider the Video-on-Demand Content License Agreement between Rogers Cable Communications Inc. and EuroMedia Holdings Corp.; What is the governing law for this contract?",
        "response":"The provided clause does not specify the governing law for the Video-on-Demand Content License Agreement between Rogers Cable Communications Inc. and EuroMedia Holdings Corp. Therefore, based on the information in the clause, I cannot provide an answer regarding the governing law for this contract.",
        "retrieved_contexts":[
            "Exhibit 10.B.01 EXECUTION COPY\n\nVIDEO-ON-DEMAND CONTENT LICENSE AGREEMENT between Rogers Cable Communications Inc. (\"Rogers\") and EuroMedia Holdings Corp. (\"Licensor\") offering EurocinemaSM Video-on-Demand service made as of July 11 , 2006 (the \"Effective Date\") (the \"Agreement\")",
            ";     (iii) it has obtained, and shall maintain throughout the Term, all approvals and\/or ratings from provincial authorities necessary to distribute and exhibit each Licensed Program, trailer and other promotional materials provided to Rogers hereunder;     (iv) it unilaterally owns or controls the VOD distribution and exhibition rights to all Licensed Programs within the Territory",
            ". Notwithstanding the foregoing, if, at the expiry of this Agreement following the Initial Term or the Renewal Term (if any), as applicable, Licensor and Rogers have not executed a new agreement governing the VOD distribution and exhibition of Licensed Programs and Rogers (or its permitted assigns) continues to distribute and exhibit Licensed Programs on the ROD Service following such expiry"
        ]
    },
    {
        "user_input":"Consider the Video-on-Demand Content License Agreement between Rogers Cable Communications Inc. and EuroMedia Holdings Corp.; Is there a most favored nation clause in this contract?",
        "response":"Yes, the Video-on-Demand Content License Agreement contains a most favored nation clause. Specifically, it states that the contract includes \"a Contract granting a 'most favored nation' or most favored customer pricing to any Person.\" This indicates that there are provisions related to ensuring that Rogers receives favorable pricing terms compared to other parties.",
        "retrieved_contexts":[
            "Exhibit 10.B.01 EXECUTION COPY\n\nVIDEO-ON-DEMAND CONTENT LICENSE AGREEMENT between Rogers Cable Communications Inc. (\"Rogers\") and EuroMedia Holdings Corp. (\"Licensor\") offering EurocinemaSM Video-on-Demand service made as of July 11 , 2006 (the \"Effective Date\") (the \"Agreement\")",
            ":   (i)                 a Contract granting a \u201cmost favored nation\u201d or most favored customer pricing to any Person, or any Contract providing for the grant of exclusive material sales, distribution, marketing or other exclusive rights, rights of first refusal, rights of first negotiation or similar rights and\/or terms to any Person, or materially limiting the right of the Company or any of its Subsidiaries to engage in any line of business or in any geographic area",
            "1. RIGHTS GRANTED   Licensor grants to Rogers the non-exclusive license and right to distribute and exhibit in Canada (the \"Territory\") all entertainment programming to which Licensor owns or controls the VOD distribution and exhibition rights in the Territory (collectively, \"Licensed Programs\") to residential subscribers of Rogers' digital cable television service on a Video-on-Demand (\"VOD\") basis"
        ]
    },
    {
        "user_input":"Consider the Video-on-Demand Content License Agreement between Rogers Cable Communications Inc. and EuroMedia Holdings Corp.; Can this contract be terminated for convenience, and under what conditions?",
        "response":"The retrieved clause does not explicitly state whether the Video-on-Demand Content License Agreement can be terminated for convenience. It discusses termination prior to expiration but does not provide details on the conditions under which either party may terminate the agreement for convenience.\n\nHowever, it does mention that if either party terminates the Agreement prior to its expiration, Rogers is entitled to continue distributing and exhibiting all Licensed Programs for a period of sixty (60) days from the effective date of termination or the expiry of the relevant License Period, whichever is earlier. In this case, Rogers must continue to fulfill its payment obligations regarding those Licensed Programs.\n\nSince the clause does not specify the ability to terminate for convenience, it is unclear if such a termination is permitted under the terms of the Agreement.",
        "retrieved_contexts":[
            "Exhibit 10.B.01 EXECUTION COPY\n\nVIDEO-ON-DEMAND CONTENT LICENSE AGREEMENT between Rogers Cable Communications Inc. (\"Rogers\") and EuroMedia Holdings Corp. (\"Licensor\") offering EurocinemaSM Video-on-Demand service made as of July 11 , 2006 (the \"Effective Date\") (the \"Agreement\")",
            ". Notwithstanding the foregoing, if, at the expiry of this Agreement following the Initial Term or the Renewal Term (if any), as applicable, Licensor and Rogers have not executed a new agreement governing the VOD distribution and exhibition of Licensed Programs and Rogers (or its permitted assigns) continues to distribute and exhibit Licensed Programs on the ROD Service following such expiry",
            ".   If either party terminates this Agreement prior to its expiration, Rogers shall be entitled to continue to distribute and exhibit all Licensed Programs then being distributed and exhibited on the ROD Service, in each case, for a period of sixty (60) days from the effective date of termination or the expiry of the relevant License Period, whichever is earlier, and, in such event, Rogers shall continue to be bound by its payment obligations set forth herein in respect of such Licensed Programs"
        ]
    },
    {
        "user_input":"Consider the Video-on-Demand Content License Agreement between Rogers Cable Communications Inc. and EuroMedia Holdings Corp.; Is there an anti-assignment clause in this contract?",
        "response":"The provided clause does not explicitly mention an anti-assignment clause. It primarily discusses the obligations of the Licensor regarding approvals, ownership of rights, and conditions related to the distribution of Licensed Programs. There is no indication of restrictions or prohibitions on the assignment of rights or obligations under the Agreement. Therefore, based on the information in the clause, it cannot be concluded that there is an anti-assignment clause present in this contract.",
        "retrieved_contexts":[
            "Exhibit 10.B.01 EXECUTION COPY\n\nVIDEO-ON-DEMAND CONTENT LICENSE AGREEMENT between Rogers Cable Communications Inc. (\"Rogers\") and EuroMedia Holdings Corp. (\"Licensor\") offering EurocinemaSM Video-on-Demand service made as of July 11 , 2006 (the \"Effective Date\") (the \"Agreement\")",
            ";     (iii) it has obtained, and shall maintain throughout the Term, all approvals and\/or ratings from provincial authorities necessary to distribute and exhibit each Licensed Program, trailer and other promotional materials provided to Rogers hereunder;     (iv) it unilaterally owns or controls the VOD distribution and exhibition rights to all Licensed Programs within the Territory",
            ". or the Territory on a VOD basis, or any other basis that permits the downloading of such Licensed Programs and the subsequent viewing of such Licensed Programs by a residential subscriber, on terms (including, without limitation, license fees, copyright royalty payments, encoding fees and obligations, and marketing support) that are more favourable than those contained in this Agreement, then Rogers has the right to incorporate, or substitute, as the case may be"
        ]
    },
    {
        "user_input":"Consider the Video-on-Demand Content License Agreement between Rogers Cable Communications Inc. and EuroMedia Holdings Corp.; Does this contract include any revenue or profit-sharing arrangements?",
        "response":"The clause provided does not explicitly mention any revenue or profit-sharing arrangements between Rogers Cable Communications Inc. and EuroMedia Holdings Corp. It states that \"in the event that Retail Revenues in a particular month are not sufficient to fully reimburse Rogers for the Rogers Costs incurred in such month, Rogers shall be entitled to recover such amounts against Retail Revenues generated by other Licensed Programs in subsequent months.\" This indicates that Rogers can offset costs against future revenues, but it does not establish a profit-sharing arrangement.\n\nAdditionally, the clause notes that \"there shall be no minimum License Fee or retail viewing fee with respect to any Licensed Program,\" which further implies that there are no guaranteed revenue-sharing terms outlined in the agreement. \n\nIn summary, while there are provisions related to revenue recovery, there are no clear profit-sharing arrangements stated in the contract.",
        "retrieved_contexts":[
            "Exhibit 10.B.01 EXECUTION COPY\n\nVIDEO-ON-DEMAND CONTENT LICENSE AGREEMENT between Rogers Cable Communications Inc. (\"Rogers\") and EuroMedia Holdings Corp. (\"Licensor\") offering EurocinemaSM Video-on-Demand service made as of July 11 , 2006 (the \"Effective Date\") (the \"Agreement\")",
            ";     (iii) it has obtained, and shall maintain throughout the Term, all approvals and\/or ratings from provincial authorities necessary to distribute and exhibit each Licensed Program, trailer and other promotional materials provided to Rogers hereunder;     (iv) it unilaterally owns or controls the VOD distribution and exhibition rights to all Licensed Programs within the Territory",
            ".     (d) In the event that Retail Revenues in a particular month are not sufficient to fully reimburse Rogers for the Rogers Costs incurred in such month, Rogers shall be entitled to recover such amounts against Retail Revenues generated by other Licensed Programs in subsequent months.     (e) There shall be no minimum License Fee or retail viewing fee with respect to any Licensed Program"
        ]
    },
    {
        "user_input":"Consider the Video-on-Demand Content License Agreement between Rogers Cable Communications Inc. and EuroMedia Holdings Corp.; Is there a minimum commitment required under this contract?",
        "response":"The provided clause does not specify any minimum commitment required under the Video-on-Demand Content License Agreement between Rogers Cable Communications Inc. and EuroMedia Holdings Corp. The details included focus on the licensed rights and distribution methods but do not mention any minimum commitment terms. Therefore, based on the information in the clause, there is no indication of a minimum commitment requirement.",
        "retrieved_contexts":[
            "Exhibit 10.B.01 EXECUTION COPY\n\nVIDEO-ON-DEMAND CONTENT LICENSE AGREEMENT between Rogers Cable Communications Inc. (\"Rogers\") and EuroMedia Holdings Corp. (\"Licensor\") offering EurocinemaSM Video-on-Demand service made as of July 11 , 2006 (the \"Effective Date\") (the \"Agreement\")",
            "CONTENT DISTRIBUTION AND LICENSE AGREEMENT   Deal Terms   Licensed Program\/ Film or Video Inevitable \"Licensed Rights\" to ConvergTV and ConvergTV Channels and\/or Distribution Outlets x All, including but not limited to: xSimultaneous Internet Streaming x OTT Television x Internet Protocol Television x Radio, short wave, microwave, fiber optic x Alternative, secondary and specialty distribution x Stored as VOD, Content Distribution Networks\/Company Servers x Full Television Broadcast Rights",
            "CONTENT LICENSE AGREEMENT"
        ]
    },
    {
        "user_input":"Consider the Video-on-Demand Content License Agreement between Rogers Cable Communications Inc. and EuroMedia Holdings Corp.; What licenses are granted under this contract?",
        "response":"Under the Video-on-Demand Content License Agreement, Licensor grants Rogers a **non-exclusive license and right to distribute and exhibit** all entertainment programming for which Licensor owns or controls the VOD distribution and exhibition rights in Canada. This includes the right to distribute the **Licensed Programs** to residential subscribers of Rogers' digital cable television service on a Video-on-Demand (VOD) basis.\n\nAdditionally, the agreement specifies that the **Licensed Rights** encompass various distribution methods, including but not limited to:\n- Simultaneous Internet Streaming\n- OTT Television\n- Internet Protocol Television\n- Radio, short wave, microwave, fiber optic\n- Alternative, secondary and specialty distribution\n- Stored as VOD, Content Distribution Networks\/Company Servers\n- Full Television Broadcast Rights\n\nThese terms indicate a broad range of distribution rights granted to Rogers for the Licensed Programs.",
        "retrieved_contexts":[
            "Exhibit 10.B.01 EXECUTION COPY\n\nVIDEO-ON-DEMAND CONTENT LICENSE AGREEMENT between Rogers Cable Communications Inc. (\"Rogers\") and EuroMedia Holdings Corp. (\"Licensor\") offering EurocinemaSM Video-on-Demand service made as of July 11 , 2006 (the \"Effective Date\") (the \"Agreement\")",
            "1. RIGHTS GRANTED   Licensor grants to Rogers the non-exclusive license and right to distribute and exhibit in Canada (the \"Territory\") all entertainment programming to which Licensor owns or controls the VOD distribution and exhibition rights in the Territory (collectively, \"Licensed Programs\") to residential subscribers of Rogers' digital cable television service on a Video-on-Demand (\"VOD\") basis",
            "CONTENT DISTRIBUTION AND LICENSE AGREEMENT   Deal Terms   Licensed Program\/ Film or Video Inevitable \"Licensed Rights\" to ConvergTV and ConvergTV Channels and\/or Distribution Outlets x All, including but not limited to: xSimultaneous Internet Streaming x OTT Television x Internet Protocol Television x Radio, short wave, microwave, fiber optic x Alternative, secondary and specialty distribution x Stored as VOD, Content Distribution Networks\/Company Servers x Full Television Broadcast Rights"
        ]
    },
    {
        "user_input":"Consider the Video-on-Demand Content License Agreement between Rogers Cable Communications Inc. and EuroMedia Holdings Corp.; Does this contract include an unlimited or all-you-can-eat license?",
        "response":"The clause does not explicitly state that the contract includes an unlimited or all-you-can-eat license. However, it does mention that there are \"Licensed Rights\" to various distribution methods, including \"Simultaneous Internet Streaming,\" \"OTT Television,\" and \"Stored as VOD,\" which may imply broad access to the content.\n\nAdditionally, the clause states that \"there shall be no minimum License Fee or retail viewing fee with respect to any Licensed Program,\" which could suggest flexibility in accessing the content without a set fee structure. \n\nHowever, without specific language indicating an unlimited or all-you-can-eat license, it cannot be definitively concluded that such a license is included. The terms primarily focus on the rights to distribute and recover costs rather than guaranteeing unlimited access.",
        "retrieved_contexts":[
            "Exhibit 10.B.01 EXECUTION COPY\n\nVIDEO-ON-DEMAND CONTENT LICENSE AGREEMENT between Rogers Cable Communications Inc. (\"Rogers\") and EuroMedia Holdings Corp. (\"Licensor\") offering EurocinemaSM Video-on-Demand service made as of July 11 , 2006 (the \"Effective Date\") (the \"Agreement\")",
            "CONTENT DISTRIBUTION AND LICENSE AGREEMENT   Deal Terms   Licensed Program\/ Film or Video Inevitable \"Licensed Rights\" to ConvergTV and ConvergTV Channels and\/or Distribution Outlets x All, including but not limited to: xSimultaneous Internet Streaming x OTT Television x Internet Protocol Television x Radio, short wave, microwave, fiber optic x Alternative, secondary and specialty distribution x Stored as VOD, Content Distribution Networks\/Company Servers x Full Television Broadcast Rights",
            ".     (d) In the event that Retail Revenues in a particular month are not sufficient to fully reimburse Rogers for the Rogers Costs incurred in such month, Rogers shall be entitled to recover such amounts against Retail Revenues generated by other Licensed Programs in subsequent months.     (e) There shall be no minimum License Fee or retail viewing fee with respect to any Licensed Program"
        ]
    },
    {
        "user_input":"Consider the Video-on-Demand Content License Agreement between Rogers Cable Communications Inc. and EuroMedia Holdings Corp.; What are the audit rights under this contract?",
        "response":"The clause states that \"Each Party shall cause any Subsidiary or other Affiliate... to grant to the other Party the audit rights granted hereunder with respect to such other Party.\" This indicates that both parties, Rogers and EuroMedia, are required to ensure that their subsidiaries or affiliates provide the other party with the audit rights specified in the agreement.\n\nHowever, the specific details of the audit rights themselves are not provided in the retrieved chunk. Therefore, while it is clear that audit rights exist and are to be extended to subsidiaries and affiliates, the exact nature, scope, or conditions of those audit rights are not detailed in this excerpt.",
        "retrieved_contexts":[
            "Exhibit 10.B.01 EXECUTION COPY\n\nVIDEO-ON-DEMAND CONTENT LICENSE AGREEMENT between Rogers Cable Communications Inc. (\"Rogers\") and EuroMedia Holdings Corp. (\"Licensor\") offering EurocinemaSM Video-on-Demand service made as of July 11 , 2006 (the \"Effective Date\") (the \"Agreement\")",
            "Each Party shall cause any Subsidiary or other Affiliate (including, without limitation, a Subsidiary or other Affiliate of the Online Group or Skype Group, as applicable) to grant to the other Party the audit rights granted hereunder with respect to such other Party.",
            ";     (iii) it has obtained, and shall maintain throughout the Term, all approvals and\/or ratings from provincial authorities necessary to distribute and exhibit each Licensed Program, trailer and other promotional materials provided to Rogers hereunder;     (iv) it unilaterally owns or controls the VOD distribution and exhibition rights to all Licensed Programs within the Territory"
        ]
    },
    {
        "user_input":"Consider the Video-on-Demand Content License Agreement between Rogers Cable Communications Inc. and EuroMedia Holdings Corp.; Is there uncapped liability under this contract?",
        "response":"The clause does not explicitly state that there is uncapped liability under the Video-on-Demand Content License Agreement. However, it does outline specific circumstances under which Rogers shall indemnify Licensor and its affiliates. \n\nRogers is responsible for indemnifying Licensor against claims arising from: \n1. Any breach by Rogers of a material term of the Agreement.\n2. Any claim by a Rogers customer, except those related to the content of Licensed Programs or promotional materials provided by Licensor.\n3. Failure to obtain necessary approvals and\/or ratings from provincial authorities for distributing and exhibiting Licensed Programs.\n4. Ownership or control of VOD distribution and exhibition rights to all Licensed Programs within the Territory.\n\nWhile the clause indicates that Rogers has significant indemnification responsibilities, it does not specify a cap on liability. Therefore, it can be interpreted that there may be potential for uncapped liability depending on the nature and extent of claims arising under these conditions.",
        "retrieved_contexts":[
            "Exhibit 10.B.01 EXECUTION COPY\n\nVIDEO-ON-DEMAND CONTENT LICENSE AGREEMENT between Rogers Cable Communications Inc. (\"Rogers\") and EuroMedia Holdings Corp. (\"Licensor\") offering EurocinemaSM Video-on-Demand service made as of July 11 , 2006 (the \"Effective Date\") (the \"Agreement\")",
            "(b) Rogers shall indemnify Licensor and its affiliates from and against any and all claims, damages, liabilities, costs and expenses (including, without limitation, reasonable legal fees) arising out of or caused by:     (i) any breach by Rogers of any material term of this Agreement; and     (ii) any claim by a Rogers customer, except a claim related to the content of any Licensed Program, trailer and\/or other promotional materials provided by Licensor to Rogers hereunder",
            ";     (iii) it has obtained, and shall maintain throughout the Term, all approvals and\/or ratings from provincial authorities necessary to distribute and exhibit each Licensed Program, trailer and other promotional materials provided to Rogers hereunder;     (iv) it unilaterally owns or controls the VOD distribution and exhibition rights to all Licensed Programs within the Territory"
        ]
    },
    {
        "user_input":"Consider the Video-on-Demand Content License Agreement between Rogers Cable Communications Inc. and EuroMedia Holdings Corp.; Is there a cap on liability under this contract?",
        "response":"The retrieved chunk does not explicitly mention a cap on liability under the Video-on-Demand Content License Agreement. The indemnification clause states that \"Rogers shall indemnify Licensor and its affiliates from and against any and all claims, damages, liabilities, costs and expenses,\" which implies a broad scope of liability without specifying any limits or caps. Therefore, based on the provided information, there is no indication of a cap on liability in this contract.",
        "retrieved_contexts":[
            "Exhibit 10.B.01 EXECUTION COPY\n\nVIDEO-ON-DEMAND CONTENT LICENSE AGREEMENT between Rogers Cable Communications Inc. (\"Rogers\") and EuroMedia Holdings Corp. (\"Licensor\") offering EurocinemaSM Video-on-Demand service made as of July 11 , 2006 (the \"Effective Date\") (the \"Agreement\")",
            "(b) Rogers shall indemnify Licensor and its affiliates from and against any and all claims, damages, liabilities, costs and expenses (including, without limitation, reasonable legal fees) arising out of or caused by:     (i) any breach by Rogers of any material term of this Agreement; and     (ii) any claim by a Rogers customer, except a claim related to the content of any Licensed Program, trailer and\/or other promotional materials provided by Licensor to Rogers hereunder",
            ".     (d) In the event that Retail Revenues in a particular month are not sufficient to fully reimburse Rogers for the Rogers Costs incurred in such month, Rogers shall be entitled to recover such amounts against Retail Revenues generated by other Licensed Programs in subsequent months.     (e) There shall be no minimum License Fee or retail viewing fee with respect to any Licensed Program"
        ]
    },
    {
        "user_input":"Consider the Content Distribution and License Agreement between ConvergTV, Inc. and Fulucai Productions Ltd.; What is the renewal term for this contract?",
        "response":"The clause does not specify a renewal term for the Content Distribution and License Agreement between ConvergTV, Inc. and Fulucai Productions Ltd. It states that the License Term is \"Perpetual, unlimited runs\" and also mentions \"Other: 2 years,\" but it does not provide any details regarding a renewal process or terms. Therefore, based on the provided information, there is no defined renewal term for this contract.",
        "retrieved_contexts":[
            ": x Free: Terrestrial, Cable, Satellite x Pay: Terrestrial, Cable, Satellite x Direct Satellite IP Distribution Systems Licensed Territory x Worldwide \u00a8 Other: _______________________________________________ License Term Perpetual, unlimited runs x Other: 2 years Commencing: November 15, 2012 Run Dates Within ConvergTV determined parameters",
            ". The Producer shall have thirty (30) days from the payment date to dispute the amount of any revenue share payout or any such claim or dispute is hereby waived by the Producer.   4. Program Exclusivity For The License Term Within The Licensed Territory",
            "This CONTENT DISTRIBUTION AND LICENSE AGREEMENT (the \"Agreement\") is entered into as of November 15, 2012 (the \"Effective Date\") by and between, CONVERGTV, INC., a Delaware Corporation, (\"ConvergTV\"), whose principal place of business is located at 3201 Budinger Ave., St. Cloud, FL 34769, P.O. Box 540817, Merritt Island, Florida 32954, and Fulucai Productions Ltd"
        ]
    },
    {
        "user_input":"Consider the Content Distribution and License Agreement between ConvergTV, Inc. and Fulucai Productions Ltd.; What is the governing law for this contract?",
        "response":"The provided clause does not specify the governing law for the Content Distribution and License Agreement between ConvergTV, Inc. and Fulucai Productions Ltd. Therefore, based on the information available in the clause, I cannot provide an answer regarding the governing law for this contract.",
        "retrieved_contexts":[
            ". Subject to the restrictions against assignment as herein contained, this Agreement shall be binding upon and inure to the benefit of the Parties, their predecessors, assigns, successors in interest, personal representatives, their past and present attorneys, principals, employees, independent contractors, officers, directors, shareholders, parents, issue, subsidiaries, agents, servants, estates, heirs, administrators, executors, conservators, trustees, legatees",
            "18. Audit. Each of the Parties may, at its own expense, audit the other Party's compliance with this Agreement, including but not limited to, auditing the other Party's representations and warranties.   19. Counterparts. This Agreement may be executed in any number of counterparts, each of which shall be deemed an original and all of which together shall be deemed to be one and the same instrument",
            ". There are no representations, agreements, arrangements, or understandings, oral or written, between and among the Parties hereto, relating to the subject matter contained in this Agreement that are not fully expressed herein.   14.. Notices"
        ]
    },
    {
        "user_input":"Consider the Content Distribution and License Agreement between ConvergTV, Inc. and Fulucai Productions Ltd.; Does this contract include an exclusivity agreement?",
        "response":"The provided clause does not explicitly mention an exclusivity agreement between ConvergTV, Inc. and Fulucai Productions Ltd. Instead, it states that \"There are no representations, agreements, arrangements, or understandings, oral or written, between and among the Parties hereto, relating to the subject matter contained in this Agreement that are not fully expressed herein.\" This indicates that any agreements, including exclusivity, would need to be explicitly stated in the contract itself.\n\nAdditionally, the clause labeled \"Entire Agreement\" confirms that this Agreement contains the entire agreement of the Parties and supersedes any prior agreements. Therefore, if there is no mention of exclusivity in the Agreement, it can be concluded that there is no exclusivity agreement included.",
        "retrieved_contexts":[
            ". There are no representations, agreements, arrangements, or understandings, oral or written, between and among the Parties hereto, relating to the subject matter contained in this Agreement that are not fully expressed herein.   14.. Notices",
            ": (i) any information contained in this Agreement",
            "13. Entire Agreement . This Agreement, which includes the Deal Terms and any and all exhibits, schedules or attachments to this Agreement, contains the entire agreement of the Parties, and supersedes any prior written or oral agreements between them concerning the subject matter contained herein"
        ]
    },
    {
        "user_input":"Consider the Content Distribution and License Agreement between ConvergTV, Inc. and Fulucai Productions Ltd.; Does this contract include any revenue or profit-sharing arrangements?",
        "response":"The retrieved chunk does not explicitly mention any revenue or profit-sharing arrangements. However, it does indicate that the Producer has the right to dispute the amount of any revenue share payout within thirty (30) days from the payment date. This suggests that there is a mechanism for revenue sharing, but the specific terms of such arrangements are not detailed in the provided text. \n\nKey phrases include \"dispute the amount of any revenue share payout,\" which implies that revenue sharing exists, but the clause does not provide further details on how it is structured or calculated.",
        "retrieved_contexts":[
            ": (i) any information contained in this Agreement",
            ";    (d) there are no agreements, contracts, commitments or licenses, nor shall Producer enter into any agreements, contracts, commitments or grant any licenses, which would prevent the fulfillment of this Agreement or impair or conflict with the rights granted hereunder",
            ". The Producer shall have thirty (30) days from the payment date to dispute the amount of any revenue share payout or any such claim or dispute is hereby waived by the Producer.   4. Program Exclusivity For The License Term Within The Licensed Territory"
        ]
    },
    {
        "user_input":"Consider the Content Distribution and License Agreement between ConvergTV, Inc. and Fulucai Productions Ltd.; Does the licensee's affiliates have any licensing rights under this contract?",
        "response":"Yes, the licensee's affiliates do have licensing rights under this contract. The clause states that the Producer grants ConvergTV the right to distribute the Program on \"any ConvergTV channel, and\/or other distribution outlets,\" which includes \"any channels of a ConvergTV affiliate.\" This indicates that the affiliates of ConvergTV are included in the distribution rights granted under the agreement.",
        "retrieved_contexts":[
            ". The Producer shall have thirty (30) days from the payment date to dispute the amount of any revenue share payout or any such claim or dispute is hereby waived by the Producer.   4. Program Exclusivity For The License Term Within The Licensed Territory",
            ".    (b) Producer further grants to ConvergTV the right and license to Distribute the Program on any ConvergTV channel, and\/or other distribution outlets, that exists today or that is created or developed in the future and this right includes the right to Distribute on any channels of a ConvergTV affiliate and\/or other distribution outlets without limitation",
            ". During the License Term (which is identified in the Deal Terms), Producer agrees that ConvergTV has the exclusive right to exercise the rights granted to it under this Agreement with respect to the Program, including those in Section 1, within the Licensed Territory."
        ]
    },
    {
        "user_input":"Consider the Content Distribution and License Agreement between ConvergTV, Inc. and Fulucai Productions Ltd.; What are the audit rights under this contract?",
        "response":"Under the Content Distribution and License Agreement, each Party has the right to audit the other Party's compliance with the Agreement. This includes the ability to audit the other Party's representations and warranties. Importantly, the audits are to be conducted at the auditing Party's own expense. \n\nThis means that if ConvergTV, Inc. or Fulucai Productions Ltd. wishes to verify compliance with the terms of the Agreement, they can do so, but they will need to bear the costs associated with the audit.",
        "retrieved_contexts":[
            "18. Audit. Each of the Parties may, at its own expense, audit the other Party's compliance with this Agreement, including but not limited to, auditing the other Party's representations and warranties.   19. Counterparts. This Agreement may be executed in any number of counterparts, each of which shall be deemed an original and all of which together shall be deemed to be one and the same instrument",
            ": (i) any information contained in this Agreement",
            ". Subject to the restrictions against assignment as herein contained, this Agreement shall be binding upon and inure to the benefit of the Parties, their predecessors, assigns, successors in interest, personal representatives, their past and present attorneys, principals, employees, independent contractors, officers, directors, shareholders, parents, issue, subsidiaries, agents, servants, estates, heirs, administrators, executors, conservators, trustees, legatees"
        ]
    },
    {
        "user_input":"Consider the Content License Agreement between PSiTech Corporation and Empirical Ventures, Inc.; What is the expiration date of this contract?",
        "response":"The retrieved chunk does not specify an expiration date for the Content License Agreement between PSiTech Corporation and Empirical Ventures, Inc. It only mentions the \"Effective Date\" as February 10, 2014. Therefore, without additional information from the clause, I cannot provide an expiration date for the contract.",
        "retrieved_contexts":[
            "PSiTECHCORPORATION   WEBSITE CONTENT LICENSE AGREEMENT     This Content License Agreement (\"Agreement\"), dated as of Feb 10, 2014 (the \"Effective Date\"), is by and between PSiTech Corporation, a BVI Corporation, with offices located at 303, 3rdFl, St. Georges Bldg, 2 Ice House St, Central, Hong Kong(\"Licensor\"), and Empirical Ventures, Inc., a Nevada corporation with offices located at 100, 40 Lake Bellevue Dr, Bellevue, WA(\"Licensee\")",
            "This CONTENT DISTRIBUTION AND LICENSE AGREEMENT (the \"Agreement\") is entered into as of November 15, 2012 (the \"Effective Date\") by and between, CONVERGTV, INC., a Delaware Corporation, (\"ConvergTV\"), whose principal place of business is located at 3201 Budinger Ave., St. Cloud, FL 34769, P.O. Box 540817, Merritt Island, Florida 32954, and Fulucai Productions Ltd",
            ".   6.3 Effect of Expiration or Termination. Upon any expiration or termination of this Agreement:   (a) All licenses granted under this Agreement shall also terminate, and Licensee shall immediately delete from its systems and servers all Licensed Content, Licensor's Marks and any other materials provided by Licensor. Upon Licensor's written request, Licensee shall promptly provide Licensor with written certification of such deletion"
        ]
    },
    {
        "user_input":"Consider the Content License Agreement between PSiTech Corporation and Empirical Ventures, Inc.; What is the renewal term for this contract?",
        "response":"The renewal term for the Content License Agreement between PSiTech Corporation and Empirical Ventures, Inc. is one (1) additional three (3) year period. This is stated in the clause: \"this Agreement shall renew automatically for one (1) additional three (3) year period.\" However, it is important to note that either party must provide written notice of non-renewal at least ninety (90) days before the expiration of the Initial Term to avoid automatic renewal.",
        "retrieved_contexts":[
            "PSiTECHCORPORATION   WEBSITE CONTENT LICENSE AGREEMENT     This Content License Agreement (\"Agreement\"), dated as of Feb 10, 2014 (the \"Effective Date\"), is by and between PSiTech Corporation, a BVI Corporation, with offices located at 303, 3rdFl, St. Georges Bldg, 2 Ice House St, Central, Hong Kong(\"Licensor\"), and Empirical Ventures, Inc., a Nevada corporation with offices located at 100, 40 Lake Bellevue Dr, Bellevue, WA(\"Licensee\")",
            ". Thereafter, this Agreement shall renew automatically for one (1) additional three (3) year period (the \"Renewal Term\" and collectively, together with the Initial Term, the \"Term\") unless either party provides the other with written notice of non-renewal at least ninety (90) days before the expiration of the Initial Term].   6.2 Termination",
            ": (i) in perpetuity with respect to Titles for which the licenses granted in Section 2(a) [License Grant] are perpetual; and (ii) for the duration of the applicable license term specified in Schedule A with respect to Titles for which the license term specified in Schedule A extends beyond the expiration or termination of this Agreement"
        ]
    },
    {
        "user_input":"Consider the Content License Agreement between PSiTech Corporation and Empirical Ventures, Inc.; What is the notice period required to terminate the renewal?",
        "response":"The clause does not specify a notice period required to terminate the renewal of the Content License Agreement. It only outlines the conditions under which either party may terminate the Agreement due to a material breach, including the requirement for written notice and specific cure periods. Therefore, based on the provided clause, there is no information regarding a notice period for terminating the renewal of the Agreement.",
        "retrieved_contexts":[
            "PSiTECHCORPORATION   WEBSITE CONTENT LICENSE AGREEMENT     This Content License Agreement (\"Agreement\"), dated as of Feb 10, 2014 (the \"Effective Date\"), is by and between PSiTech Corporation, a BVI Corporation, with offices located at 303, 3rdFl, St. Georges Bldg, 2 Ice House St, Central, Hong Kong(\"Licensor\"), and Empirical Ventures, Inc., a Nevada corporation with offices located at 100, 40 Lake Bellevue Dr, Bellevue, WA(\"Licensee\")",
            ".   (a) Either party may terminate this Agreement, effective upon written notice to the other party, if the other partymaterially breaches this Agreement, and such breach is incapable of cure or, if capable of cure, (i) fails to commence a plan of action approved by Licensor to cure such breach within thirty (30) days, or (ii) fails to cure such breach within ninety (90) days after receiving written notice thereof, in either case after receiving notice of the breach",
            ". Provided, however, that if the breach giving rise to the termination right under this Section 6.2is non-payment of License Fees or Royalties, the cure period shall be ten (10) days"
        ]
    },
    {
        "user_input":"Consider the Content License Agreement between PSiTech Corporation and Empirical Ventures, Inc.; What is the governing law for this contract?",
        "response":"The provided clause does not specify the governing law for the Content License Agreement between PSiTech Corporation and Empirical Ventures, Inc. Therefore, based on the information in the clause, I cannot provide an answer regarding the governing law for this contract.",
        "retrieved_contexts":[
            "PSiTECHCORPORATION   WEBSITE CONTENT LICENSE AGREEMENT     This Content License Agreement (\"Agreement\"), dated as of Feb 10, 2014 (the \"Effective Date\"), is by and between PSiTech Corporation, a BVI Corporation, with offices located at 303, 3rdFl, St. Georges Bldg, 2 Ice House St, Central, Hong Kong(\"Licensor\"), and Empirical Ventures, Inc., a Nevada corporation with offices located at 100, 40 Lake Bellevue Dr, Bellevue, WA(\"Licensee\")",
            "CONTENT LICENSE AGREEMENT",
            "4.2.3.2. If any intellectual property rights that are subject to legal protection are created or developed jointly by the Parties as a result of the collaboration under this Agreement, such intellectual property rights shall be owned as follows:"
        ]
    },
    {
        "user_input":"Consider the Content License Agreement between PSiTech Corporation and Empirical Ventures, Inc.; Does this contract include an exclusivity agreement?",
        "response":"The Content License Agreement does not include an exclusivity agreement. According to the clause, it explicitly states that \"Nothing in this Agreement limits or restricts Licensee from entering into any similar agreements with any third party.\" This indicates that the Licensee is free to engage in similar licensing agreements with others, confirming the non-exclusive nature of the agreement.",
        "retrieved_contexts":[
            "PSiTECHCORPORATION   WEBSITE CONTENT LICENSE AGREEMENT     This Content License Agreement (\"Agreement\"), dated as of Feb 10, 2014 (the \"Effective Date\"), is by and between PSiTech Corporation, a BVI Corporation, with offices located at 303, 3rdFl, St. Georges Bldg, 2 Ice House St, Central, Hong Kong(\"Licensor\"), and Empirical Ventures, Inc., a Nevada corporation with offices located at 100, 40 Lake Bellevue Dr, Bellevue, WA(\"Licensee\")",
            "13\n\nSource: IDEANOMICS, INC., 10-K, 3\/30\/2016\n\n\n\n\n\n(c) Non-Exclusivity. Nothing in this Agreement limits or restricts Licensee from entering into any similar agreements with any third party.",
            ", exclusive or non-exclusive) licenses granted in connection with distribution agreements entered into in the Ordinary Course of Business and non-exclusive licenses granted or received in the Ordinary Course of Business consistent with past practice), or (B) is restricted in its rights, or permits other Persons, to use or register any material Intellectual Property Rights or Key Marks, including any license agreements, coexistence agreements"
        ]
    },
    {
        "user_input":"Consider the Content License Agreement between PSiTech Corporation and Empirical Ventures, Inc.; What happens in the event of a change of control of one of the parties in this contract?",
        "response":"In the event of a change of control of one of the parties in the Content License Agreement, specifically a merger, consolidation, or reorganization involving the Licensee, it is deemed a transfer of rights, obligations, or performance under the Agreement. This situation requires the Licensor's prior written consent. Additionally, it is important to note that \"no delegation or other transfer will relieve Licensee of any of its obligations or performance under this Agreement.\" This means that even if consent is obtained, the Licensee remains responsible for fulfilling its obligations under the Agreement.",
        "retrieved_contexts":[
            "PSiTECHCORPORATION   WEBSITE CONTENT LICENSE AGREEMENT     This Content License Agreement (\"Agreement\"), dated as of Feb 10, 2014 (the \"Effective Date\"), is by and between PSiTech Corporation, a BVI Corporation, with offices located at 303, 3rdFl, St. Georges Bldg, 2 Ice House St, Central, Hong Kong(\"Licensor\"), and Empirical Ventures, Inc., a Nevada corporation with offices located at 100, 40 Lake Bellevue Dr, Bellevue, WA(\"Licensee\")",
            "CONTENT LICENSE AGREEMENT",
            ". For purposes of the preceding sentence, and without limiting its generality, any merger, consolidation or reorganization involving Licensee (regardless of whether Licensee is a surviving or disappearing entity) will be deemed to be a transfer of rights, obligations or performance under this Agreement for which Licensor's prior written consent is required. No delegation or other transfer will relieve Licensee of any of its obligations or performance under this Agreement"
        ]
    },
    {
        "user_input":"Consider the Content License Agreement between PSiTech Corporation and Empirical Ventures, Inc.; Is there an anti-assignment clause in this contract?",
        "response":"Yes, there is an anti-assignment clause in the contract. Specifically, the clause states that \"Neither this Agreement nor any of the rights, interests or obligations under this Agreement may be assigned by any of the parties... without the prior written consent of the other parties.\" This means that any assignment or delegation of rights or obligations under the Agreement requires consent from the other parties involved. Additionally, any assignment made without such consent is deemed \"null and void.\" \n\nThis clause clearly establishes restrictions on assignment, indicating that both parties must agree in writing before any transfer can occur.",
        "retrieved_contexts":[
            ". Any purported assignment, delegation or transfer in violation of this Section 11.7 is void from the outset and shall be of no force or effect. Licensor may freely assign or otherwise transfer all or any of its rights, or delegate or otherwise transfer all or any of its obligations or performance, under this Agreement without Licensee's consent. This Agreement is binding upon and inures to the benefit of the parties hereto and their respective permitted successors and assigns.",
            ".9 No Assignment. Neither this Agreement nor any of the rights, interests or obligations under this Agreement may be assigned by any of the parties (whether by operation of Law or otherwise) without the prior written consent of the other parties. Subject to the preceding sentence, this Agreement will be binding upon, inure to the benefit of and be enforceable by the parties and their respective successors and assigns",
            "10.5    Assignment. Neither this Agreement nor any of the rights, interests or obligations under this Agreement may be assigned or delegated, in whole or in part, by operation of law or otherwise by any of the parties hereto without the prior written consent of the other parties, and any such assignment without such prior written consent shall be null and void"
        ]
    },
    {
        "user_input":"Consider the Content License Agreement between PSiTech Corporation and Empirical Ventures, Inc.; Does this contract include any revenue or profit-sharing arrangements?",
        "response":"The Content License Agreement does not include any revenue or profit-sharing arrangements. The clause explicitly states that \"No royalty or fees of any kind shall be owed by Licensee under this Agreement.\" Instead, the consideration for the licenses granted is the issuance of IP Common Shares, as defined in a separate agreement. Therefore, there are no provisions for revenue or profit-sharing in this contract.",
        "retrieved_contexts":[
            "PSiTECHCORPORATION   WEBSITE CONTENT LICENSE AGREEMENT     This Content License Agreement (\"Agreement\"), dated as of Feb 10, 2014 (the \"Effective Date\"), is by and between PSiTech Corporation, a BVI Corporation, with offices located at 303, 3rdFl, St. Georges Bldg, 2 Ice House St, Central, Hong Kong(\"Licensor\"), and Empirical Ventures, Inc., a Nevada corporation with offices located at 100, 40 Lake Bellevue Dr, Bellevue, WA(\"Licensee\")",
            "No royalty or fees of any kind shall be owed by Licensee under this Agreement. The consideration for the licenses granted by Licensor to Licensee under this Agreement is the issuance of the IP Common Shares as defined in the Amended and Securities Purchase Agreement, dated as of December 21, 2015, by and among the Licensee and the Licensor (the \"Share Consideration\").\n\n11. Use of Licensor Marks.",
            "CONTENT LICENSE AGREEMENT"
        ]
    },
    {
        "user_input":"Consider the Content License Agreement between PSiTech Corporation and Empirical Ventures, Inc.; What licenses are granted under this contract?",
        "response":"The retrieved chunk does not explicitly detail the specific licenses granted under the Content License Agreement between PSiTech Corporation and Empirical Ventures, Inc. It mentions that the agreement is a license agreement but does not specify the nature or scope of the licenses granted. \n\nAdditionally, it references a condition regarding third-party licenses for Intellectual Property or Intellectual Property Rights that require annual payments exceeding $2,000,000, but it does not clarify what specific licenses are included or the rights conferred to the Licensee. \n\nTherefore, based on the provided information, I cannot provide a direct answer regarding the specific licenses granted under this contract.",
        "retrieved_contexts":[
            "PSiTECHCORPORATION   WEBSITE CONTENT LICENSE AGREEMENT     This Content License Agreement (\"Agreement\"), dated as of Feb 10, 2014 (the \"Effective Date\"), is by and between PSiTech Corporation, a BVI Corporation, with offices located at 303, 3rdFl, St. Georges Bldg, 2 Ice House St, Central, Hong Kong(\"Licensor\"), and Empirical Ventures, Inc., a Nevada corporation with offices located at 100, 40 Lake Bellevue Dr, Bellevue, WA(\"Licensee\")",
            "CONTENT LICENSE AGREEMENT",
            "(vii)          is (A) a license agreement pursuant to which the Company or any Company Subsidiary is licensed by a third party to use any Intellectual Property or Intellectual Property Rights for which the Company or any Company Subsidiary is required to make annual payments in excess of $2,000,000 (other than any \u201ccommercially available off-the-shelf software package,\u201d or other software licensed pursuant to a software \u201cshrink wrap"
        ]
    },
    {
        "user_input":"Consider the Content License Agreement between PSiTech Corporation and Empirical Ventures, Inc.; Are the licenses granted under this contract non-transferable?",
        "response":"The licenses granted under this Content License Agreement are not non-transferable for the Licensor. According to the clause, \"Licensor may freely assign or otherwise transfer all or any of its rights, or delegate or otherwise transfer all or any of its obligations or performance, under this Agreement without Licensee's consent.\" \n\nHowever, it is important to note that any purported assignment, delegation, or transfer by the Licensee in violation of Section 11.7 is void from the outset. This indicates that while the Licensor has the freedom to transfer its rights, the Licensee's ability to do so is restricted. Therefore, the licenses are non-transferable for the Licensee but transferable for the Licensor.",
        "retrieved_contexts":[
            "PSiTECHCORPORATION   WEBSITE CONTENT LICENSE AGREEMENT     This Content License Agreement (\"Agreement\"), dated as of Feb 10, 2014 (the \"Effective Date\"), is by and between PSiTech Corporation, a BVI Corporation, with offices located at 303, 3rdFl, St. Georges Bldg, 2 Ice House St, Central, Hong Kong(\"Licensor\"), and Empirical Ventures, Inc., a Nevada corporation with offices located at 100, 40 Lake Bellevue Dr, Bellevue, WA(\"Licensee\")",
            ". Any purported assignment, delegation or transfer in violation of this Section 11.7 is void from the outset and shall be of no force or effect. Licensor may freely assign or otherwise transfer all or any of its rights, or delegate or otherwise transfer all or any of its obligations or performance, under this Agreement without Licensee's consent. This Agreement is binding upon and inures to the benefit of the parties hereto and their respective permitted successors and assigns.",
            ". Neither this Agreement nor the licenses granted hereunder convey any ownership right in any of the Licensed Content, Licensor's Marks or other materials provided by or on behalf of Licensor under this Agreement. Except for the express licenses granted in this Agreement, all right, title and interest in and to the Licensed Content and Licensor's Marks are and will remain with Licensor and its licensors.   4. Licensee Obligations.   4.1 Content Display"
        ]
    },
    {
        "user_input":"Consider the Content License Agreement between PSiTech Corporation and Empirical Ventures, Inc.; What are the audit rights under this contract?",
        "response":"The audit rights under the Content License Agreement between PSiTech Corporation and Empirical Ventures, Inc. are outlined in clause 18.02. According to this clause, the parties (referred to as \"AS Parties\") have the right to inspect MusclePharm's books and records, as well as all other documents and materials related to the Licensed Products. \n\nKey details include:\n\n- The inspection can occur upon providing \"at least five (5) days written notice.\"\n- The audit can be conducted \"no more than once each Contract Year of the Term.\"\n- The inspection is limited to the place or places where such records are \"normally retained by MusclePharm.\"\n\nThese conditions specify the process and limitations regarding the audit rights.",
        "retrieved_contexts":[
            "PSiTECHCORPORATION   WEBSITE CONTENT LICENSE AGREEMENT     This Content License Agreement (\"Agreement\"), dated as of Feb 10, 2014 (the \"Effective Date\"), is by and between PSiTech Corporation, a BVI Corporation, with offices located at 303, 3rdFl, St. Georges Bldg, 2 Ice House St, Central, Hong Kong(\"Licensor\"), and Empirical Ventures, Inc., a Nevada corporation with offices located at 100, 40 Lake Bellevue Dr, Bellevue, WA(\"Licensee\")",
            "18.02 Audit Rights",
            ". Audit Rights:   (a) The AS Parties shall have the right, upon at least five (5) days written notice and no more than once each Contract Year of the Term to inspect MusclePharm's books and records and all other documents and material in the possession of or under the control of MusclePharm with respect to the Licensed Products at the place or places where such records are normally retained by MusclePharm"
        ]
    },
    {
        "user_input":"Consider the Content License Agreement between PSiTech Corporation and Empirical Ventures, Inc.; Is there uncapped liability under this contract?",
        "response":"The Content License Agreement clearly states limitations on liability. According to the clause, \"NEITHER PARTY SHALL BE LIABLE UNDER OR IN CONNECTION WITH THIS AGREEMENT FOR INDIRECT, INCIDENTAL, CONSEQUENTIAL, LIQUIDATED, SPECIAL OR EXEMPLARY DAMAGES.\" This indicates that both parties are not liable for certain types of damages, which suggests a limitation on liability.\n\nFurthermore, it specifies that \"EXCEPT FOR BREACHES OF SECTION 11 OR BREACHES OF ANY LICENSE GRANT SET FORTH IN THIS AGREEMENT,\" there will be no liability for special, incidental, indirect, or consequential damages. This means that there are specific exceptions where liability may arise, but generally, liability is capped concerning these types of damages.\n\nTherefore, while there may be some limited liability under specific circumstances (like breaches of Section 11 or license grants), the contract does not provide for uncapped liability overall.",
        "retrieved_contexts":[
            "PSiTECHCORPORATION   WEBSITE CONTENT LICENSE AGREEMENT     This Content License Agreement (\"Agreement\"), dated as of Feb 10, 2014 (the \"Effective Date\"), is by and between PSiTech Corporation, a BVI Corporation, with offices located at 303, 3rdFl, St. Georges Bldg, 2 Ice House St, Central, Hong Kong(\"Licensor\"), and Empirical Ventures, Inc., a Nevada corporation with offices located at 100, 40 Lake Bellevue Dr, Bellevue, WA(\"Licensee\")",
            ". NEITHER PARTY SHALL BE LIABLE UNDER OR IN CONNECTION WITH THIS AGREEMENT FOR INDIRECT, INCIDENTAL, CONSEQUENTIAL, LIQUIDATED, SPECIAL OR EXEMPLARY DAMAGES OR PENALTIES, INCLUDING WITHOUT LIMITATION, LOSSES OF BUSINESS, REVENUE OR ANTICIPATED PROFITS, REGARDLESS OF WHETHER SUCH DAMAGE WAS FORESEEABLE AND WHETHER LICENSOR HAS BEEN ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.",
            ". EXCEPT FOR BREACHES OF SECTION 11 OR BREACHES OF ANY LICENSE GRANT SET FORTH IN THIS AGREEMENT, IN NO EVENT WILL EITHER PARTY BE LIABLE TO THE OTHER FOR ANY SPECIAL, INCIDENTAL, INDIRECT OR CONSEQUENTIAL DAMAGES, WHETHER BASED ON BREACH OF CONTRACT, TORT (INCLUDING NEGLIGENCE) OR OTHERWISE, WHETHER OR NOT THAT PARTY HAS BEEN ADVISED OF, KNEW, OR SHOULD HAVE KNOWN OF, THE POSSIBILITY OF SUCH DAMAGE AND NOTWITHSTANDING THE FAILURE OF ESSENTIAL PURPOSE OF ANY LIMITED REMEDY"
        ]
    },
    {
        "user_input":"Consider the Content License Agreement between PSiTech Corporation and Empirical Ventures, Inc.; Is there a cap on liability under this contract?",
        "response":"Yes, there is a cap on liability under the Content License Agreement between PSiTech Corporation and Empirical Ventures, Inc. According to Section 9.2 of the agreement, \"EACH PARTY'S LIABILITY ARISING OUT OF OR RELATED TO THIS AGREEMENT WILL NOT EXCEED AN AMOUNT EQUAL TO THE AGGREGATE AMOUNTS PAID OR PAYABLE TO LICENSOR IN THE TWELVE (12) MONTHS PRECEDING THE COMMENCEMENT OF THE CLAIM.\" \n\nThis means that the maximum liability for either party is limited to the total amounts paid or payable to the Licensor in the year prior to the claim. However, it's important to note that this cap does not apply to the Licensee's indemnification obligations under Section 8.2, or in cases of the Licensee's gross negligence or willful misconduct, as stated in Section 9.3.",
        "retrieved_contexts":[
            "9.2 Cap on Monetary Damages. EACH PARTY'S LIABILITY ARISING OUT OF OR RELATED TO THIS AGREEMENT WILL NOT EXCEED AN AMOUNT EQUAL TO THE AGGREGATE AMOUNTS PAID OR PAYABLE TO LICENSOR IN THE TWELVE (12) MONTHS PRECEDING THE COMMENCEMENT OF THE CLAIM.   9.3 Exceptions. The provisions of Section 9.1 and Section 9.2 will not apply to limit the Licensee's indemnification obligations under Section 8.2, or in the case of Licensee's gross negligence or wilful misconduct.   10. Confidentiality",
            "PSiTECHCORPORATION   WEBSITE CONTENT LICENSE AGREEMENT     This Content License Agreement (\"Agreement\"), dated as of Feb 10, 2014 (the \"Effective Date\"), is by and between PSiTech Corporation, a BVI Corporation, with offices located at 303, 3rdFl, St. Georges Bldg, 2 Ice House St, Central, Hong Kong(\"Licensor\"), and Empirical Ventures, Inc., a Nevada corporation with offices located at 100, 40 Lake Bellevue Dr, Bellevue, WA(\"Licensee\")",
            ". EXCEPT FOR BREACHES OF SECTION 11 OR BREACHES OF ANY LICENSE GRANT SET FORTH IN THIS AGREEMENT, IN NO EVENT WILL EITHER PARTY BE LIABLE TO THE OTHER FOR ANY SPECIAL, INCIDENTAL, INDIRECT OR CONSEQUENTIAL DAMAGES, WHETHER BASED ON BREACH OF CONTRACT, TORT (INCLUDING NEGLIGENCE) OR OTHERWISE, WHETHER OR NOT THAT PARTY HAS BEEN ADVISED OF, KNEW, OR SHOULD HAVE KNOWN OF, THE POSSIBILITY OF SUCH DAMAGE AND NOTWITHSTANDING THE FAILURE OF ESSENTIAL PURPOSE OF ANY LIMITED REMEDY"
        ]
    },
    {
        "user_input":"Consider the Content License Agreement between Beijing Sun Seven Stars Culture Development Limited and You On Demand Holdings, Inc.; What is the expiration date of this contract?",
        "response":"The retrieved chunk does not specify an expiration date for the Content License Agreement between Beijing Sun Seven Stars Culture Development Limited and You On Demand Holdings, Inc. It only provides the effective date of the agreement, which is December 21, 2015. Therefore, based on the information available, I cannot provide an expiration date for this contract.",
        "retrieved_contexts":[
            "THIS CONTENT LICENSE AGREEMENT (this \"Agreement\"), dated as of December 21, 2015 (the \"Effective Date\"), is entered into between Beijing Sun Seven Stars Culture Development Limited, a P.R.C. company with an address at Eastern Fangzheng Road, Southern Dongying Village, Hancunhe Town, Fangshan District, Beijing City, P.R.C. (\"Licensor\"), and YOU ON DEMAND HOLDINGS, INC., a Nevada corporation with an address at 375 Greenwich Street, Suite 516, New York, New York 10013 (\"Licensee\").",
            "IN WITNESS WHEREOF and intending to be legally bound hereby, the parties have executed this Content License Agreement as of the date first set forth above.\n\nLICENSOR:\n\nBEIJING SUN SEVEN STARS CULTURE DEVELOPMENT LIMITED\n\nBy: \/s\/ Bruno Wu Name: Bruno Wu Title:Chairman & CEO\n\nLICENSEE:\n\nYOU ON DEMAND HOLDINGS, INC.\n\nBy: \/s\/ Shane McMahon Name: Shane McMahon Title:Chairman\n\n[SIGNATURE PAGE TO CONTENT LICENSE AGREEMENT]\n\nSource: IDEANOMICS, INC., 10-K, 3\/30\/2016\n\n\n\n\n\nSCHEDULE A\n\nTITLES\n\n[Attached]",
            "This CONTENT DISTRIBUTION AND LICENSE AGREEMENT (the \"Agreement\") is entered into as of November 15, 2012 (the \"Effective Date\") by and between, CONVERGTV, INC., a Delaware Corporation, (\"ConvergTV\"), whose principal place of business is located at 3201 Budinger Ave., St. Cloud, FL 34769, P.O. Box 540817, Merritt Island, Florida 32954, and Fulucai Productions Ltd"
        ]
    },
    {
        "user_input":"Consider the Content License Agreement between Beijing Sun Seven Stars Culture Development Limited and You On Demand Holdings, Inc.; What is the governing law for this contract?",
        "response":"The provided chunk does not specify the governing law for the Content License Agreement between Beijing Sun Seven Stars Culture Development Limited and You On Demand Holdings, Inc. There is no mention of any jurisdiction or legal framework that governs the contract. Therefore, based on the information available in the retrieved chunk, I cannot provide an answer regarding the governing law for this contract.",
        "retrieved_contexts":[
            "THIS CONTENT LICENSE AGREEMENT (this \"Agreement\"), dated as of December 21, 2015 (the \"Effective Date\"), is entered into between Beijing Sun Seven Stars Culture Development Limited, a P.R.C. company with an address at Eastern Fangzheng Road, Southern Dongying Village, Hancunhe Town, Fangshan District, Beijing City, P.R.C. (\"Licensor\"), and YOU ON DEMAND HOLDINGS, INC., a Nevada corporation with an address at 375 Greenwich Street, Suite 516, New York, New York 10013 (\"Licensee\").",
            "CONTENT LICENSE AGREEMENT",
            "IN WITNESS WHEREOF and intending to be legally bound hereby, the parties have executed this Content License Agreement as of the date first set forth above.\n\nLICENSOR:\n\nBEIJING SUN SEVEN STARS CULTURE DEVELOPMENT LIMITED\n\nBy: \/s\/ Bruno Wu Name: Bruno Wu Title:Chairman & CEO\n\nLICENSEE:\n\nYOU ON DEMAND HOLDINGS, INC.\n\nBy: \/s\/ Shane McMahon Name: Shane McMahon Title:Chairman\n\n[SIGNATURE PAGE TO CONTENT LICENSE AGREEMENT]\n\nSource: IDEANOMICS, INC., 10-K, 3\/30\/2016\n\n\n\n\n\nSCHEDULE A\n\nTITLES\n\n[Attached]"
        ]
    },
    {
        "user_input":"Consider the Content License Agreement between Beijing Sun Seven Stars Culture Development Limited and You On Demand Holdings, Inc.; Does this contract include any right of first refusal, right of first offer, or right of first negotiation?",
        "response":"Yes, the Content License Agreement includes provisions related to rights of first refusal and rights of first negotiation. According to the clause, it states that any contract that \"grants any rights of first refusal or rights of first negotiation with respect to any product, service or Company Owned IP\" is relevant to the agreement. This indicates that such rights may be included in the contracts referenced within the agreement.",
        "retrieved_contexts":[
            ";   (iii)            each Contract that (A) grants any exclusive rights to any Third Party, including any exclusive license or supply or distribution agreement or other exclusive rights or which, pursuant to its terms, could have such effect after the Closing solely as a result of the consummation of the transactions contemplated hereby, (B) grants any rights of first refusal or rights of first negotiation with respect to any product, service or Company Owned IP",
            "THIS CONTENT LICENSE AGREEMENT (this \"Agreement\"), dated as of December 21, 2015 (the \"Effective Date\"), is entered into between Beijing Sun Seven Stars Culture Development Limited, a P.R.C. company with an address at Eastern Fangzheng Road, Southern Dongying Village, Hancunhe Town, Fangshan District, Beijing City, P.R.C. (\"Licensor\"), and YOU ON DEMAND HOLDINGS, INC., a Nevada corporation with an address at 375 Greenwich Street, Suite 516, New York, New York 10013 (\"Licensee\").",
            "CONTENT LICENSE AGREEMENT"
        ]
    },
    {
        "user_input":"Consider the Content License Agreement between Beijing Sun Seven Stars Culture Development Limited and You On Demand Holdings, Inc.; Is there an anti-assignment clause in this contract?",
        "response":"The provided chunk does not contain any information regarding an anti-assignment clause in the Content License Agreement between Beijing Sun Seven Stars Culture Development Limited and You On Demand Holdings, Inc. The text primarily includes the parties involved, their addresses, and the execution details of the agreement, but it does not specify any terms related to assignment or restrictions on assignment of rights or obligations. Therefore, based on the retrieved chunk, there is no indication of an anti-assignment clause present in this contract.",
        "retrieved_contexts":[
            "THIS CONTENT LICENSE AGREEMENT (this \"Agreement\"), dated as of December 21, 2015 (the \"Effective Date\"), is entered into between Beijing Sun Seven Stars Culture Development Limited, a P.R.C. company with an address at Eastern Fangzheng Road, Southern Dongying Village, Hancunhe Town, Fangshan District, Beijing City, P.R.C. (\"Licensor\"), and YOU ON DEMAND HOLDINGS, INC., a Nevada corporation with an address at 375 Greenwich Street, Suite 516, New York, New York 10013 (\"Licensee\").",
            "CONTENT LICENSE AGREEMENT",
            "IN WITNESS WHEREOF and intending to be legally bound hereby, the parties have executed this Content License Agreement as of the date first set forth above.\n\nLICENSOR:\n\nBEIJING SUN SEVEN STARS CULTURE DEVELOPMENT LIMITED\n\nBy: \/s\/ Bruno Wu Name: Bruno Wu Title:Chairman & CEO\n\nLICENSEE:\n\nYOU ON DEMAND HOLDINGS, INC.\n\nBy: \/s\/ Shane McMahon Name: Shane McMahon Title:Chairman\n\n[SIGNATURE PAGE TO CONTENT LICENSE AGREEMENT]\n\nSource: IDEANOMICS, INC., 10-K, 3\/30\/2016\n\n\n\n\n\nSCHEDULE A\n\nTITLES\n\n[Attached]"
        ]
    },
    {
        "user_input":"Consider the Content License Agreement between Beijing Sun Seven Stars Culture Development Limited and You On Demand Holdings, Inc.; Does this contract include any revenue or profit-sharing arrangements?",
        "response":"The provided clause does not mention any revenue or profit-sharing arrangements between Beijing Sun Seven Stars Culture Development Limited and You On Demand Holdings, Inc. The excerpt focuses on the parties involved in the Content License Agreement and their signatures, without detailing any financial terms or conditions related to revenue or profit-sharing. Therefore, based on the information available in the clause, there is no indication of such arrangements.",
        "retrieved_contexts":[
            "THIS CONTENT LICENSE AGREEMENT (this \"Agreement\"), dated as of December 21, 2015 (the \"Effective Date\"), is entered into between Beijing Sun Seven Stars Culture Development Limited, a P.R.C. company with an address at Eastern Fangzheng Road, Southern Dongying Village, Hancunhe Town, Fangshan District, Beijing City, P.R.C. (\"Licensor\"), and YOU ON DEMAND HOLDINGS, INC., a Nevada corporation with an address at 375 Greenwich Street, Suite 516, New York, New York 10013 (\"Licensee\").",
            "IN WITNESS WHEREOF and intending to be legally bound hereby, the parties have executed this Content License Agreement as of the date first set forth above.\n\nLICENSOR:\n\nBEIJING SUN SEVEN STARS CULTURE DEVELOPMENT LIMITED\n\nBy: \/s\/ Bruno Wu Name: Bruno Wu Title:Chairman & CEO\n\nLICENSEE:\n\nYOU ON DEMAND HOLDINGS, INC.\n\nBy: \/s\/ Shane McMahon Name: Shane McMahon Title:Chairman\n\n[SIGNATURE PAGE TO CONTENT LICENSE AGREEMENT]\n\nSource: IDEANOMICS, INC., 10-K, 3\/30\/2016\n\n\n\n\n\nSCHEDULE A\n\nTITLES\n\n[Attached]",
            "CONTENT LICENSE AGREEMENT"
        ]
    },
    {
        "user_input":"Consider the Content License Agreement between Beijing Sun Seven Stars Culture Development Limited and You On Demand Holdings, Inc.; What are the audit rights under this contract?",
        "response":"The provided clause does not contain any information regarding audit rights under the Content License Agreement between Beijing Sun Seven Stars Culture Development Limited and You On Demand Holdings, Inc. There are no terms, conditions, or restrictions related to audit rights mentioned in the retrieved chunk. Therefore, I cannot provide an answer regarding audit rights as they are not addressed in the text.",
        "retrieved_contexts":[
            "THIS CONTENT LICENSE AGREEMENT (this \"Agreement\"), dated as of December 21, 2015 (the \"Effective Date\"), is entered into between Beijing Sun Seven Stars Culture Development Limited, a P.R.C. company with an address at Eastern Fangzheng Road, Southern Dongying Village, Hancunhe Town, Fangshan District, Beijing City, P.R.C. (\"Licensor\"), and YOU ON DEMAND HOLDINGS, INC., a Nevada corporation with an address at 375 Greenwich Street, Suite 516, New York, New York 10013 (\"Licensee\").",
            "IN WITNESS WHEREOF and intending to be legally bound hereby, the parties have executed this Content License Agreement as of the date first set forth above.\n\nLICENSOR:\n\nBEIJING SUN SEVEN STARS CULTURE DEVELOPMENT LIMITED\n\nBy: \/s\/ Bruno Wu Name: Bruno Wu Title:Chairman & CEO\n\nLICENSEE:\n\nYOU ON DEMAND HOLDINGS, INC.\n\nBy: \/s\/ Shane McMahon Name: Shane McMahon Title:Chairman\n\n[SIGNATURE PAGE TO CONTENT LICENSE AGREEMENT]\n\nSource: IDEANOMICS, INC., 10-K, 3\/30\/2016\n\n\n\n\n\nSCHEDULE A\n\nTITLES\n\n[Attached]",
            "CONTENT LICENSE AGREEMENT"
        ]
    },
    {
        "user_input":"Consider the Content License Agreement between Beijing Sun Seven Stars Culture Development Limited and You On Demand Holdings, Inc.; Is there uncapped liability under this contract?",
        "response":"The provided clause does not explicitly address the issue of liability, including whether there is uncapped liability under the Content License Agreement. It primarily outlines the parties involved and the execution of the agreement without detailing any terms related to liability or limitations thereof. Therefore, based on the information available in the clause, I cannot determine if there is uncapped liability under this contract.",
        "retrieved_contexts":[
            "THIS CONTENT LICENSE AGREEMENT (this \"Agreement\"), dated as of December 21, 2015 (the \"Effective Date\"), is entered into between Beijing Sun Seven Stars Culture Development Limited, a P.R.C. company with an address at Eastern Fangzheng Road, Southern Dongying Village, Hancunhe Town, Fangshan District, Beijing City, P.R.C. (\"Licensor\"), and YOU ON DEMAND HOLDINGS, INC., a Nevada corporation with an address at 375 Greenwich Street, Suite 516, New York, New York 10013 (\"Licensee\").",
            "IN WITNESS WHEREOF and intending to be legally bound hereby, the parties have executed this Content License Agreement as of the date first set forth above.\n\nLICENSOR:\n\nBEIJING SUN SEVEN STARS CULTURE DEVELOPMENT LIMITED\n\nBy: \/s\/ Bruno Wu Name: Bruno Wu Title:Chairman & CEO\n\nLICENSEE:\n\nYOU ON DEMAND HOLDINGS, INC.\n\nBy: \/s\/ Shane McMahon Name: Shane McMahon Title:Chairman\n\n[SIGNATURE PAGE TO CONTENT LICENSE AGREEMENT]\n\nSource: IDEANOMICS, INC., 10-K, 3\/30\/2016\n\n\n\n\n\nSCHEDULE A\n\nTITLES\n\n[Attached]",
            "CONTENT LICENSE AGREEMENT"
        ]
    },
    {
        "user_input":"Consider the Content License Agreement between Beijing Sun Seven Stars Culture Development Limited and You On Demand Holdings, Inc.; Is there a cap on liability under this contract?",
        "response":"The provided clause does not mention any terms related to a cap on liability under the Content License Agreement between Beijing Sun Seven Stars Culture Development Limited and You On Demand Holdings, Inc. Therefore, based on the information available in the clause, there is no indication of a cap on liability specified in this contract.",
        "retrieved_contexts":[
            "THIS CONTENT LICENSE AGREEMENT (this \"Agreement\"), dated as of December 21, 2015 (the \"Effective Date\"), is entered into between Beijing Sun Seven Stars Culture Development Limited, a P.R.C. company with an address at Eastern Fangzheng Road, Southern Dongying Village, Hancunhe Town, Fangshan District, Beijing City, P.R.C. (\"Licensor\"), and YOU ON DEMAND HOLDINGS, INC., a Nevada corporation with an address at 375 Greenwich Street, Suite 516, New York, New York 10013 (\"Licensee\").",
            "CONTENT LICENSE AGREEMENT",
            "IN WITNESS WHEREOF and intending to be legally bound hereby, the parties have executed this Content License Agreement as of the date first set forth above.\n\nLICENSOR:\n\nBEIJING SUN SEVEN STARS CULTURE DEVELOPMENT LIMITED\n\nBy: \/s\/ Bruno Wu Name: Bruno Wu Title:Chairman & CEO\n\nLICENSEE:\n\nYOU ON DEMAND HOLDINGS, INC.\n\nBy: \/s\/ Shane McMahon Name: Shane McMahon Title:Chairman\n\n[SIGNATURE PAGE TO CONTENT LICENSE AGREEMENT]\n\nSource: IDEANOMICS, INC., 10-K, 3\/30\/2016\n\n\n\n\n\nSCHEDULE A\n\nTITLES\n\n[Attached]"
        ]
    },
    {
        "user_input":"Consider the Co-Branding and Services Agreement between RSL COM PrimeCall, Inc. and deltathree.com, Inc.; What is the expiration date of this contract?",
        "response":"The expiration date of the Co-Branding and Services Agreement is three (3) years from the effective date stated in the agreement. According to Section 1.01, the term \"shall continue for a term of three (3) years, unless terminated earlier in accordance with the provisions of this Agreement.\" Therefore, the contract will expire three years after its effective date unless it is terminated earlier. The specific effective date is not provided in the retrieved chunk, so you would need to refer to the beginning of the agreement to find that date.",
        "retrieved_contexts":[
            "Section 1.01. Term. The term of this Agreement shall be effective as of the date first stated above and shall continue for a term of three (3) years, unless terminated earlier in accordance with the provisions of this Agreement (the \"Term\"); provided, however, that PrimeCall may elect to terminate this Agreement, upon thirty (30) days' written notice, at any time from and after the time that collectively RSL Communications, Ltd",
            "4\n\ndate shall be no earlier than ten (10) days after the date of such notice.",
            "Section 5.01. Payment Terms. Any amounts due hereunder shall be calculated and paid in U.S. dollars on a monthly basis within twenty-five (25) business days following the receipt of the reports detailed in Sections 3.06  [Reporting] and 4.02  [Reporting] hereof or any other invoices provided for herein. All payments shall be made via wire transfer in accordance with written instructions from the parties.\n\n                                   ARTICLE VI  [Termination]"
        ]
    },
    {
        "user_input":"Consider the Co-Branding and Services Agreement between RSL COM PrimeCall, Inc. and deltathree.com, Inc.; What is the governing law for this contract?",
        "response":"The provided clause does not specify the governing law for the Co-Branding and Services Agreement between RSL COM PrimeCall, Inc. and deltathree.com, Inc. Therefore, based on the information given, I cannot provide an answer regarding the governing law for this contract.",
        "retrieved_contexts":[
            ". Each party will, at any time and from time to time after the date hereof, upon the request of the other, do, execute, acknowledge and deliver, or shall cause to be done, executed, acknowledged and delivered, all such other instruments as may be reasonably required in connection with the performance of this Agreement and each shall take all such further actions as may be reasonably required to carry out or further effect the transactions contemplated by this Agreement",
            "Section 9.05  [No Modification Except in Writing]. No Modification Except in Writing. This Agreement shall not be changed, modified, or amended except by a writing signed by the party to be charged and this Agreement may not be discharged except by performance in accordance with its terms or by a writing signed by the party to be charged.",
            "ARTICLE VII  [Limited Warranty]\n\n                                Limited Warranty"
        ]
    },
    {
        "user_input":"Consider the Co-Branding and Services Agreement between RSL COM PrimeCall, Inc. and deltathree.com, Inc.; What happens in the event of a change of control of one of the parties in this contract?",
        "response":"The provided clause does not explicitly address what happens in the event of a change of control of one of the parties in the Co-Branding and Services Agreement between RSL COM PrimeCall, Inc. and deltathree.com, Inc. \n\nHowever, Section 9.09 regarding Assignment states that \"this Agreement may not be assigned by DeltaThree without the prior written consent of PrimeCall.\" It also mentions that \"PrimeCall may assign this Agreement to any affiliate of PrimeCall or in connection with a merger or consolidation of PrimeCall or a sale of all or substantially all of PrimeCall's business.\" \n\nThis implies that while DeltaThree cannot assign the Agreement without consent, PrimeCall has more flexibility in assigning the Agreement in the event of a merger or consolidation. \n\nTo summarize, the clause does not provide a direct answer regarding a change of control, but it indicates that PrimeCall can assign the Agreement under certain conditions, while DeltaThree requires consent for any assignment.",
        "retrieved_contexts":[
            ". Each party will, at any time and from time to time after the date hereof, upon the request of the other, do, execute, acknowledge and deliver, or shall cause to be done, executed, acknowledged and delivered, all such other instruments as may be reasonably required in connection with the performance of this Agreement and each shall take all such further actions as may be reasonably required to carry out or further effect the transactions contemplated by this Agreement",
            "Section 9.05  [No Modification Except in Writing]. No Modification Except in Writing. This Agreement shall not be changed, modified, or amended except by a writing signed by the party to be charged and this Agreement may not be discharged except by performance in accordance with its terms or by a writing signed by the party to be charged.",
            "Section 9.09  [Assignment]. Assignment. This Agreement shall be binding upon and inure to the benefit of the parties hereto and their respective successors and permitted assigns. This Agreement may not be assigned by DeltaThree without the prior written consent of PrimeCall. PrimeCall may assign this Agreement to any affiliate of PrimeCall or in connection with a merger or consolidation of PrimeCall or a sale of all or substantially all of PrimeCall's business"
        ]
    },
    {
        "user_input":"Consider the Co-Branding and Services Agreement between RSL COM PrimeCall, Inc. and deltathree.com, Inc.; Is there an anti-assignment clause in this contract?",
        "response":"Yes, there is an anti-assignment clause in the contract. According to Section 9.09 [Assignment], \"This Agreement may not be assigned by DeltaThree without the prior written consent of PrimeCall.\" This means that DeltaThree cannot assign its rights or obligations under the agreement to another party unless it obtains written consent from PrimeCall. However, it is noted that PrimeCall may assign the agreement to any affiliate or in connection with a merger or consolidation, which indicates a specific exception for PrimeCall.",
        "retrieved_contexts":[
            "Section 9.04  [Independent Contractors]. Independent Contractors. At all times the parties hereto shall be considered independent contractors and this Agreement shall not create any agency, partnership or employment relationship between the parties. Except as specifically set forth herein, neither party shall have the right to act for or on behalf of or in the name of the other party.",
            "Section 9.09  [Assignment]. Assignment. This Agreement shall be binding upon and inure to the benefit of the parties hereto and their respective successors and permitted assigns. This Agreement may not be assigned by DeltaThree without the prior written consent of PrimeCall. PrimeCall may assign this Agreement to any affiliate of PrimeCall or in connection with a merger or consolidation of PrimeCall or a sale of all or substantially all of PrimeCall's business",
            "Section 9.05  [No Modification Except in Writing]. No Modification Except in Writing. This Agreement shall not be changed, modified, or amended except by a writing signed by the party to be charged and this Agreement may not be discharged except by performance in accordance with its terms or by a writing signed by the party to be charged."
        ]
    },
    {
        "user_input":"Consider the Co-Branding and Services Agreement between RSL COM PrimeCall, Inc. and deltathree.com, Inc.; What licenses are granted under this contract?",
        "response":"Under the Co-Branding and Services Agreement, a limited license is granted between the parties. Specifically, Section 2.03 states that both parties agree to grant each other a \"limited license to use each other's proprietary marks solely in connection with the sale, distribution, marketing and promotion of each party's calling cards by the other party.\" \n\nIt is important to note that both parties must exercise this license in compliance with the quality and other standards established by the party owning such marks. This means that the use of the proprietary marks is restricted to specific purposes related to calling cards and must adhere to the quality standards set by the mark owner.",
        "retrieved_contexts":[
            "Section 2.03  [Limited License]. Limited License. Throughout the Term of this Agreement, the parties hereby agree to grant to each other a limited license to use each other's proprietary marks solely in connection with the sale, distribution, marketing and promotion of each party's calling cards by the other party. Both parties hereto shall exercise such license in compliance with the quality and other standards established by the party owning such marks",
            "Section 9.09  [Assignment]. Assignment. This Agreement shall be binding upon and inure to the benefit of the parties hereto and their respective successors and permitted assigns. This Agreement may not be assigned by DeltaThree without the prior written consent of PrimeCall. PrimeCall may assign this Agreement to any affiliate of PrimeCall or in connection with a merger or consolidation of PrimeCall or a sale of all or substantially all of PrimeCall's business",
            ". Each party will, at any time and from time to time after the date hereof, upon the request of the other, do, execute, acknowledge and deliver, or shall cause to be done, executed, acknowledged and delivered, all such other instruments as may be reasonably required in connection with the performance of this Agreement and each shall take all such further actions as may be reasonably required to carry out or further effect the transactions contemplated by this Agreement"
        ]
    },
    {
        "user_input":"Consider the Co-Branding and Services Agreement between RSL COM PrimeCall, Inc. and deltathree.com, Inc.; Is there a cap on liability under this contract?",
        "response":"Yes, there is a cap on liability under the contract between RSL COM PrimeCall, Inc. and deltathree.com, Inc. According to the clause, the liability of both parties is limited to direct damages. Specifically, it states that \"THE LIABILITY OF DELTATHREE FOR DAMAGES OR ALLEGED DAMAGES HEREUNDER... IS LIMITED TO, AND WILL NOT EXCEED, PRIMECALL'S DIRECT DAMAGES\" and similarly, \"THE LIABILITY OF PRIMECALL FOR DAMAGES OR ALLEGED DAMAGES HEREUNDER... IS LIMITED TO, AND WILL NOT EXCEED, DELTATHREE'S DIRECT DAMAGES.\" \n\nThis means that neither party can claim more than the direct damages incurred, and they are not liable for any special, incidental, or consequential damages, including loss of profits, revenues, or data.",
        "retrieved_contexts":[
            "ARTICLE VII  [Limited Warranty]\n\n                                Limited Warranty",
            ". IN NO EVENT SHALL DELTATHREE BE LIABLE TO PRIMECALL FOR ANY SPECIAL, INCIDENTIAL OR CONSEQUENTIAL DAMAGES, INCLUDING, WITHOUT LIMITATION, LOSS OF PROFITS, REVENUES OR DATA WHETHER BASED ON BREACH OF CONTRACT, TORT OR OTHERWISE, WHETHER OR NOT PRIMECALL HAS BEEN ADVISED OF THE POSSIBILITY OF SUCH DAMAGE. THE LIABILITY OF DELTATHREE FOR DAMAGES OR ALLEGED DAMAGES HEREUNDER, WHETHER IN CONTRACT, TORT OR ANY OTHER LEGAL THEORY, IS LIMITED TO, AND WILL NOT EXCEED, PRIMECALL'S DIRECT DAMAGES.",
            ". IN NO EVENT SHALL PRIMECALL BE LIABLE TO DELTATHREE FOR ANY SPECIAL, INCIDENTIAL OR CONSEQUENTIAL DAMAGES, INCLUDING, WITHOUT LIMITATION, LOSS OF PROFITS, REVENUES OR DATA WHETHER BASED ON BREACH OF CONTRACT, TORT OR OTHERWISE, WHETHER OR NOT DELTATHREE HAS BEEN ADVISED OF THE POSSIBILITY OF SUCH DAMAGE. THE LIABILITY OF PRIMECALL FOR DAMAGES OR ALLEGED DAMAGES HEREUNDER, WHETHER IN CONTRACT, TORT OR ANY OTHER LEGAL THEORY, IS LIMITED TO, AND WILL NOT EXCEED, DELTATHREE'S DIRECT DAMAGES."
        ]
    },
    {
        "user_input":"Consider the Co-Branding Agreement between Women.com Networks, Inc. and eDiets.com, Inc. for the Establishment of a Diet Center; What is the renewal term for this contract?",
        "response":"The renewal term for the Co-Branding Agreement between Women.com Networks, Inc. and eDiets.com, Inc. is twelve (12) months. According to the clause, the agreement \"shall automatically renew for additional successive terms of twelve (12) months each at the end of the Initial Term,\" unless either party provides written notice at least sixty (60) days prior to the end of the Initial Term.",
        "retrieved_contexts":[
            ". This agreement shall automatically renew for additional successive terms of twelve (12) months each at the end of the Initial Term (\"Renewal Terms\"), unless either party notifies the other in writing at least sixty (60) days prior to the end of the Initial Term. As used in this agreement, \"Term\" shall mean the Initial Term and the Renewal Terms, if any.",
            "10.1 Initial Term. This Agreement will become effective as of the Effective Date and, unless sooner terminated pursuant to Sections 3.1  [Advertising and Promotion] or 10.2  [Termination for Breach], shall remain effective for two (2) years from and after the Effective Date (the \"Initial Term\")",
            "12.5 EXCEPT AS SPECIFIED IN THIS AGREEMENT, NEITHER PARTY MAKES ANY WARRANTY IN CONNECTION WITH THE SUBJECT MATTER OF THIS AGREEMENT AND HEREBY DISCLAIMS ANY AND ALL IMPLIED OR STATUTORY WARRANTIES, INCLUDING ALL IMPLIED WARRANTIES OF TITLE, MERCHANTABILITY, NONINFRINGEMENT AND FITNESS FOR A PARTICULAR USE OR PURPOSE REGARDING SUCH SUBJECT MATTER. NEITHER PARTY WARRANTS THAT ITS WEB SITE(S) OR THE CENTER WILL FUNCTION WITHOUT INTERRUPTION OR THAT THEY ARE ERROR FREE"
        ]
    },
    {
        "user_input":"Consider the Co-Branding Agreement between Women.com Networks, Inc. and eDiets.com, Inc. for the Establishment of a Diet Center; What is the notice period required to terminate the renewal?",
        "response":"The notice period required to terminate the renewal of the Co-Branding Agreement is at least sixty (60) days prior to the end of the Initial Term. This is specified in the clause stating that the agreement \"shall automatically renew for additional successive terms... unless either party notifies the other in writing at least sixty (60) days prior to the end of the Initial Term.\"",
        "retrieved_contexts":[
            ". This agreement shall automatically renew for additional successive terms of twelve (12) months each at the end of the Initial Term (\"Renewal Terms\"), unless either party notifies the other in writing at least sixty (60) days prior to the end of the Initial Term. As used in this agreement, \"Term\" shall mean the Initial Term and the Renewal Terms, if any.",
            "10.1 Initial Term. This Agreement will become effective as of the Effective Date and, unless sooner terminated pursuant to Sections 3.1  [Advertising and Promotion] or 10.2  [Termination for Breach], shall remain effective for two (2) years from and after the Effective Date (the \"Initial Term\")",
            "10.2 Termination for Breach. In the event of a material breach of this Agreement by either party, the non-breaching party may terminate this Agreement if such breach is not cured within thirty (30) days from receipt of written notice of such breach sent to the address of the breaching party as specified herein. Such termination shall be in addition to any and all other actions or remedies the parties may seek at law or equity with respect to a breach of this Agreement."
        ]
    },
    {
        "user_input":"Consider the Co-Branding Agreement between Women.com Networks, Inc. and eDiets.com, Inc. for the Establishment of a Diet Center; What is the governing law for this contract?",
        "response":"The retrieved chunk does not provide any information regarding the governing law for the Co-Branding Agreement between Women.com Networks, Inc. and eDiets.com, Inc. It focuses on representations, warranties, and assignment conditions but does not specify the governing law clause. Therefore, I cannot provide an answer to your question based on the provided text.",
        "retrieved_contexts":[
            "by such party of its obligations and duties hereunder, do not and will not violate any agreement to which such party is a party or by which it is bound, (c) when executed and delivered by such party, this Agreement will constitute the legal, valid and binding obligation of such party, enforceable against such party in accordance with its terms and (d) such party will perform its obligations hereunder in compliance with applicable law and regulations.",
            "15.      GENERAL.\n\n         15.1 Assignment. Neither party may assign this Agreement, in whole or in part, without the other party's written consent (which will not be unreasonably delayed or withheld), except that no such consent will be required in connection with an assignment or transfer of this Agreement to (a) a party's successor in connection with a Change in Control of such party, provided that such successor is not a competitor of the other party, or (b) to any entity that is",
            "12.1 General. Each party represents and warrants to the other that: (a) such party has the full corporate right, power, and authority to enter into this Agreement and perform the acts required of it hereunder, (b) the execution of this Agreement by such party, and the performance\n\n                                       10"
        ]
    },
    {
        "user_input":"Consider the Co-Branding Agreement between Women.com Networks, Inc. and eDiets.com, Inc. for the Establishment of a Diet Center; Are there any exceptions to competitive restrictions in this contract?",
        "response":"Yes, there are exceptions to the competitive restrictions in this contract. According to the clause, Women.com will not enter into a relationship with a Competitive Company involving specific activities such as custom developed mini or micro web sites, content integration, discounts for Women.com members, and editorial endorsements. However, it explicitly states that these restrictions do not apply in cases of \"breaches of Section 11 or breaches of any license grant set forth in this Agreement.\" This means that if there is a breach of those specific sections, the competitive restrictions may not be enforced.",
        "retrieved_contexts":[
            "5.       EXCLUSIVITY.",
            ".com will not enter into a relationship with a Competitive Company that involves any of the following; (i) custom developed mini or micro web sites; (ii) content integration; (iii) discounts offered only to Women.com members on the Member Central page of the Women.com Sites; (iv) editorial endorsement (such as",
            ". EXCEPT FOR BREACHES OF SECTION 11 OR BREACHES OF ANY LICENSE GRANT SET FORTH IN THIS AGREEMENT, IN NO EVENT WILL EITHER PARTY BE LIABLE TO THE OTHER FOR ANY SPECIAL, INCIDENTAL, INDIRECT OR CONSEQUENTIAL DAMAGES, WHETHER BASED ON BREACH OF CONTRACT, TORT (INCLUDING NEGLIGENCE) OR OTHERWISE, WHETHER OR NOT THAT PARTY HAS BEEN ADVISED OF, KNEW, OR SHOULD HAVE KNOWN OF, THE POSSIBILITY OF SUCH DAMAGE AND NOTWITHSTANDING THE FAILURE OF ESSENTIAL PURPOSE OF ANY LIMITED REMEDY"
        ]
    },
    {
        "user_input":"Consider the Co-Branding Agreement between Women.com Networks, Inc. and eDiets.com, Inc. for the Establishment of a Diet Center; Does this contract include any right of first refusal, right of first offer, or right of first negotiation?",
        "response":"The provided clause does not mention any right of first refusal, right of first offer, or right of first negotiation. It primarily addresses the nature of the relationship between the parties (independent contractors), the initial term of the agreement, severability of provisions, and the completeness of the agreement. Therefore, based on the information in the clause, there is no indication that such rights are included in the contract.",
        "retrieved_contexts":[
            "15.5 No Agency. The parties are independent contractors and will have no power or authority to assume or create any obligation or responsibility on behalf of each other. This Agreement will not be construed to create or imply any partnership, agency or joint venture.",
            "10.1 Initial Term. This Agreement will become effective as of the Effective Date and, unless sooner terminated pursuant to Sections 3.1  [Advertising and Promotion] or 10.2  [Termination for Breach], shall remain effective for two (2) years from and after the Effective Date (the \"Initial Term\")",
            "15.7 Severability. In the event that any of the provisions of this Agreement are held to be unenforceable, the remaining portions of the Agreement will remain in full force and effect.\n\n         15.8 Entire Agreement. This Agreement is the complete and exclusive agreement between the parties with respect to the subject matter hereof, superseding that certain Letter of\n\n                                       14"
        ]
    },
    {
        "user_input":"Consider the Co-Branding Agreement between Women.com Networks, Inc. and eDiets.com, Inc. for the Establishment of a Diet Center; What happens in the event of a change of control of one of the parties in this contract?",
        "response":"In the event of a Change in Control of one of the parties in the Co-Branding Agreement between Women.com Networks, Inc. and eDiets.com, Inc., the agreement allows for the assignment or transfer of the contract to the party's successor without requiring the other party's written consent, provided that the successor is not a competitor of the other party. This is outlined in the clause stating, \"no such consent will be required in connection with an assignment or transfer of this Agreement to (a) a party's successor in connection with a Change in Control of such party, provided that such successor is not a competitor of the other party.\"\n\nAdditionally, the agreement permits assignment to any entity that is controlled by, under common control with, or controls a party. Therefore, if there is a Change in Control, the successor can take over the agreement as long as they meet these conditions.",
        "retrieved_contexts":[
            ". For purposes of this Agreement, \"Change in Control\" means a merger or consolidation of the party with, or any sale of all or substantially all of the assets of such party to, any other person, corporation or entity, unless as a result of such merger",
            "15.      GENERAL.\n\n         15.1 Assignment. Neither party may assign this Agreement, in whole or in part, without the other party's written consent (which will not be unreasonably delayed or withheld), except that no such consent will be required in connection with an assignment or transfer of this Agreement to (a) a party's successor in connection with a Change in Control of such party, provided that such successor is not a competitor of the other party, or (b) to any entity that is",
            "controlled by, under common control with, or controls a party. For purposes hereof, the terms \"control\", \"controlled by\" or \"under common control with\" refer to the possession, directly or indirectly, of the power to direct or cause the direction of the management and policies of an entity, whether through the ownership of voting securities, by contract or otherwise. Any attempt to assign this Agreement other than as permitted above will be null and void"
        ]
    },
    {
        "user_input":"Consider the Co-Branding Agreement between Women.com Networks, Inc. and eDiets.com, Inc. for the Establishment of a Diet Center; Are there any price restrictions or controls specified in this contract?",
        "response":"The provided clause does not contain any information regarding price restrictions or controls in the Co-Branding Agreement between Women.com Networks, Inc. and eDiets.com, Inc. The sections included focus on confidentiality and warranties, specifically stating that \"neither party makes any warranty in connection with the subject matter of this Agreement\" and disclaims various implied warranties. However, there are no terms or conditions related to pricing mentioned in the retrieved chunk. Therefore, based on the information available, there are no specified price restrictions or controls in this contract.",
        "retrieved_contexts":[
            "11.8 The terms and conditions of this Agreement will be deemed to be the Confidential Information of each party and will not be disclosed without the written consent of the other party.\n\n12.      WARRANTY.",
            ", \"Indemnifiable Sums\") that the other party may incur as a result of third party claims arising from circumstances that constitute a breach or alleged breach of such party's warranties set forth in Section 12 or otherwise explicitly set forth in this Agreement",
            "12.5 EXCEPT AS SPECIFIED IN THIS AGREEMENT, NEITHER PARTY MAKES ANY WARRANTY IN CONNECTION WITH THE SUBJECT MATTER OF THIS AGREEMENT AND HEREBY DISCLAIMS ANY AND ALL IMPLIED OR STATUTORY WARRANTIES, INCLUDING ALL IMPLIED WARRANTIES OF TITLE, MERCHANTABILITY, NONINFRINGEMENT AND FITNESS FOR A PARTICULAR USE OR PURPOSE REGARDING SUCH SUBJECT MATTER. NEITHER PARTY WARRANTS THAT ITS WEB SITE(S) OR THE CENTER WILL FUNCTION WITHOUT INTERRUPTION OR THAT THEY ARE ERROR FREE"
        ]
    },
    {
        "user_input":"Consider the Co-Branding Agreement between Women.com Networks, Inc. and eDiets.com, Inc. for the Establishment of a Diet Center; Is there a minimum commitment required under this contract?",
        "response":"The provided clauses do not specify any minimum commitment required under the Co-Branding Agreement between Women.com Networks, Inc. and eDiets.com, Inc. The clauses focus on the nature of the relationship between the parties (independent contractors), the disclaiming of warranties, and the conditions regarding assignment of the agreement. However, there is no mention of any minimum commitment or obligation that either party must fulfill. Therefore, based on the retrieved chunk, it can be concluded that there is no stated minimum commitment required under this contract.",
        "retrieved_contexts":[
            "15.5 No Agency. The parties are independent contractors and will have no power or authority to assume or create any obligation or responsibility on behalf of each other. This Agreement will not be construed to create or imply any partnership, agency or joint venture.",
            "12.5 EXCEPT AS SPECIFIED IN THIS AGREEMENT, NEITHER PARTY MAKES ANY WARRANTY IN CONNECTION WITH THE SUBJECT MATTER OF THIS AGREEMENT AND HEREBY DISCLAIMS ANY AND ALL IMPLIED OR STATUTORY WARRANTIES, INCLUDING ALL IMPLIED WARRANTIES OF TITLE, MERCHANTABILITY, NONINFRINGEMENT AND FITNESS FOR A PARTICULAR USE OR PURPOSE REGARDING SUCH SUBJECT MATTER. NEITHER PARTY WARRANTS THAT ITS WEB SITE(S) OR THE CENTER WILL FUNCTION WITHOUT INTERRUPTION OR THAT THEY ARE ERROR FREE",
            "15.      GENERAL.\n\n         15.1 Assignment. Neither party may assign this Agreement, in whole or in part, without the other party's written consent (which will not be unreasonably delayed or withheld), except that no such consent will be required in connection with an assignment or transfer of this Agreement to (a) a party's successor in connection with a Change in Control of such party, provided that such successor is not a competitor of the other party, or (b) to any entity that is"
        ]
    },
    {
        "user_input":"Consider the Co-Branding Agreement between Women.com Networks, Inc. and eDiets.com, Inc. for the Establishment of a Diet Center; What licenses are granted under this contract?",
        "response":"The retrieved chunk does not provide specific information regarding the licenses granted under the Co-Branding Agreement between Women.com Networks, Inc. and eDiets.com, Inc. It mentions that \"the rights and licenses granted by each party to the other pursuant to this Agreement shall automatically terminate\" upon termination, expiration, or earlier termination of the Agreement, but it does not detail what those rights and licenses are.\n\nTo find the specific licenses granted under this contract, you would need to refer to the relevant sections of the full agreement that outline the licensing terms. The provided clause does not contain that information.",
        "retrieved_contexts":[
            ". EXCEPT FOR BREACHES OF SECTION 11 OR BREACHES OF ANY LICENSE GRANT SET FORTH IN THIS AGREEMENT, IN NO EVENT WILL EITHER PARTY BE LIABLE TO THE OTHER FOR ANY SPECIAL, INCIDENTAL, INDIRECT OR CONSEQUENTIAL DAMAGES, WHETHER BASED ON BREACH OF CONTRACT, TORT (INCLUDING NEGLIGENCE) OR OTHERWISE, WHETHER OR NOT THAT PARTY HAS BEEN ADVISED OF, KNEW, OR SHOULD HAVE KNOWN OF, THE POSSIBILITY OF SUCH DAMAGE AND NOTWITHSTANDING THE FAILURE OF ESSENTIAL PURPOSE OF ANY LIMITED REMEDY",
            "8.5 Tools. To the extent either party, directly or indirectly, utilizes any software, HTML and\/or Java scripts, proprietary tools and\/or methodologies (collectively the \"Tools\") in performing under this Agreement, such party and its licensors retain all right, title and interest in and to any such Tools.\n\n9.       TRADEMARK OWNERSHIP AND LICENSE.",
            "10.3 Effect of Termination. Upon the termination, expiration or earlier termination of this Agreement in accordance with its terms (the \"Termination Date\"):\n\n              (a) the rights and licenses granted by each party to the other pursuant to this Agreement shall automatically terminate;"
        ]
    },
    {
        "user_input":"Consider the Co-Branding Agreement between Women.com Networks, Inc. and eDiets.com, Inc. for the Establishment of a Diet Center; Are the licenses granted under this contract non-transferable?",
        "response":"The clause does not explicitly state that the licenses granted under the contract are non-transferable. However, it does include a provision regarding assignment that may imply restrictions on transferability. Specifically, it states that \"Neither party may assign this Agreement, in whole or in part, without the other party's written consent,\" indicating that any assignment or transfer of the agreement, including licenses, requires consent from the other party.\n\nAdditionally, it mentions exceptions where consent is not required, such as in the case of an assignment to a successor in connection with a Change in Control, provided that the successor is not a competitor. This suggests that while there are conditions under which licenses may be transferred, they are not automatically transferable without consent.\n\nTherefore, while the licenses are not outright non-transferable, their transferability is subject to the conditions outlined in the assignment clause.",
        "retrieved_contexts":[
            ". EXCEPT FOR BREACHES OF SECTION 11 OR BREACHES OF ANY LICENSE GRANT SET FORTH IN THIS AGREEMENT, IN NO EVENT WILL EITHER PARTY BE LIABLE TO THE OTHER FOR ANY SPECIAL, INCIDENTAL, INDIRECT OR CONSEQUENTIAL DAMAGES, WHETHER BASED ON BREACH OF CONTRACT, TORT (INCLUDING NEGLIGENCE) OR OTHERWISE, WHETHER OR NOT THAT PARTY HAS BEEN ADVISED OF, KNEW, OR SHOULD HAVE KNOWN OF, THE POSSIBILITY OF SUCH DAMAGE AND NOTWITHSTANDING THE FAILURE OF ESSENTIAL PURPOSE OF ANY LIMITED REMEDY",
            "15.      GENERAL.\n\n         15.1 Assignment. Neither party may assign this Agreement, in whole or in part, without the other party's written consent (which will not be unreasonably delayed or withheld), except that no such consent will be required in connection with an assignment or transfer of this Agreement to (a) a party's successor in connection with a Change in Control of such party, provided that such successor is not a competitor of the other party, or (b) to any entity that is",
            "10.3 Effect of Termination. Upon the termination, expiration or earlier termination of this Agreement in accordance with its terms (the \"Termination Date\"):\n\n              (a) the rights and licenses granted by each party to the other pursuant to this Agreement shall automatically terminate;"
        ]
    },
    {
        "user_input":"Consider the Co-Branding Agreement between Women.com Networks, Inc. and eDiets.com, Inc. for the Establishment of a Diet Center; Is there uncapped liability under this contract?",
        "response":"The clause provided indicates that there are limitations on liability for both parties, specifically stating that \"in no event will either party be liable to the other for any special, incidental, indirect or consequential damages.\" This limitation applies unless there are breaches of Section 11 or breaches of any license grant set forth in the agreement.\n\nHowever, it is important to note that the limitations on liability do not apply to each party's contractual obligation to indemnify the other party as outlined in Sections 2.6 and 13. This means that while there are caps on certain types of damages, there is an exception for indemnification obligations, which could potentially lead to uncapped liability in those specific circumstances.\n\nIn summary, while the contract generally limits liability, there are exceptions related to indemnification that could result in uncapped liability.",
        "retrieved_contexts":[
            "14.      LIMITATION OF LIABILITY",
            ". EXCEPT FOR BREACHES OF SECTION 11 OR BREACHES OF ANY LICENSE GRANT SET FORTH IN THIS AGREEMENT, IN NO EVENT WILL EITHER PARTY BE LIABLE TO THE OTHER FOR ANY SPECIAL, INCIDENTAL, INDIRECT OR CONSEQUENTIAL DAMAGES, WHETHER BASED ON BREACH OF CONTRACT, TORT (INCLUDING NEGLIGENCE) OR OTHERWISE, WHETHER OR NOT THAT PARTY HAS BEEN ADVISED OF, KNEW, OR SHOULD HAVE KNOWN OF, THE POSSIBILITY OF SUCH DAMAGE AND NOTWITHSTANDING THE FAILURE OF ESSENTIAL PURPOSE OF ANY LIMITED REMEDY",
            ". THE LIMITATIONS ON LIABILITY FOR DAMAGES SET FORTH IN THIS AGREEMENT SHALL BE INAPPLICABLE TO EACH PARTY'S CONTRACTUAL OBLIGATION TO INDEMNIFY THE OTHER PARTY AS SET FORTH IN SECTIONS 2.6 AND 13."
        ]
    },
    {
        "user_input":"Consider the Co-Branding Agreement between Women.com Networks, Inc. and eDiets.com, Inc. for the Establishment of a Diet Center; Is there a cap on liability under this contract?",
        "response":"The clause provided does not explicitly mention a cap on liability under the contract. However, it does outline limitations on liability for damages. Specifically, it states that \"in no event will either party be liable to the other for any special, incidental, indirect or consequential damages.\" This indicates that while there are limitations on certain types of damages, it does not set a specific monetary cap on liability.\n\nAdditionally, the clause notes that the limitations on liability do not apply to each party's contractual obligation to indemnify the other party, as referenced in Sections 2.6 and 13. Therefore, while there are restrictions on liability for certain damages, the clause does not provide a clear cap on overall liability.",
        "retrieved_contexts":[
            "14.      LIMITATION OF LIABILITY",
            ". THE LIMITATIONS ON LIABILITY FOR DAMAGES SET FORTH IN THIS AGREEMENT SHALL BE INAPPLICABLE TO EACH PARTY'S CONTRACTUAL OBLIGATION TO INDEMNIFY THE OTHER PARTY AS SET FORTH IN SECTIONS 2.6 AND 13.",
            ". EXCEPT FOR BREACHES OF SECTION 11 OR BREACHES OF ANY LICENSE GRANT SET FORTH IN THIS AGREEMENT, IN NO EVENT WILL EITHER PARTY BE LIABLE TO THE OTHER FOR ANY SPECIAL, INCIDENTAL, INDIRECT OR CONSEQUENTIAL DAMAGES, WHETHER BASED ON BREACH OF CONTRACT, TORT (INCLUDING NEGLIGENCE) OR OTHERWISE, WHETHER OR NOT THAT PARTY HAS BEEN ADVISED OF, KNEW, OR SHOULD HAVE KNOWN OF, THE POSSIBILITY OF SUCH DAMAGE AND NOTWITHSTANDING THE FAILURE OF ESSENTIAL PURPOSE OF ANY LIMITED REMEDY"
        ]
    },
    {
        "user_input":"Consider the Co-Branding Agreement between Women.com Networks, Inc. and eDiets.com, Inc. for the Establishment of a Diet Center; Is there a covenant not to sue included in this contract?",
        "response":"The retrieved chunk does not explicitly mention a covenant not to sue. It primarily discusses the rights and responsibilities related to indemnification, including the participation in defense of claims and the requirement for prior written consent before settling any indemnifiable claims. \n\nAdditionally, it states that, except for breaches of specific sections, neither party will be liable for certain types of damages. However, there is no clear indication of a covenant not to sue within the provided text. Therefore, based on the information available, there is no covenant not to sue included in this contract.",
        "retrieved_contexts":[
            ". Each party, as Indemnitee, may participate, at its own cost, in the defense of any indemnifiable claim with counsel of its own choosing. Each party agrees not to settle any indemnifiable claim without the prior written consent of the other party, which consent shall not be unreasonably withheld or delayed.",
            ". EXCEPT FOR BREACHES OF SECTION 11 OR BREACHES OF ANY LICENSE GRANT SET FORTH IN THIS AGREEMENT, IN NO EVENT WILL EITHER PARTY BE LIABLE TO THE OTHER FOR ANY SPECIAL, INCIDENTAL, INDIRECT OR CONSEQUENTIAL DAMAGES, WHETHER BASED ON BREACH OF CONTRACT, TORT (INCLUDING NEGLIGENCE) OR OTHERWISE, WHETHER OR NOT THAT PARTY HAS BEEN ADVISED OF, KNEW, OR SHOULD HAVE KNOWN OF, THE POSSIBILITY OF SUCH DAMAGE AND NOTWITHSTANDING THE FAILURE OF ESSENTIAL PURPOSE OF ANY LIMITED REMEDY",
            "13.      INDEMNIFICATION."
        ]
    },
    {
        "user_input":"Consider the Product Development and Co-Branding Agreement between Integrity Incorporated and Time Life, Inc. for 'Songs 4 Worship' Series; What is the expiration date of this contract?",
        "response":"The provided clause does not specify an expiration date for the Product Development and Co-Branding Agreement between Integrity Incorporated and Time Life, Inc. Therefore, based on the information available in the retrieved chunk, I cannot provide an answer regarding the expiration date of this contract.",
        "retrieved_contexts":[
            "3\n\n               PRODUCT DEVELOPMENT AND CO-BRANDING AGREEMENT                             \"SONGS 4 WORSHIP SERIES\"",
            "This Agreement, entered into this the 10th day of January 2000, by and between INTEGRITY INCORPORATED, a Delaware corporation with principal offices at 1000 Cody Road, Mobile, Alabama (\"Integrity\") and TIME LIFE, INC., a Delaware corporation d\/b\/a Time Life Music, with principal offices located at 2000 Duke Street, Alexandria, Virginia 22314 (\"TL\")",
            "1                                                                    EXHIBIT 10.17\n\n               PRODUCT DEVELOPMENT AND CO-BRANDING AGREEMENT\n\n                         \"SONGS 4 WORSHIP SERIES\"\n\n                      EXCLUDING CONFIDENTIAL PORTIONS\n\n\/1\/ Indicates information which has been redacted pursuant to a request for     confidential treatment.\n\n2\n\n                    INDEX TO THE CONFIDENTIAL PORTIONS"
        ]
    },
    {
        "user_input":"Consider the Product Development and Co-Branding Agreement between Integrity Incorporated and Time Life, Inc. for 'Songs 4 Worship' Series; What is the governing law for this contract?",
        "response":"The provided clause does not specify the governing law for the Product Development and Co-Branding Agreement between Integrity Incorporated and Time Life, Inc. Therefore, I cannot provide an answer regarding the governing law based on the information in the clause.",
        "retrieved_contexts":[
            "3\n\n               PRODUCT DEVELOPMENT AND CO-BRANDING AGREEMENT                             \"SONGS 4 WORSHIP SERIES\"",
            "EXHIBIT 10.4\n\n                              CO-BRANDING AGREEMENT",
            "e.       Shared expenses. The parties agree to share equally in costs                   of additional products created (excluding the Product, and                   song books, which such song books shall be created at                   Integrity's sole discretion and expense), by mutual agreement                   under the \"Songs 4 Worship\" branding.\n\n2.       Marketing and Distribution."
        ]
    },
    {
        "user_input":"Consider the Product Development and Co-Branding Agreement between Integrity Incorporated and Time Life, Inc. for 'Songs 4 Worship' Series; Is there a most favored nation clause in this contract?",
        "response":"Yes, the Product Development and Co-Branding Agreement contains a reference to a \"most favored nation\" clause. Specifically, it states that the contract cannot grant a \u201cmost favored nation\u201d or most favored customer pricing to any person, nor can it grant \u201cmost favored nation\u201d rights, except for rights and provisions that are not material to the Company and its Subsidiaries, taken as a whole. This indicates that while there is a restriction on granting such rights, there are exceptions for non-material provisions.",
        "retrieved_contexts":[
            ":   (i)                 a Contract granting a \u201cmost favored nation\u201d or most favored customer pricing to any Person, or any Contract providing for the grant of exclusive material sales, distribution, marketing or other exclusive rights, rights of first refusal, rights of first negotiation or similar rights and\/or terms to any Person, or materially limiting the right of the Company or any of its Subsidiaries to engage in any line of business or in any geographic area",
            ", (C) contains any provision that requires the purchase of all or any portion of the Company\u2019s or any of its Subsidiaries\u2019 requirements from any Third Party or (D) grants \u201cmost favored nation\u201d rights, except in the case of each of clauses (A), (B), (C) and (D) for such rights and provisions that are not material to the Company and its Subsidiaries, taken as a whole",
            "3\n\n               PRODUCT DEVELOPMENT AND CO-BRANDING AGREEMENT                             \"SONGS 4 WORSHIP SERIES\""
        ]
    },
    {
        "user_input":"Consider the Product Development and Co-Branding Agreement between Integrity Incorporated and Time Life, Inc. for 'Songs 4 Worship' Series; Does this contract include an exclusivity agreement?",
        "response":"The provided clause does not explicitly mention an exclusivity agreement between Integrity Incorporated and Time Life, Inc. for the \"Songs 4 Worship Series.\" The text primarily outlines the parties involved in the agreement and indicates that certain portions are confidential and redacted. \n\nSince there is no direct reference to exclusivity terms or conditions in the retrieved chunk, we cannot conclude that the contract includes an exclusivity agreement based solely on this information.",
        "retrieved_contexts":[
            "3\n\n               PRODUCT DEVELOPMENT AND CO-BRANDING AGREEMENT                             \"SONGS 4 WORSHIP SERIES\"",
            "1                                                                    EXHIBIT 10.17\n\n               PRODUCT DEVELOPMENT AND CO-BRANDING AGREEMENT\n\n                         \"SONGS 4 WORSHIP SERIES\"\n\n                      EXCLUDING CONFIDENTIAL PORTIONS\n\n\/1\/ Indicates information which has been redacted pursuant to a request for     confidential treatment.\n\n2\n\n                    INDEX TO THE CONFIDENTIAL PORTIONS",
            "This Agreement, entered into this the 10th day of January 2000, by and between INTEGRITY INCORPORATED, a Delaware corporation with principal offices at 1000 Cody Road, Mobile, Alabama (\"Integrity\") and TIME LIFE, INC., a Delaware corporation d\/b\/a Time Life Music, with principal offices located at 2000 Duke Street, Alexandria, Virginia 22314 (\"TL\")"
        ]
    },
    {
        "user_input":"Consider the Product Development and Co-Branding Agreement between Integrity Incorporated and Time Life, Inc. for 'Songs 4 Worship' Series; Does this contract include any revenue or profit-sharing arrangements?",
        "response":"The provided clause does not mention any revenue or profit-sharing arrangements between Integrity Incorporated and Time Life, Inc. It specifically addresses the sharing of expenses related to additional products created under the \"Songs 4 Worship\" branding, stating that \"the parties agree to share equally in costs of additional products created.\" However, it explicitly excludes the Product and song books from this sharing arrangement, noting that song books will be created at Integrity's \"sole discretion and expense.\" \n\nTherefore, based on the information in the clause, there is no indication of any revenue or profit-sharing arrangements included in the contract.",
        "retrieved_contexts":[
            "3\n\n               PRODUCT DEVELOPMENT AND CO-BRANDING AGREEMENT                             \"SONGS 4 WORSHIP SERIES\"",
            "e.       Shared expenses. The parties agree to share equally in costs                   of additional products created (excluding the Product, and                   song books, which such song books shall be created at                   Integrity's sole discretion and expense), by mutual agreement                   under the \"Songs 4 Worship\" branding.\n\n2.       Marketing and Distribution.",
            "1                                                                    EXHIBIT 10.17\n\n               PRODUCT DEVELOPMENT AND CO-BRANDING AGREEMENT\n\n                         \"SONGS 4 WORSHIP SERIES\"\n\n                      EXCLUDING CONFIDENTIAL PORTIONS\n\n\/1\/ Indicates information which has been redacted pursuant to a request for     confidential treatment.\n\n2\n\n                    INDEX TO THE CONFIDENTIAL PORTIONS"
        ]
    },
    {
        "user_input":"Consider the Product Development and Co-Branding Agreement between Integrity Incorporated and Time Life, Inc. for 'Songs 4 Worship' Series; Is there a minimum commitment required under this contract?",
        "response":"The provided clause does not specify any minimum commitment required under the Product Development and Co-Branding Agreement between Integrity Incorporated and Time Life, Inc. for the 'Songs 4 Worship' Series. The text primarily identifies the parties involved and indicates that certain portions of the agreement are confidential, but it does not detail any specific terms regarding minimum commitments. Therefore, based on the information available in the clause, there is no direct answer to your question regarding minimum commitments.",
        "retrieved_contexts":[
            "3\n\n               PRODUCT DEVELOPMENT AND CO-BRANDING AGREEMENT                             \"SONGS 4 WORSHIP SERIES\"",
            "This Agreement, entered into this the 10th day of January 2000, by and between INTEGRITY INCORPORATED, a Delaware corporation with principal offices at 1000 Cody Road, Mobile, Alabama (\"Integrity\") and TIME LIFE, INC., a Delaware corporation d\/b\/a Time Life Music, with principal offices located at 2000 Duke Street, Alexandria, Virginia 22314 (\"TL\")",
            "1                                                                    EXHIBIT 10.17\n\n               PRODUCT DEVELOPMENT AND CO-BRANDING AGREEMENT\n\n                         \"SONGS 4 WORSHIP SERIES\"\n\n                      EXCLUDING CONFIDENTIAL PORTIONS\n\n\/1\/ Indicates information which has been redacted pursuant to a request for     confidential treatment.\n\n2\n\n                    INDEX TO THE CONFIDENTIAL PORTIONS"
        ]
    },
    {
        "user_input":"Consider the Product Development and Co-Branding Agreement between Integrity Incorporated and Time Life, Inc. for 'Songs 4 Worship' Series; Does this contract include any volume restrictions?",
        "response":"The provided clause does not mention any volume restrictions related to the Product Development and Co-Branding Agreement for the 'Songs 4 Worship' Series. It primarily discusses the sharing of expenses for additional products created under the branding, stating that \"the parties agree to share equally in costs of additional products created\" but does not specify any limitations or restrictions on the volume of products that can be developed or marketed. Therefore, based on the information in the clause, there are no volume restrictions indicated.",
        "retrieved_contexts":[
            "3\n\n               PRODUCT DEVELOPMENT AND CO-BRANDING AGREEMENT                             \"SONGS 4 WORSHIP SERIES\"",
            "1                                                                    EXHIBIT 10.17\n\n               PRODUCT DEVELOPMENT AND CO-BRANDING AGREEMENT\n\n                         \"SONGS 4 WORSHIP SERIES\"\n\n                      EXCLUDING CONFIDENTIAL PORTIONS\n\n\/1\/ Indicates information which has been redacted pursuant to a request for     confidential treatment.\n\n2\n\n                    INDEX TO THE CONFIDENTIAL PORTIONS",
            "e.       Shared expenses. The parties agree to share equally in costs                   of additional products created (excluding the Product, and                   song books, which such song books shall be created at                   Integrity's sole discretion and expense), by mutual agreement                   under the \"Songs 4 Worship\" branding.\n\n2.       Marketing and Distribution."
        ]
    },
    {
        "user_input":"Consider the Product Development and Co-Branding Agreement between Integrity Incorporated and Time Life, Inc. for 'Songs 4 Worship' Series; Does this contract provide for joint intellectual property ownership?",
        "response":"The provided clause does not explicitly state that there is joint intellectual property ownership between Integrity Incorporated and Time Life, Inc. Instead, it grants Time Life the right to use Integrity's trademarks (\"Integrity Music\" name and logo) in connection with the products produced during the term of the agreement. This right is granted \"at no additional cost to TL\" and is subject to the terms and conditions of the agreement.\n\nHowever, the clause does not mention any shared ownership of intellectual property or any rights that would imply joint ownership. Therefore, based on the information provided in the clause, there is no indication of joint intellectual property ownership in this contract.",
        "retrieved_contexts":[
            "3\n\n               PRODUCT DEVELOPMENT AND CO-BRANDING AGREEMENT                             \"SONGS 4 WORSHIP SERIES\"",
            "a.       Integrity Trademarks. Integrity hereby grants to TL the right                   to use its \"Integrity Music\" name and logo (\"the Integrity                   Trademarks') in connection with the products produced during                   the Term of this Agreement for as long as the parties continue                   to sell and distribute such products at no additional cost to                   TL, and in accordance with the terms and conditions contained                   herein",
            "This Agreement, entered into this the 10th day of January 2000, by and between INTEGRITY INCORPORATED, a Delaware corporation with principal offices at 1000 Cody Road, Mobile, Alabama (\"Integrity\") and TIME LIFE, INC., a Delaware corporation d\/b\/a Time Life Music, with principal offices located at 2000 Duke Street, Alexandria, Virginia 22314 (\"TL\")"
        ]
    },
    {
        "user_input":"Consider the Product Development and Co-Branding Agreement between Integrity Incorporated and Time Life, Inc. for 'Songs 4 Worship' Series; What licenses are granted under this contract?",
        "response":"Under the Product Development and Co-Branding Agreement between Integrity Incorporated and Time Life, Inc. for the \"Songs 4 Worship Series,\" Integrity grants Time Life the right to use its \"Integrity Music\" name and logo, referred to as the \"Integrity Trademarks.\" This license is specifically for use in connection with the products produced during the term of the agreement. \n\nKey details include:\n- The right to use the Integrity Trademarks is granted \"at no additional cost to TL.\"\n- The use of these trademarks is contingent upon the parties continuing to sell and distribute the products.\n\nThus, the license allows for the use of the Integrity Trademarks under the specified conditions of ongoing sales and distribution.",
        "retrieved_contexts":[
            "3\n\n               PRODUCT DEVELOPMENT AND CO-BRANDING AGREEMENT                             \"SONGS 4 WORSHIP SERIES\"",
            "1                                                                    EXHIBIT 10.17\n\n               PRODUCT DEVELOPMENT AND CO-BRANDING AGREEMENT\n\n                         \"SONGS 4 WORSHIP SERIES\"\n\n                      EXCLUDING CONFIDENTIAL PORTIONS\n\n\/1\/ Indicates information which has been redacted pursuant to a request for     confidential treatment.\n\n2\n\n                    INDEX TO THE CONFIDENTIAL PORTIONS",
            "a.       Integrity Trademarks. Integrity hereby grants to TL the right                   to use its \"Integrity Music\" name and logo (\"the Integrity                   Trademarks') in connection with the products produced during                   the Term of this Agreement for as long as the parties continue                   to sell and distribute such products at no additional cost to                   TL, and in accordance with the terms and conditions contained                   herein"
        ]
    },
    {
        "user_input":"Consider the Product Development and Co-Branding Agreement between Integrity Incorporated and Time Life, Inc. for 'Songs 4 Worship' Series; What are the audit rights under this contract?",
        "response":"The provided clause does not contain any information regarding audit rights under the Product Development and Co-Branding Agreement between Integrity Incorporated and Time Life, Inc. It primarily includes introductory details about the agreement, such as the parties involved and the date of the agreement, but does not specify any terms related to audit rights. Therefore, I cannot provide an answer regarding audit rights based on the information available in the retrieved chunk.",
        "retrieved_contexts":[
            "3\n\n               PRODUCT DEVELOPMENT AND CO-BRANDING AGREEMENT                             \"SONGS 4 WORSHIP SERIES\"",
            "1                                                                    EXHIBIT 10.17\n\n               PRODUCT DEVELOPMENT AND CO-BRANDING AGREEMENT\n\n                         \"SONGS 4 WORSHIP SERIES\"\n\n                      EXCLUDING CONFIDENTIAL PORTIONS\n\n\/1\/ Indicates information which has been redacted pursuant to a request for     confidential treatment.\n\n2\n\n                    INDEX TO THE CONFIDENTIAL PORTIONS",
            "This Agreement, entered into this the 10th day of January 2000, by and between INTEGRITY INCORPORATED, a Delaware corporation with principal offices at 1000 Cody Road, Mobile, Alabama (\"Integrity\") and TIME LIFE, INC., a Delaware corporation d\/b\/a Time Life Music, with principal offices located at 2000 Duke Street, Alexandria, Virginia 22314 (\"TL\")"
        ]
    },
    {
        "user_input":"Consider the Product Development and Co-Branding Agreement between Integrity Incorporated and Time Life, Inc. for 'Songs 4 Worship' Series; Is there a covenant not to sue included in this contract?",
        "response":"The provided clause does not explicitly mention a covenant not to sue within the Product Development and Co-Branding Agreement for the \"Songs 4 Worship Series.\" The text primarily outlines the structure of the agreement and indicates that certain portions are confidential, but it does not provide specific details regarding any covenants or legal restrictions, including a covenant not to sue. Therefore, based on the information available in the retrieved chunk, there is no direct answer to your question regarding a covenant not to sue.",
        "retrieved_contexts":[
            "3\n\n               PRODUCT DEVELOPMENT AND CO-BRANDING AGREEMENT                             \"SONGS 4 WORSHIP SERIES\"",
            "1                                                                    EXHIBIT 10.17\n\n               PRODUCT DEVELOPMENT AND CO-BRANDING AGREEMENT\n\n                         \"SONGS 4 WORSHIP SERIES\"\n\n                      EXCLUDING CONFIDENTIAL PORTIONS\n\n\/1\/ Indicates information which has been redacted pursuant to a request for     confidential treatment.\n\n2\n\n                    INDEX TO THE CONFIDENTIAL PORTIONS",
            "EXHIBIT 10.4\n\n                              CO-BRANDING AGREEMENT"
        ]
    },
    {
        "user_input":"Consider the Co-Branding and Endorsement Licensing Agreement between MusclePharm Corporation, Arnold Schwarzenegger, Marine MP, LLC, and Fitness Publications, Inc.; What is the expiration date of this contract?",
        "response":"The expiration date of the contract is July 22, 2016, which marks the end of the Initial Term of three (3) years that commences on July 23, 2013. If the Agreement is renewed for additional terms, the First Additional Term would then run from July 23, 2016, to July 22, 2019, and the Second Additional Term from July 23, 2019, to July 22, 2022. However, the original contract itself expires on July 22, 2016, unless terminated earlier as per Section 9 of the Agreement.",
        "retrieved_contexts":[
            ".0 million during each Contract Year of the First Additional Term (subject to Section 12(b) of this Agreement). If this Agreement is renewed for the First Additional Term, then the First Additional Term shall commence on July 23, 2016, and the Agreement shall expire and terminate automatically without further notice on July 22, 2019",
            ".0 in each Contract Year of the Second Additional Term (subject to Section 12(b) of this Agreement). If this Agreement is renewed for the Second Additional Term, then the Second Additional Term shall commence on July 23, 2019 and the Agreement shall expire and terminate automatically without further notice on July 22, 2022.   2",
            "1. Term:   (a) This Agreement shall have an Initial Term of three (3) years. The Term shall commence on July 23, 2013 and shall expire on July 22, 2016, unless otherwise terminated earlier pursuant to Section 9 of this Agreement. The period from July 23, 2013 to July 22, 2014 shall be referred to as the \"First Contract Year\". The period from July 23, 2014 to July 22, 2015 shall be referred to as the \"Second Contract Year\""
        ]
    },
    {
        "user_input":"Consider the Co-Branding and Endorsement Licensing Agreement between MusclePharm Corporation, Arnold Schwarzenegger, Marine MP, LLC, and Fitness Publications, Inc.; What is the renewal term for this contract?",
        "response":"The renewal term for the contract is referred to as the \"First Additional Term,\" which commences on July 23, 2016, and expires automatically without further notice on July 22, 2019. If the contract is renewed for a \"Second Additional Term,\" that term would begin on July 23, 2019, and expire automatically on July 22, 2022. \n\nKey phrases from the clause include: \"If this Agreement is renewed for the First Additional Term, then the First Additional Term shall commence on July 23, 2016, and the Agreement shall expire and terminate automatically without further notice on July 22, 2019,\" and \"If this Agreement is renewed for the Second Additional Term, then the Second Additional Term shall commence on July 23, 2019 and the Agreement shall expire and terminate automatically without further notice on July 22, 2022.\"",
        "retrieved_contexts":[
            ".0 million during each Contract Year of the First Additional Term (subject to Section 12(b) of this Agreement). If this Agreement is renewed for the First Additional Term, then the First Additional Term shall commence on July 23, 2016, and the Agreement shall expire and terminate automatically without further notice on July 22, 2019",
            "1. Term:   (a) This Agreement shall have an Initial Term of three (3) years. The Term shall commence on July 23, 2013 and shall expire on July 22, 2016, unless otherwise terminated earlier pursuant to Section 9 of this Agreement. The period from July 23, 2013 to July 22, 2014 shall be referred to as the \"First Contract Year\". The period from July 23, 2014 to July 22, 2015 shall be referred to as the \"Second Contract Year\"",
            ".0 in each Contract Year of the Second Additional Term (subject to Section 12(b) of this Agreement). If this Agreement is renewed for the Second Additional Term, then the Second Additional Term shall commence on July 23, 2019 and the Agreement shall expire and terminate automatically without further notice on July 22, 2022.   2"
        ]
    },
    {
        "user_input":"Consider the Co-Branding and Endorsement Licensing Agreement between MusclePharm Corporation, Arnold Schwarzenegger, Marine MP, LLC, and Fitness Publications, Inc.; What is the governing law for this contract?",
        "response":"The retrieved chunk does not provide any information regarding the governing law for the Co-Branding and Endorsement Licensing Agreement between MusclePharm Corporation, Arnold Schwarzenegger, Marine MP, LLC, and Fitness Publications, Inc. Therefore, I cannot answer your question based on the provided clause.",
        "retrieved_contexts":[
            ". Neither party shall voluntarily or by operation of law assign or otherwise transfer the rights and\/or obligations incurred pursuant to the terms of this Agreement without the prior written consent of the other party. Any attempted assignment or transfer by a party of their rights and\/or obligations without such consent shall be void",
            ".   (iv) Neither the execution, delivery nor performance by it of this Agreement does or will (a) violate, conflict with or result in the breach of any provision of its organizational documents, (b) conflict with or violate any law or governmental authorization applicable to it or any of its assets or its business, or (c) conflict with, result in any breach of, constitute a default (or event which with the giving of notice or lapse of time, or both, would become a default) under",
            "1. Term:   (a) This Agreement shall have an Initial Term of three (3) years. The Term shall commence on July 23, 2013 and shall expire on July 22, 2016, unless otherwise terminated earlier pursuant to Section 9 of this Agreement. The period from July 23, 2013 to July 22, 2014 shall be referred to as the \"First Contract Year\". The period from July 23, 2014 to July 22, 2015 shall be referred to as the \"Second Contract Year\""
        ]
    },
    {
        "user_input":"Consider the Co-Branding and Endorsement Licensing Agreement between MusclePharm Corporation, Arnold Schwarzenegger, Marine MP, LLC, and Fitness Publications, Inc.; Are there any exceptions to competitive restrictions in this contract?",
        "response":"The provided clause does not address competitive restrictions or any exceptions to them in the Co-Branding and Endorsement Licensing Agreement. It primarily outlines the Guaranteed Minimum Royalty payments for the initial term, including specific amounts and payment dates, as well as a provision regarding the Marketing Budget. \n\nSince there is no mention of competitive restrictions or exceptions in the retrieved chunk, I cannot provide an answer regarding that aspect of the contract. If you have access to other sections of the agreement that may discuss competitive restrictions, I would recommend reviewing those for relevant information.",
        "retrieved_contexts":[
            "Exhibit \"C\"   Section (1)   Guaranteed Minimum Royalty during the initial Term:   Contract Year   Minimum Royalty   Timing of Payment One   $1,500,000   $500,000 payment due on the following dates: July 23, 2013; October 1, 2013; February 1, 2014 Two   $2,000,000   $666,666.66 payment due on the following dates: July 23, 2014; October 1, 2014; February 1, 2015 Three   $2,500,000   $833,333.33 payment due on the following dates: July 23, 2015; October 1, 2015; February 1, 2016",
            "; it being understood that the parties may mutually decide not to deploy the full Marketing Budget in any Contract Year if in the good faith determination by the parties that the deployment of the full Marketing Budget is unnecessary to achieve its projected revenue targets in connection with the sale of the Licensed Products",
            ".   (iv) Neither the execution, delivery nor performance by it of this Agreement does or will (a) violate, conflict with or result in the breach of any provision of its organizational documents, (b) conflict with or violate any law or governmental authorization applicable to it or any of its assets or its business, or (c) conflict with, result in any breach of, constitute a default (or event which with the giving of notice or lapse of time, or both, would become a default) under"
        ]
    },
    {
        "user_input":"Consider the Co-Branding and Endorsement Licensing Agreement between MusclePharm Corporation, Arnold Schwarzenegger, Marine MP, LLC, and Fitness Publications, Inc.; Is there a non-compete clause in this contract?",
        "response":"Yes, there is a non-compete clause in the contract. The clause states that the \"Endorser's non-competition obligation shall not be required in the event of a material breach of this Agreement by MusclePharm.\" This indicates that while there is a non-competition obligation, it is contingent upon MusclePharm not breaching the agreement. If MusclePharm commits a material breach, the Endorser is not bound by the non-competition obligation.",
        "retrieved_contexts":[
            ". Endorser's non-competition obligation shall not be required in the event of a material breach of this Agreement by MusclePharm",
            ".   (iv) Neither the execution, delivery nor performance by it of this Agreement does or will (a) violate, conflict with or result in the breach of any provision of its organizational documents, (b) conflict with or violate any law or governmental authorization applicable to it or any of its assets or its business, or (c) conflict with, result in any breach of, constitute a default (or event which with the giving of notice or lapse of time, or both, would become a default) under",
            ". Nothwithstanding the foregoing, this Agreement may be assigned without the AS Parties' consent by MusclePharm in connection with a change of control transaction; provided that the acquirer of MusclePharm shall have financial resources substantially similar or greater than MusclePharm and shall specifically assume the obligations of MusclePharm under this Agreement in writing prior to the consummation of the change of control transaction"
        ]
    },
    {
        "user_input":"Consider the Co-Branding and Endorsement Licensing Agreement between MusclePharm Corporation, Arnold Schwarzenegger, Marine MP, LLC, and Fitness Publications, Inc.; Does this contract include an exclusivity agreement?",
        "response":"The provided clause does not explicitly mention an exclusivity agreement between the parties involved in the Co-Branding and Endorsement Licensing Agreement. It primarily addresses restrictions on making public announcements or news releases regarding the agreement and the assignment or transfer of rights and obligations without prior written consent from the other party.\n\nKey phrases from the clause include:\n\n- \"Neither party may, without the other party's prior written consent, make any news release or public announcement of the existence or value of this Agreement.\"\n- \"Neither party shall voluntarily or by operation of law assign or otherwise transfer the rights and\/or obligations incurred pursuant to the terms of this Agreement without the prior written consent of the other party.\"\n\nSince there is no mention of exclusivity or exclusive rights granted to any party, it can be concluded that the clause does not provide information regarding an exclusivity agreement.",
        "retrieved_contexts":[
            ":   Neither party may, without the other party's prior written consent, make any news release or public announcement of the existence or value of this Agreement or its terms and conditions, or in any other manner advertise or publish its value, or its terms and conditions and neither party shall issue any press release or other public announcement which includes the name of the other party without such party's prior written consent, such consent not to be unreasonably withheld or delayed",
            ". Neither party shall voluntarily or by operation of law assign or otherwise transfer the rights and\/or obligations incurred pursuant to the terms of this Agreement without the prior written consent of the other party. Any attempted assignment or transfer by a party of their rights and\/or obligations without such consent shall be void",
            "; provided however, nothing herein shall preclude MusclePharm from using any of the intellectual property to be retained by MusclePharm contemplated pursuant to Section 9(f) of this Agreement after the termination of this Agreement"
        ]
    },
    {
        "user_input":"Consider the Co-Branding and Endorsement Licensing Agreement between MusclePharm Corporation, Arnold Schwarzenegger, Marine MP, LLC, and Fitness Publications, Inc.; Does this contract include any right of first refusal, right of first offer, or right of first negotiation?",
        "response":"The provided clause does not mention any right of first refusal, right of first offer, or right of first negotiation. It primarily discusses the Guaranteed Minimum Royalty payments for the initial term and does not address any negotiation rights or options related to co-branding or endorsement agreements. Therefore, based on the information in the clause, there is no indication that such rights are included in the contract.",
        "retrieved_contexts":[
            "Exhibit \"C\"   Section (1)   Guaranteed Minimum Royalty during the initial Term:   Contract Year   Minimum Royalty   Timing of Payment One   $1,500,000   $500,000 payment due on the following dates: July 23, 2013; October 1, 2013; February 1, 2014 Two   $2,000,000   $666,666.66 payment due on the following dates: July 23, 2014; October 1, 2014; February 1, 2015 Three   $2,500,000   $833,333.33 payment due on the following dates: July 23, 2015; October 1, 2015; February 1, 2016",
            ".   Notwithstanding the foregoing, Lender shall be entitled to receive a guaranteed minimum royalty for each Contract Year including the Additional Term, if any (the \"Guaranteed Minimum Royalty\"), payable in accordance with Exhibit \"C\" attached hereto.   8",
            ".   (iv) Neither the execution, delivery nor performance by it of this Agreement does or will (a) violate, conflict with or result in the breach of any provision of its organizational documents, (b) conflict with or violate any law or governmental authorization applicable to it or any of its assets or its business, or (c) conflict with, result in any breach of, constitute a default (or event which with the giving of notice or lapse of time, or both, would become a default) under"
        ]
    },
    {
        "user_input":"Consider the Co-Branding and Endorsement Licensing Agreement between MusclePharm Corporation, Arnold Schwarzenegger, Marine MP, LLC, and Fitness Publications, Inc.; What happens in the event of a change of control of one of the parties in this contract?",
        "response":"In the event of a change of control of MusclePharm Corporation, the agreement allows for MusclePharm to assign its rights and obligations without the consent of the other parties involved. However, this is contingent upon two specific conditions: \n\n1. The acquirer of MusclePharm must have financial resources that are \"substantially similar or greater than MusclePharm.\"\n2. The acquirer must specifically assume the obligations of MusclePharm under the agreement in writing prior to the consummation of the change of control transaction.\n\nIf these conditions are met, the assignment can proceed without the consent of the other parties.",
        "retrieved_contexts":[
            ". Neither party shall voluntarily or by operation of law assign or otherwise transfer the rights and\/or obligations incurred pursuant to the terms of this Agreement without the prior written consent of the other party. Any attempted assignment or transfer by a party of their rights and\/or obligations without such consent shall be void",
            ". Nothwithstanding the foregoing, this Agreement may be assigned without the AS Parties' consent by MusclePharm in connection with a change of control transaction; provided that the acquirer of MusclePharm shall have financial resources substantially similar or greater than MusclePharm and shall specifically assume the obligations of MusclePharm under this Agreement in writing prior to the consummation of the change of control transaction",
            ".   (v)  In the event Musclepharm is in material breach or default of this Agreement, the AS Parties may give written notice to Musclepharm of intent to terminate, and such notice shall set forth in reasonable detail the facts, circumstances or events causing the alleged breach or default (\"MusclePharm Events of Default\"). Musclepharm shall have thirty (30) days' notice in which to cure the MusclePharm Events of Default to the reasonable and objective satisfaction of the terminating party"
        ]
    },
    {
        "user_input":"Consider the Co-Branding and Endorsement Licensing Agreement between MusclePharm Corporation, Arnold Schwarzenegger, Marine MP, LLC, and Fitness Publications, Inc.; Is there an anti-assignment clause in this contract?",
        "response":"Yes, there is an anti-assignment clause in the contract. The clause states that \"Neither party shall voluntarily or by operation of law assign or otherwise transfer the rights and\/or obligations incurred pursuant to the terms of this Agreement without the prior written consent of the other party.\" It further specifies that any attempted assignment or transfer without such consent shall be void. \n\nHowever, there is an exception noted in the clause: MusclePharm may assign the Agreement without the consent of the other parties in connection with a change of control transaction, provided that the acquirer has financial resources substantially similar to or greater than MusclePharm and specifically assumes the obligations of MusclePharm under the Agreement in writing prior to the consummation of the change of control transaction.",
        "retrieved_contexts":[
            ". Neither party shall voluntarily or by operation of law assign or otherwise transfer the rights and\/or obligations incurred pursuant to the terms of this Agreement without the prior written consent of the other party. Any attempted assignment or transfer by a party of their rights and\/or obligations without such consent shall be void",
            ".   (iv) Neither the execution, delivery nor performance by it of this Agreement does or will (a) violate, conflict with or result in the breach of any provision of its organizational documents, (b) conflict with or violate any law or governmental authorization applicable to it or any of its assets or its business, or (c) conflict with, result in any breach of, constitute a default (or event which with the giving of notice or lapse of time, or both, would become a default) under",
            ". Nothwithstanding the foregoing, this Agreement may be assigned without the AS Parties' consent by MusclePharm in connection with a change of control transaction; provided that the acquirer of MusclePharm shall have financial resources substantially similar or greater than MusclePharm and shall specifically assume the obligations of MusclePharm under this Agreement in writing prior to the consummation of the change of control transaction"
        ]
    },
    {
        "user_input":"Consider the Co-Branding and Endorsement Licensing Agreement between MusclePharm Corporation, Arnold Schwarzenegger, Marine MP, LLC, and Fitness Publications, Inc.; Does this contract include any revenue or profit-sharing arrangements?",
        "response":"Yes, the contract includes revenue-sharing arrangements. Specifically, under the \"Compensation\" section, it states that MusclePharm shall pay Lender a royalty of 10% on Net Sales of Licensed Products sold through its wholesale and retail Distribution Channels. This indicates a profit-sharing mechanism based on the sales of the products. \n\nAdditionally, it mentions a royalty of 10% on Net Sales of the Training Video and any Products sold in connection with the Training Video, further confirming the presence of revenue-sharing arrangements. \n\nHowever, it is important to note that there are conditions regarding stock compensation and obligations for appearances during the contract term, which may affect the overall compensation structure.",
        "retrieved_contexts":[
            "Exhibit \"C\"   Section (1)   Guaranteed Minimum Royalty during the initial Term:   Contract Year   Minimum Royalty   Timing of Payment One   $1,500,000   $500,000 payment due on the following dates: July 23, 2013; October 1, 2013; February 1, 2014 Two   $2,000,000   $666,666.66 payment due on the following dates: July 23, 2014; October 1, 2014; February 1, 2015 Three   $2,500,000   $833,333.33 payment due on the following dates: July 23, 2015; October 1, 2015; February 1, 2016",
            "7. Compensation:   (a) Cash:   (i) During the Term of this Agreement and during any sell-off period, MusclePharm shall pay Lender a royalty (the \"Royalty\") of 10% on Net Sales (as defined below) of Licensed Products sold through its wholesale Distribution Channels or retail Distribution Channels, as the case may be and 10% on Net Sales of the Training Video and any Products sold in connection with any Training Video as contemplated pursuant to the last sentence of Section 4(a)(i) above",
            ": (i) no additional Stock Compensation (as defined below) shall be issued in connection with the renewal Term, (ii) the Cash Compensation for the First Additional Term shall be as set forth in Section 7 and Exhibit \"C\" Section (2) attached hereto, (iii) Endorser shall only be obligated to make two (2) Appearances in each Contract Year during the First Additional Term pursuant to Section 4(a)(ii) below and (iv) the marketing budget to promote the Licensed Products shall be $5"
        ]
    },
    {
        "user_input":"Consider the Co-Branding and Endorsement Licensing Agreement between MusclePharm Corporation, Arnold Schwarzenegger, Marine MP, LLC, and Fitness Publications, Inc.; Is there a minimum commitment required under this contract?",
        "response":"Yes, there is a minimum commitment required under the contract. The clause specifies that the Lender is entitled to receive a \"guaranteed minimum royalty\" for each Contract Year, including any Additional Term. This \"Guaranteed Minimum Royalty\" is detailed in Exhibit \"C,\" which outlines specific amounts for each Contract Year. \n\nFor example, during the initial Term:\n- In the first Contract Year, the minimum royalty is $1,500,000.\n- In the second Contract Year, it increases to $2,000,000.\n- In the third Contract Year, it further increases to $2,500,000.\n\nThese amounts are payable in specified installments on designated dates. Therefore, the contract establishes a clear minimum financial commitment for each year of the agreement.",
        "retrieved_contexts":[
            ".   Notwithstanding the foregoing, Lender shall be entitled to receive a guaranteed minimum royalty for each Contract Year including the Additional Term, if any (the \"Guaranteed Minimum Royalty\"), payable in accordance with Exhibit \"C\" attached hereto.   8",
            "Exhibit \"C\"   Section (1)   Guaranteed Minimum Royalty during the initial Term:   Contract Year   Minimum Royalty   Timing of Payment One   $1,500,000   $500,000 payment due on the following dates: July 23, 2013; October 1, 2013; February 1, 2014 Two   $2,000,000   $666,666.66 payment due on the following dates: July 23, 2014; October 1, 2014; February 1, 2015 Three   $2,500,000   $833,333.33 payment due on the following dates: July 23, 2015; October 1, 2015; February 1, 2016",
            ". Neither party shall voluntarily or by operation of law assign or otherwise transfer the rights and\/or obligations incurred pursuant to the terms of this Agreement without the prior written consent of the other party. Any attempted assignment or transfer by a party of their rights and\/or obligations without such consent shall be void"
        ]
    },
    {
        "user_input":"Consider the Co-Branding and Endorsement Licensing Agreement between MusclePharm Corporation, Arnold Schwarzenegger, Marine MP, LLC, and Fitness Publications, Inc.; Does this contract include any volume restrictions?",
        "response":"The provided clause does not mention any volume restrictions related to the Co-Branding and Endorsement Licensing Agreement between MusclePharm Corporation, Arnold Schwarzenegger, Marine MP, LLC, and Fitness Publications, Inc. The clause primarily discusses the guaranteed minimum royalty payments, the timing of those payments, and restrictions on public announcements and assignments of rights and obligations. \n\nSince there is no reference to volume restrictions in the clause, it can be concluded that the contract does not include any such restrictions based on the information provided.",
        "retrieved_contexts":[
            "Exhibit \"C\"   Section (1)   Guaranteed Minimum Royalty during the initial Term:   Contract Year   Minimum Royalty   Timing of Payment One   $1,500,000   $500,000 payment due on the following dates: July 23, 2013; October 1, 2013; February 1, 2014 Two   $2,000,000   $666,666.66 payment due on the following dates: July 23, 2014; October 1, 2014; February 1, 2015 Three   $2,500,000   $833,333.33 payment due on the following dates: July 23, 2015; October 1, 2015; February 1, 2016",
            ":   Neither party may, without the other party's prior written consent, make any news release or public announcement of the existence or value of this Agreement or its terms and conditions, or in any other manner advertise or publish its value, or its terms and conditions and neither party shall issue any press release or other public announcement which includes the name of the other party without such party's prior written consent, such consent not to be unreasonably withheld or delayed",
            ". Neither party shall voluntarily or by operation of law assign or otherwise transfer the rights and\/or obligations incurred pursuant to the terms of this Agreement without the prior written consent of the other party. Any attempted assignment or transfer by a party of their rights and\/or obligations without such consent shall be void"
        ]
    },
    {
        "user_input":"Consider the Co-Branding and Endorsement Licensing Agreement between MusclePharm Corporation, Arnold Schwarzenegger, Marine MP, LLC, and Fitness Publications, Inc.; How is intellectual property ownership assigned in this contract?",
        "response":"In the Co-Branding and Endorsement Licensing Agreement, the ownership of intellectual property is addressed in a few key ways:\n\n1. **Retention of Intellectual Property by MusclePharm**: The clause states that \"nothing herein shall preclude MusclePharm from using any of the intellectual property to be retained by MusclePharm contemplated pursuant to Section 9(f) of this Agreement after the termination of this Agreement.\" This indicates that MusclePharm retains certain intellectual property rights even after the agreement ends.\n\n2. **Assignment Restrictions**: The clause also specifies that \"Neither party shall voluntarily or by operation of law assign or otherwise transfer the rights and\/or obligations incurred pursuant to the terms of this Agreement without the prior written consent of the other party.\" This means that any assignment or transfer of rights related to the intellectual property requires consent from the other party, and any attempt to do so without consent will be considered void.\n\n3. **Copyrights in Works Created**: Additionally, it states that \"MusclePharm agrees that any copyrights in works created based upon the Trademarks and\/or Name and Appearance Rights shall become the rights of the AS Parties (as among them to be determined among them).\" This indicates that any copyrights resulting from the use of trademarks and rights associated with Arnold Schwarzenegger will belong to the AS Parties, which suggests a shared ownership among them.\n\nIn summary, MusclePharm retains certain intellectual property rights post-termination, while any assignment of rights requires mutual consent, and copyrights from specific works are assigned to the AS Parties.",
        "retrieved_contexts":[
            ", nothing herein shall preclude MusclePharm from using any of the intellectual property to be retained by MusclePharm contemplated pursuant to Section 9(f) of this Agreement after the termination of this Agreement",
            ". Neither party shall voluntarily or by operation of law assign or otherwise transfer the rights and\/or obligations incurred pursuant to the terms of this Agreement without the prior written consent of the other party. Any attempted assignment or transfer by a party of their rights and\/or obligations without such consent shall be void",
            ".   (e) MusclePharm agrees that any copyrights in works created based upon the Trademarks and\/or Name and Appearance Rights shall become the rights of the AS Parties (as among them to be determined among them)"
        ]
    },
    {
        "user_input":"Consider the Co-Branding and Endorsement Licensing Agreement between MusclePharm Corporation, Arnold Schwarzenegger, Marine MP, LLC, and Fitness Publications, Inc.; What licenses are granted under this contract?",
        "response":"The retrieved chunk does not explicitly detail the specific licenses granted under the Co-Branding and Endorsement Licensing Agreement between MusclePharm Corporation, Arnold Schwarzenegger, Marine MP, LLC, and Fitness Publications, Inc. It primarily outlines the rights and obligations of MusclePharm, including the authority to enter into the agreement, the necessity of acquiring rights to perform the agreement, and restrictions on the content of promotional materials.\n\nTo summarize, the clause indicates that MusclePharm has the authority to perform its obligations and exploit the Licensed Products, but it does not specify the exact nature of the licenses granted. Therefore, based on the provided information, I cannot provide a direct answer regarding the specific licenses granted under this contract.",
        "retrieved_contexts":[
            ":   (i) It has the full right, power and authority to enter into this Agreement and to perform its obligations hereunder; (ii) it has acquired all rights necessary to perform this Agreement and exploit the Licensed Products as contemplated herein; (iii) the Licensed Products, any element thereof, or any advertising, promotional or publicity materials supplied by Licensee or third parties hereunder will not contain any language or material which is obscene, libelous, slanderous or defamatory",
            ".   17. [RESERVED.]   18. Assignment:   The license granted by this Agreement is personal to MusclePharm. Except as set forth below, MusclePharm shall not assign or otherwise transfer, license, sublicense, or delegate any rights or obligations under this Agreement without the express prior written consent of the AS Parties",
            ". Each such royalty payment shall include an itemized statement showing the nature and source of such royalties, including (i) the number of units of Licensed Products sold (by country and customer); (ii) the total number of units returned for which credit was given and the total dollar amount of such credits, and (iii) the total gross sales and the total royalties due with respect to such gross sales, and each itemized statement shall be certified by a duly authorized officer of MusclePharm"
        ]
    },
    {
        "user_input":"Consider the Co-Branding and Endorsement Licensing Agreement between MusclePharm Corporation, Arnold Schwarzenegger, Marine MP, LLC, and Fitness Publications, Inc.; Are there any services to be provided after the termination of this contract?",
        "response":"According to the clause, upon expiration or termination of the Agreement, \"Endorser shall have no further obligation to render any services whatsoever.\" This clearly indicates that no services are to be provided after the termination of the contract. Therefore, once the Agreement is terminated, the Endorser is not required to perform any additional services.",
        "retrieved_contexts":[
            ": Upon expiration or termination of the Agreement for pursuant to Section 9 herein, Endorser shall have no further obligation to render any services whatsoever",
            ". In the event of a termination by MusclePharm pursuant to paragraph 9(a)(i)-(ii), Musclepharm shall not be required to pay Endorser any further compensation except for Royalties earned up until such termination date, and provided, however, that if Musclepharm terminates this Agreement because of death, disability, physical injury, or other incapacity of Endorser, if Endorser has performed all services required by this Agreement for a particular Contract Year",
            "1. Term:   (a) This Agreement shall have an Initial Term of three (3) years. The Term shall commence on July 23, 2013 and shall expire on July 22, 2016, unless otherwise terminated earlier pursuant to Section 9 of this Agreement. The period from July 23, 2013 to July 22, 2014 shall be referred to as the \"First Contract Year\". The period from July 23, 2014 to July 22, 2015 shall be referred to as the \"Second Contract Year\""
        ]
    },
    {
        "user_input":"Consider the Co-Branding and Endorsement Licensing Agreement between MusclePharm Corporation, Arnold Schwarzenegger, Marine MP, LLC, and Fitness Publications, Inc.; What are the audit rights under this contract?",
        "response":"The audit rights under the Co-Branding and Endorsement Licensing Agreement are outlined in the clause as follows:\n\n1. **Inspection Rights**: The AS Parties (which include Arnold Schwarzenegger and others) have the right to inspect MusclePharm's books and records related to the Licensed Products. This inspection can occur upon providing at least five (5) days written notice and is limited to no more than once each Contract Year during the Term.\n\n2. **Location of Records**: The inspection can take place at the locations where MusclePharm normally retains these records.\n\n3. **Facility Inspection**: Additionally, MusclePharm must allow the AS Parties to send their authorized representatives to inspect MusclePharm's facilities (or those of its agents) to confirm compliance with the quality standards for the Licensed Products. This inspection can also occur no more than once during each Contract Year and must be conducted at MusclePharm's expense.\n\nIn summary, the audit rights include the ability to inspect financial records and facilities once per year, with prior notice, to ensure compliance with the agreement's terms.",
        "retrieved_contexts":[
            ". Audit Rights:   (a) The AS Parties shall have the right, upon at least five (5) days written notice and no more than once each Contract Year of the Term to inspect MusclePharm's books and records and all other documents and material in the possession of or under the control of MusclePharm with respect to the Licensed Products at the place or places where such records are normally retained by MusclePharm",
            ". Each party shall be entitled to share such confidential information received by such party only with such party's representatives, legal and accounting advisors who shall agree to be bound by the confidentiality obligations set forth in this Section 26. During the term of this Agreement and for three (3) years thereafter, each party shall hold in strict confidence all such information",
            "(b) MusclePharm shall at all reasonable times during the Term (but no more than once during each Contract Year of the Term), and upon reasonable notice, permit the AS Parties to send their authorized representatives to inspect the facilities of MusclePharm or its agents in order to confirm that the production of the Licensed Products hereunder is in compliance with the quality standards set out herein and, at MusclePharm's expense"
        ]
    },
    {
        "user_input":"Consider the Co-Branding and Endorsement Licensing Agreement between MusclePharm Corporation, Arnold Schwarzenegger, Marine MP, LLC, and Fitness Publications, Inc.; Is there a cap on liability under this contract?",
        "response":"Yes, there is a cap on liability under this contract. The clause states that \"in no event shall the AS Parties' indemnification obligations to MusclePharm hereunder exceed the after-tax value of the Cash Consideration received by Lender under this Agreement.\" This indicates that the indemnification obligations are limited to a specific financial threshold, which is tied to the cash consideration received by the lender.",
        "retrieved_contexts":[
            ". In no event shall the AS Parties' indemnification obligations to MusclePharm hereunder exceed the after-tax value of the Cash Consideration received by Lender under this Agreement.   (b) By MusclePharm",
            "; both those incurred in connection with the defense or prosecution of the indemnifiable claim and those incurred in connection with the enforcement of this provision), caused by, arising out of, or in any way connected with (i) any injury, death, or other harm or claim connected with, or claimed defect in, Products or Licensed Products provided, manufactured, produced, marketed, promoted, sold, and\/or distributed by MusclePharm (including any party affiliated with MusclePharm)",
            ". MusclePharm shall be responsible to provide for any appearances pursuant to this Agreement by Endorser appropriate certificates of insurance with coverage limits of at least Five Million Dollars (US$5,000,000) per occurrence endorsed to name the AS Parties as additional named insureds with respect to claims arising out of appearances by Endorser. MusclePharm shall be responsible to pay the deductible under any such insurance policies with respect to any claims made under such policies."
        ]
    },
    {
        "user_input":"Consider the Co-Branding and Endorsement Licensing Agreement between MusclePharm Corporation, Arnold Schwarzenegger, Marine MP, LLC, and Fitness Publications, Inc.; What are the insurance requirements under this contract?",
        "response":"Under the Co-Branding and Endorsement Licensing Agreement, MusclePharm is required to obtain and maintain a commercial general liability insurance policy throughout the term of the agreement and for a period of not less than four years thereafter. This insurance must be obtained from a qualified insurance company licensed to do business in California and New York. \n\nThe insurance policy must include coverage for:\n\n- Contractual liability (applying to the terms and conditions of this agreement)\n- Product liability\n- Personal injury liability\n- Advertiser's liability\n\nMusclePharm is also responsible for providing appropriate certificates of insurance for any appearances made by the Endorser, with coverage limits of at least Five Million Dollars (US$5,000,000) per occurrence. Additionally, the AS Parties must be named as additional insureds concerning claims arising from these appearances. \n\nFurthermore, MusclePharm is responsible for paying the deductible under any such insurance policies related to claims made. \n\nIn summary, the key insurance requirements include maintaining a comprehensive insurance policy with specific coverages, providing certificates of insurance for endorsements, and ensuring coverage limits and additional insured status.",
        "retrieved_contexts":[
            ":   MusclePharm shall, throughout the Term of the Agreement and for a period of not less than four years thereafter, obtain and maintain at its own cost and expense from a qualified insurance company licensed to do business in California and New York, a commercial general liability insurance policy including coverage for contractual liability (applying to the terms and conditions of this agreement), product liability, personal injury liability, and advertiser's liability",
            ". MusclePharm shall be responsible to provide for any appearances pursuant to this Agreement by Endorser appropriate certificates of insurance with coverage limits of at least Five Million Dollars (US$5,000,000) per occurrence endorsed to name the AS Parties as additional named insureds with respect to claims arising out of appearances by Endorser. MusclePharm shall be responsible to pay the deductible under any such insurance policies with respect to any claims made under such policies.",
            ". Representations, Warranties and Covenants"
        ]
    },
    {
        "user_input":"Consider the Co-Branding and Endorsement Licensing Agreement between MusclePharm Corporation, Arnold Schwarzenegger, Marine MP, LLC, and Fitness Publications, Inc.; Is there a covenant not to sue included in this contract?",
        "response":"The provided clause does not mention a covenant not to sue. It primarily addresses the assignment or transfer of rights and obligations under the agreement, stating that \"Neither party shall voluntarily or by operation of law assign or otherwise transfer the rights and\/or obligations incurred pursuant to the terms of this Agreement without the prior written consent of the other party.\" There is no indication of a covenant not to sue within this clause. Therefore, based on the information provided, there is no explicit covenant not to sue included in the contract.",
        "retrieved_contexts":[
            ". Representations, Warranties and Covenants",
            ". Notwithstanding the foregoing, the following will not be a breach of this Agreement",
            ". Neither party shall voluntarily or by operation of law assign or otherwise transfer the rights and\/or obligations incurred pursuant to the terms of this Agreement without the prior written consent of the other party. Any attempted assignment or transfer by a party of their rights and\/or obligations without such consent shall be void"
        ]
    },
    {
        "user_input":"Consider the Co-Branding Agreement between Skype Communications, Skype Technologies, TOM Online (BVI) Limited, TOM Online Inc., and Tel-Online Limited; What is the expiration date of this contract?",
        "response":"The expiration date of the Co-Branding Agreement is determined by the terms outlined in the clause. The Agreement has an \"Initial Term\" of five years from the date of execution of the Memorandum. After this Initial Term, it automatically continues for an \"Extended Term\" of three additional years unless a party provides written notice of termination at least sixty days prior to the expiration of the Initial Term.\n\nTo summarize, the contract will last for a total of eight years unless terminated earlier. The exact expiration date would depend on the initial execution date of the Memorandum, which is not provided in the retrieved chunk.",
        "retrieved_contexts":[
            ", during the term of this Agreement and for a period of two (2) years following the expiration or termination hereof",
            "6.1 Term. The term of this Agreement shall continue for a period of five years following the initial date of execution of the Memorandum, unless terminated earlier pursuant to Section 6.2 or Section 2.8 (\"Initial Term\")",
            ". This Agreement shall automatically continue following the Initial Term, for an additional period of three (3) years, unless a party to this Agreement provides written notice of termination to the other parties at least sixty (60) days prior to the expiration of the Initial Term or this Agreement (\"Extended Term\" and, with the Initial Term, \"Term\")."
        ]
    },
    {
        "user_input":"Consider the Co-Branding Agreement between Skype Communications, Skype Technologies, TOM Online (BVI) Limited, TOM Online Inc., and Tel-Online Limited; What is the renewal term for this contract?",
        "response":"The renewal term for the Co-Branding Agreement is three (3) years. According to the clause, \"This Agreement shall automatically continue following the Initial Term, for an additional period of three (3) years,\" unless a party provides written notice of termination at least sixty (60) days prior to the expiration of the Initial Term.",
        "retrieved_contexts":[
            ". This Agreement shall automatically continue following the Initial Term, for an additional period of three (3) years, unless a party to this Agreement provides written notice of termination to the other parties at least sixty (60) days prior to the expiration of the Initial Term or this Agreement (\"Extended Term\" and, with the Initial Term, \"Term\").",
            "6.1 Term. The term of this Agreement shall continue for a period of five years following the initial date of execution of the Memorandum, unless terminated earlier pursuant to Section 6.2 or Section 2.8 (\"Initial Term\")",
            ", during the term of this Agreement and for a period of two (2) years following the expiration or termination hereof"
        ]
    },
    {
        "user_input":"Consider the Co-Branding Agreement between Skype Communications, Skype Technologies, TOM Online (BVI) Limited, TOM Online Inc., and Tel-Online Limited; What is the notice period required to terminate the renewal?",
        "response":"The notice period required to terminate the renewal of the Co-Branding Agreement is at least sixty (60) days prior to the expiration of the Initial Term or the Agreement itself. This is specified in the clause stating, \"unless a party to this Agreement provides written notice of termination to the other parties at least sixty (60) days prior to the expiration of the Initial Term or this Agreement.\"",
        "retrieved_contexts":[
            ". This Agreement shall automatically continue following the Initial Term, for an additional period of three (3) years, unless a party to this Agreement provides written notice of termination to the other parties at least sixty (60) days prior to the expiration of the Initial Term or this Agreement (\"Extended Term\" and, with the Initial Term, \"Term\").",
            ", during the term of this Agreement and for a period of two (2) years following the expiration or termination hereof",
            "6.1 Term. The term of this Agreement shall continue for a period of five years following the initial date of execution of the Memorandum, unless terminated earlier pursuant to Section 6.2 or Section 2.8 (\"Initial Term\")"
        ]
    },
    {
        "user_input":"Consider the Co-Branding Agreement between Skype Communications, Skype Technologies, TOM Online (BVI) Limited, TOM Online Inc., and Tel-Online Limited; What is the governing law for this contract?",
        "response":"The provided clause does not specify the governing law for the Co-Branding Agreement between Skype Communications, Skype Technologies, TOM Online (BVI) Limited, TOM Online Inc., and Tel-Online Limited. It primarily addresses liability limitations and mutual representations and warranties but does not mention any governing law provisions. Therefore, based on the information in the clause, I cannot provide an answer regarding the governing law for this contract.",
        "retrieved_contexts":[
            "; AND (B) IN NO EVENT SHALL ANY PARTY TO THIS AGREEMENT BE LIABLE TO THE OTHER PARTIES TO THIS AGREEMENT FOR SPECIAL, INDIRECT, CONSEQUENTIAL, INCIDENTAL, PUNITIVE OR CONSEQUENTIAL DAMAGES",
            ", express or implied and whether negligently or innocently made) of any Person (whether a party to this Agreement or not) which is not expressly set out in this Agreement and the only remedy available in respect of any misrepresentation or untrue statement made to such party shall be a claim for breach of contract under this Agreement except to the extent that the misrepresentation or untrue statement is repeated in this Agreement in which case any remedies for misrepresentation shall be",
            "7.1 Mutual Representations and Warranties. Each of the parties to this Agreement warrant and represent that it has the full right and power to enter into this Agreement and that no contractual right of any third party will be violated, breached or negatively impacted by entering into this Agreement"
        ]
    },
    {
        "user_input":"Consider the Co-Branding Agreement between Skype Communications, Skype Technologies, TOM Online (BVI) Limited, TOM Online Inc., and Tel-Online Limited; Is there a most favored nation clause in this contract?",
        "response":"The provided clause does not mention a \"most favored nation\" clause. It primarily discusses the assignment of the agreement and the guarantees related to the obligations of the parties involved. Specifically, it states that \"this Agreement may not be assigned by a party... without the express written approval of the other parties\" and that any attempt at assignment in violation of this section shall be \"null and void.\" \n\nSince there is no reference to a most favored nation clause or any related terms in the retrieved chunk, I cannot confirm the presence of such a clause in the Co-Branding Agreement.",
        "retrieved_contexts":[
            "., with HGC), or (b) to any agreement now existing or hereafter entered into with an entity that operates in multiple international markets, which may include the PRC, so long as such agreement applies to multiple territories, which may include the PRC in addition to other territories, and does not, directly or indirectly",
            ". Subject to any other provisions of this Agreement, the guarantees are in addition to and without prejudice to and not in substitution for any rights or security which parties may now or hereafter have or hold for the performance and observance of the obligations, commitments, undertakings and warranties of the parties under this Agreement.",
            "14.4 Assignment. This Agreement may not be assigned by a party to this Agreement to any other Person without the express written approval of the other parties to this Agreement and any attempt at assignment in violation of this section shall be null and void"
        ]
    },
    {
        "user_input":"Consider the Co-Branding Agreement between Skype Communications, Skype Technologies, TOM Online (BVI) Limited, TOM Online Inc., and Tel-Online Limited; Are there any exceptions to competitive restrictions in this contract?",
        "response":"The retrieved chunk does not explicitly outline any exceptions to the competitive restrictions in the Co-Branding Agreement. It primarily discusses the Non-Competition Period and states that \"the Non-Competition Period shall terminate prior to the End Date,\" indicating that parties are not obligated to comply with the restrictions after this termination. However, it does not provide specific exceptions or conditions under which the competitive restrictions may not apply during the Non-Competition Period itself.\n\nTherefore, based on the provided clause, there are no stated exceptions to the competitive restrictions during the Non-Competition Period.",
        "retrieved_contexts":[
            "8.2.2 with respect to the provisions of Section 8.1.2, during any period following the expiration of the Enterprise Non-Competition Period.\n\n8.3 Termination of Non-Competition Period. Notwithstanding any portion of the foregoing to the contrary, the Non-Competition Period shall terminate prior to the End Date, and for the avoidance of doubt, no party shall be obligated to comply with the restrictions set out in Section 8.1 after the termination of the Non-Competition Period:",
            "8. NON-COMPETITION\n\n8.1 Non-Competition.",
            "; AND (B) IN NO EVENT SHALL ANY PARTY TO THIS AGREEMENT BE LIABLE TO THE OTHER PARTIES TO THIS AGREEMENT FOR SPECIAL, INDIRECT, CONSEQUENTIAL, INCIDENTAL, PUNITIVE OR CONSEQUENTIAL DAMAGES"
        ]
    },
    {
        "user_input":"Consider the Co-Branding Agreement between Skype Communications, Skype Technologies, TOM Online (BVI) Limited, TOM Online Inc., and Tel-Online Limited; Is there a non-compete clause in this contract?",
        "response":"Yes, there is a non-compete clause in the contract. Specifically, Section 8.1 outlines the restrictions related to the Non-Competition Period. The clause states that during the Enterprise Non-Competition Period, the parties are obligated to comply with certain restrictions. However, it also mentions that the Non-Competition Period can terminate prior to the End Date, and once it is terminated, \"no party shall be obligated to comply with the restrictions set out in Section 8.1.\" \n\nThis indicates that while the non-compete obligations are in effect during the specified period, they cease to apply once the Non-Competition Period ends.",
        "retrieved_contexts":[
            "8.2.2 with respect to the provisions of Section 8.1.2, during any period following the expiration of the Enterprise Non-Competition Period.\n\n8.3 Termination of Non-Competition Period. Notwithstanding any portion of the foregoing to the contrary, the Non-Competition Period shall terminate prior to the End Date, and for the avoidance of doubt, no party shall be obligated to comply with the restrictions set out in Section 8.1 after the termination of the Non-Competition Period:",
            "14.9 Independent Contractors. The parties to this Agreement acknowledge and agree that they are dealing with each other hereunder as independent contractors. Nothing contained in this Agreement shall be interpreted as constituting any party the joint venturer, employee or partner of the other party or as conferring upon any party the power of authority to bind another party in any transaction with third parties.",
            ". During the Enterprise Non-Competition Period, the Parties agree to use their commercially reasonable efforts to discuss mutually agreeable terms pursuant to which the Company would, and Online BVI would cause the Company to, promote, market and distribute in the PRC an enterprise co-branded Internet-based application in simplified Chinese that is focused on, and targeted primarily at, non-Consumers within the PRC"
        ]
    },
    {
        "user_input":"Consider the Co-Branding Agreement between Skype Communications, Skype Technologies, TOM Online (BVI) Limited, TOM Online Inc., and Tel-Online Limited; What happens in the event of a change of control of one of the parties in this contract?",
        "response":"The provided clause does not address the scenario of a change of control of one of the parties in the Co-Branding Agreement. It primarily discusses the rights of parties to terminate the Agreement in the event of a breach, the process for notifying the breaching party, and the ability of a party to change its address. There are no terms or conditions related to a change of control mentioned in the clause. Therefore, based on the information provided, I cannot provide an answer regarding the implications of a change of control for any of the parties involved in the contract.",
        "retrieved_contexts":[
            ". Any party to this Agreement shall have the right to terminate this Agreement during the Term by giving notice to another party to this Agreement or to any party that is not an Affiliate of the terminating party (collectively, \"Defaulter\")",
            "and the Affected Party provides written notice to the breaching party detailing the Breach and requiring the breaching party to cure the Breach within thirty (30) days of the date of the notice, the Affected Party shall not be obligated to perform the relevant obligation or undertaking affected by the Breach so long as such Breach continues uncured where such non-performance or non-compliance would be deemed a material breach of this Agreement or the Deed",
            ". A party to this Agreement may change its address for purposes hereof by written notice to the other in accordance with the provisions of this Section 14.5. The addresses for the parties to this Agreement are as set forth in the preamble hereof, with attention in each case to the respective Chief Executive Officer."
        ]
    },
    {
        "user_input":"Consider the Co-Branding Agreement between Skype Communications, Skype Technologies, TOM Online (BVI) Limited, TOM Online Inc., and Tel-Online Limited; Is there an anti-assignment clause in this contract?",
        "response":"Yes, there is an anti-assignment clause in the contract. Clause 14.4 states that \"This Agreement may not be assigned by a party to this Agreement to any other Person without the express written approval of the other parties to this Agreement.\" It further specifies that any attempt at assignment in violation of this section shall be \"null and void.\" This means that a party cannot transfer their rights or obligations under the agreement to another party without obtaining prior written consent from the other parties involved.",
        "retrieved_contexts":[
            "14.4 Assignment. This Agreement may not be assigned by a party to this Agreement to any other Person without the express written approval of the other parties to this Agreement and any attempt at assignment in violation of this section shall be null and void",
            "; AND (B) IN NO EVENT SHALL ANY PARTY TO THIS AGREEMENT BE LIABLE TO THE OTHER PARTIES TO THIS AGREEMENT FOR SPECIAL, INDIRECT, CONSEQUENTIAL, INCIDENTAL, PUNITIVE OR CONSEQUENTIAL DAMAGES",
            "14.9 Independent Contractors. The parties to this Agreement acknowledge and agree that they are dealing with each other hereunder as independent contractors. Nothing contained in this Agreement shall be interpreted as constituting any party the joint venturer, employee or partner of the other party or as conferring upon any party the power of authority to bind another party in any transaction with third parties."
        ]
    },
    {
        "user_input":"Consider the Co-Branding Agreement between Skype Communications, Skype Technologies, TOM Online (BVI) Limited, TOM Online Inc., and Tel-Online Limited; Does this contract include any revenue or profit-sharing arrangements?",
        "response":"Yes, the contract includes a revenue-sharing arrangement. Specifically, it states that Online BVI is entitled to receive 50% of all Adjusted Net Revenue in lieu of the Company's right to be paid, under certain conditions. These conditions are: \n\n(A) the Agreement must remain in effect, \n(B) Online BVI must assume the obligations of the Company, and \n(C) either (i) the Deed is terminated according to its terms, or (ii) the Company is being or has been wound up, liquidated, or dissolved.\n\nThis revenue-sharing arrangement is applicable during the term of the Agreement and for a period of two years following its expiration or termination.",
        "retrieved_contexts":[
            ", the determination of the amounts of Gross Revenue under this Agreement",
            ". Notwithstanding the foregoing, Online BVI shall be entitled to receive 50% of all Adjusted Net Revenue, in lieu of the Company's right to be paid hereunder, in the event that (A) this Agreement remains in effect, (B) Online BVI assumes the obligations of the Company hereunder, and (C) (i) the Deed is terminated pursuant to the terms thereof, or (ii)) the Company is being or has been wound up, liquidated or dissolved",
            ", during the term of this Agreement and for a period of two (2) years following the expiration or termination hereof"
        ]
    },
    {
        "user_input":"Consider the Co-Branding Agreement between Skype Communications, Skype Technologies, TOM Online (BVI) Limited, TOM Online Inc., and Tel-Online Limited; How is intellectual property ownership assigned in this contract?",
        "response":"In the Co-Branding Agreement, the ownership of any intellectual property rights that are created or developed jointly by the Parties as a result of the collaboration is specified in clause 4.2.3.2. According to this clause, such intellectual property rights shall be owned as outlined in Section 4, specifically regarding \"Intellectual Property deemed to be owned by the other Parties under Section 4.\"\n\nThis indicates that the ownership of jointly created intellectual property is determined by the provisions in Section 4 of the Agreement. However, the specific details of how ownership is assigned are not fully detailed in the provided chunk, as it references another section for further clarification. Therefore, to fully understand the assignment of intellectual property ownership, one would need to review Section 4 of the Agreement.",
        "retrieved_contexts":[
            "4.2.3.2. If any intellectual property rights that are subject to legal protection are created or developed jointly by the Parties as a result of the collaboration under this Agreement, such intellectual property rights shall be owned as follows:",
            ", Intellectual Property deemed to be owned by the other Parties under Section 4",
            "4.2.3 Improvements; Jointly Created Intellectual Property."
        ]
    },
    {
        "user_input":"Consider the Co-Branding Agreement between Skype Communications, Skype Technologies, TOM Online (BVI) Limited, TOM Online Inc., and Tel-Online Limited; Does this contract provide for joint intellectual property ownership?",
        "response":"Yes, the contract does provide for joint intellectual property ownership. According to clause 4.2.3.2, any intellectual property rights that are created or developed jointly by the Parties as a result of the collaboration under this Agreement shall be owned jointly. This indicates that the Parties involved in the Co-Branding Agreement will share ownership of any jointly created intellectual property rights.",
        "retrieved_contexts":[
            "4.2.3.2. If any intellectual property rights that are subject to legal protection are created or developed jointly by the Parties as a result of the collaboration under this Agreement, such intellectual property rights shall be owned as follows:",
            "4.2.3 Improvements; Jointly Created Intellectual Property.",
            ", Intellectual Property deemed to be owned by the other Parties under Section 4"
        ]
    },
    {
        "user_input":"Consider the Co-Branding Agreement between Skype Communications, Skype Technologies, TOM Online (BVI) Limited, TOM Online Inc., and Tel-Online Limited; What licenses are granted under this contract?",
        "response":"The clause provided outlines that licenses are granted under the terms and conditions of the Agreement, specifically in Section 4.1.2, referred to as the \"Company License.\" However, it also states that \"upon termination or expiration of this Agreement all rights and licenses granted hereunder shall immediately terminate,\" as noted in Section 6.5. \n\nThis means that while licenses are granted during the term of the Agreement, they will cease to exist once the Agreement is terminated or expires. \n\nTo summarize, the licenses granted under this contract are subject to the terms of the Agreement and will terminate upon its expiration or termination.",
        "retrieved_contexts":[
            "4. PROPRIETARY RIGHTS & LICENSE GRANTS\n\n4.1 Licenses.",
            "4.1.2 Company License. Subject to the terms and conditions of this Agreement:",
            "6.5 Except as otherwise set forth in Section 4.2.3.2.3 and this Section 6, upon termination or expiration of this Agreement all rights and licenses granted hereunder shall immediately terminate.\n\n7. REPRESENTATIONS AND WARRANTIES"
        ]
    },
    {
        "user_input":"Consider the Co-Branding Agreement between Skype Communications, Skype Technologies, TOM Online (BVI) Limited, TOM Online Inc., and Tel-Online Limited; Does the licensor's affiliates have any licensing rights under this contract?",
        "response":"The provided clause does not explicitly state whether the licensor's affiliates have any licensing rights under the Co-Branding Agreement. It defines \"Affiliate\" in Section 7.1.2 but does not clarify the licensing rights of affiliates in relation to the agreement. \n\nAdditionally, Section 6.5 indicates that upon termination or expiration of the Agreement, all rights and licenses granted shall immediately terminate, but it does not specify if affiliates retain any rights. Therefore, based on the information in the clause, it cannot be determined if the licensor's affiliates have any licensing rights under this contract.",
        "retrieved_contexts":[
            "6.5 Except as otherwise set forth in Section 4.2.3.2.3 and this Section 6, upon termination or expiration of this Agreement all rights and licenses granted hereunder shall immediately terminate.\n\n7. REPRESENTATIONS AND WARRANTIES",
            "1.2 \"Affiliate\" means in relation to any Person, any Subsidiary or Holding Company, and any company in which such Person or any such Holding Company holds or Controls directly or indirectly not less than 30% of the issued share capital.",
            "4.1.2 Company License. Subject to the terms and conditions of this Agreement:"
        ]
    },
    {
        "user_input":"Consider the Co-Branding Agreement between Skype Communications, Skype Technologies, TOM Online (BVI) Limited, TOM Online Inc., and Tel-Online Limited; Does the licensee's affiliates have any licensing rights under this contract?",
        "response":"The provided clause does not explicitly state whether the licensee's affiliates have any licensing rights under the Co-Branding Agreement. However, it does define \"Affiliate\" in relation to any Person, which includes any Subsidiary or Holding Company, and any company in which such Person or any such Holding Company holds or controls directly or indirectly not less than 30% of the issued share capital.\n\nThe clause also mentions that \"upon termination or expiration of this Agreement all rights and licenses granted hereunder shall immediately terminate,\" except as otherwise set forth in specific sections. This implies that any rights or licenses that may be granted to affiliates would be contingent upon the terms outlined in the agreement.\n\nTo determine if the licensee's affiliates have any specific licensing rights, one would need to refer to the specific terms and conditions outlined in the agreement, particularly in Section 4.2.3.2.3 and any other relevant sections not provided in the retrieved chunk. Therefore, based on the information given, it cannot be definitively concluded that the licensee's affiliates have licensing rights without further details from the agreement.",
        "retrieved_contexts":[
            "6.5 Except as otherwise set forth in Section 4.2.3.2.3 and this Section 6, upon termination or expiration of this Agreement all rights and licenses granted hereunder shall immediately terminate.\n\n7. REPRESENTATIONS AND WARRANTIES",
            "1.2 \"Affiliate\" means in relation to any Person, any Subsidiary or Holding Company, and any company in which such Person or any such Holding Company holds or Controls directly or indirectly not less than 30% of the issued share capital.",
            ", provided that, in each case, the arrangement with the Third Party Affiliate Partner applies to multiple territories (which may include the PRC)"
        ]
    },
    {
        "user_input":"Consider the Co-Branding Agreement between Skype Communications, Skype Technologies, TOM Online (BVI) Limited, TOM Online Inc., and Tel-Online Limited; Are there any services to be provided after the termination of this contract?",
        "response":"The clause provided does not explicitly state any services to be provided after the termination of the contract. It indicates that upon termination or expiration of the Agreement, \"all rights and licenses granted hereunder shall immediately terminate\" (Section 6.5). This suggests that the parties will not have any ongoing obligations or services to provide after the termination of the Agreement, except as required to give effect to Section 6.4 and subject to Section 6.5.\n\nTherefore, based on the information in the clause, there are no services mandated to be provided after the termination of the contract.",
        "retrieved_contexts":[
            "Source: TOM ONLINE INC, 20-F, 5\/1\/2006\n\n\n\n\n\n6.3 Duties Upon Termination. Subject to Section 6.5 and to the extent required for the Parties to give effect to Section 6.4, upon termination or expiration of this Agreement, the following shall occur:",
            ", during the term of this Agreement and for a period of two (2) years following the expiration or termination hereof",
            "6.5 Except as otherwise set forth in Section 4.2.3.2.3 and this Section 6, upon termination or expiration of this Agreement all rights and licenses granted hereunder shall immediately terminate.\n\n7. REPRESENTATIONS AND WARRANTIES"
        ]
    },
    {
        "user_input":"Consider the Co-Branding Agreement between Skype Communications, Skype Technologies, TOM Online (BVI) Limited, TOM Online Inc., and Tel-Online Limited; What are the audit rights under this contract?",
        "response":"Under the Co-Branding Agreement, the audit rights are outlined in Section 5.4. The Parties, including Online BVI on behalf of the Online Group, agree to maintain records that are necessary to verify calculations made under Section 8.3. Each Party is required to ensure that any Subsidiary or Affiliate grants the other Party the same audit rights.\n\nThe audits are to be conducted at the premises where the audited Party maintains its consolidated books of account. However, the auditing Party is permitted to conduct the audit at any of the audited Party's premises where relevant records are located. During these audits, the auditing Party has the right to take extracts and make copies of the audited Party's records as deemed necessary.\n\nIn summary, the audit rights allow for verification of records and calculations, with specific provisions for the location of audits and the handling of records.",
        "retrieved_contexts":[
            "5.4 Audit Rights. The Parties (including Online BVI on behalf of the Online Group) agree to maintain records (i) of all information reasonably necessary to verify all calculations to be made under Section 8.3",
            "Each Party shall cause any Subsidiary or other Affiliate (including, without limitation, a Subsidiary or other Affiliate of the Online Group or Skype Group, as applicable) to grant to the other Party the audit rights granted hereunder with respect to such other Party.",
            ". Such audit shall be conducted at the premises where the audited Party maintains consolidated books of account; provided however, that the auditing Party may conduct all or any part of such audit at any of the audited Party's premises where any relevant books of account and\/or records are located. During such audits, the auditing Party shall have the right to take extracts and\/or make copies of the audited Party's records as it deems necessary"
        ]
    },
    {
        "user_input":"Consider the Co-Branding Agreement between Skype Communications, Skype Technologies, TOM Online (BVI) Limited, TOM Online Inc., and Tel-Online Limited; Is there uncapped liability under this contract?",
        "response":"The provided clause does not contain sufficient information to determine whether there is uncapped liability under the Co-Branding Agreement. It mentions \"Limitation of Liability\" and \"material breach,\" but does not specify the extent or limits of liability, nor does it clarify if there are any caps or exceptions to liability. Therefore, based on the clause provided, I cannot conclude if there is uncapped liability in the contract.",
        "retrieved_contexts":[
            "12.2 Limitation of Liability.",
            "13. INDEMNIFICATION",
            ", and shall not be liable for such material breach"
        ]
    },
    {
        "user_input":"Consider the Co-Branding Agreement between Skype Communications, Skype Technologies, TOM Online (BVI) Limited, TOM Online Inc., and Tel-Online Limited; Is there a cap on liability under this contract?",
        "response":"The clause provided does not explicitly state a cap on liability under the Co-Branding Agreement. It mentions that \"the liability of any party to this Agreement, if any, for damages for any claim of any kind whatsoever and regardless of the legal theory\" is limited to the maximum extent permissible under applicable law, but it does not specify a numerical limit or cap. \n\nAdditionally, it notes exceptions for \"the wilful misappropriation or infringement of the intellectual property of a party\" and obligations pursuant to Section 13, which may imply that certain liabilities are not limited. Therefore, while there are limitations on liability, the clause does not provide a clear cap.",
        "retrieved_contexts":[
            "12.2 Limitation of Liability.",
            "Source: TOM ONLINE INC, 20-F, 5\/1\/2006\n\n\n\n\n\n12. DISCLAIMER & LIMITATION OF LIABILITY",
            ".1 TO THE MAXIMUM EXTENT PERMISSIBLE UNDER APPLICABLE LAW, EXCEPT FOR THE WILFUL MISAPPROPRIATION OR INFRINGEMENT OF THE INTELLECTUAL PROPERTY OF A PARTY TO THIS AGREEMENT, OR THE OBLIGATIONS OF THE PARTIES TO THIS AGREEMENT PURSUANT TO SECTION 13, (A) THE LIABILITY OF ANY PARTY TO THIS AGREEMENT, IF ANY, FOR DAMAGES FOR ANY CLAIM OF ANY KIND WHATSOEVER AND REGARDLESS OF THE LEGAL THEORY, WITH REGARD TO THE RIGHTS GRANTED HEREUNDER OR THE SERVICES PERFORMED HEREUNDER"
        ]
    },
    {
        "user_input":"Consider the Development Agreement between Howmedica Osteonics Corp. (Stryker) and Conformis, Inc. for Patient-Specific Instrumentation; What is the expiration date of this contract?",
        "response":"The provided clause does not specify an expiration date for the Development Agreement between Howmedica Osteonics Corp. (Stryker) and Conformis, Inc. It only includes details about the execution of the agreement and milestone payments related to the development work. Therefore, based on the information in the clause, there is no direct answer regarding the expiration date of the contract.",
        "retrieved_contexts":[
            "IN WITNESS WHEREOF, the parties have caused this Development Agreement to be duly executed as of the respective   dates written below.   HOWMEDICA OSTEONICS CORP. CONFORMIS, INC.   By: \/s\/ Spencer Stiles By: \/s\/ Mark A. Augusti Name: Spencer Stiles Name: Mark A. Augusti Title: President Title: President and CEO Date: September 26, 2019 Date: 9-30-2019   [Signature Page to Development Agreement]   Source: CONFORMIS INC, 10-Q, 11\/1\/2019",
            ". Stryker shall pay to Conformis the following milestone payments for the development   work to be conducted hereunder if and when the following milestones are met, as follows:   (a) Milestone #1 - Within thirty (30) days following the date on which Stryker receives the first prototype of the Patient-   Specific Instrumentation delivered to it by Conformis in accordance with the R&D Work Plan, Stryker shall pay to Conformis a   total of two million U.S",
            ".5 of the Distribution Agreement), with the exception that Conformis (including any entity involved in a   Change of Control of Conformis, any such entity an \"Acquirer\"), may develop Patient-Specific Instrumentation for any Off-The-   Shelf Implants of Conformis, an Acquirer or any of their Affiliates"
        ]
    },
    {
        "user_input":"Consider the Development Agreement between Howmedica Osteonics Corp. (Stryker) and Conformis, Inc. for Patient-Specific Instrumentation; What is the governing law for this contract?",
        "response":"The provided clause does not specify the governing law for the Development Agreement between Howmedica Osteonics Corp. (Stryker) and Conformis, Inc. Therefore, based on the information given, I cannot provide an answer regarding the governing law for this contract.",
        "retrieved_contexts":[
            ".5 of the Distribution Agreement), with the exception that Conformis (including any entity involved in a   Change of Control of Conformis, any such entity an \"Acquirer\"), may develop Patient-Specific Instrumentation for any Off-The-   Shelf Implants of Conformis, an Acquirer or any of their Affiliates",
            "IN WITNESS WHEREOF, the parties have caused this Development Agreement to be duly executed as of the respective   dates written below.   HOWMEDICA OSTEONICS CORP. CONFORMIS, INC.   By: \/s\/ Spencer Stiles By: \/s\/ Mark A. Augusti Name: Spencer Stiles Name: Mark A. Augusti Title: President Title: President and CEO Date: September 26, 2019 Date: 9-30-2019   [Signature Page to Development Agreement]   Source: CONFORMIS INC, 10-Q, 11\/1\/2019",
            ".\"   WHEREAS, the Parties are concurrently entering into an asset purchase agreement for Stryker's purchase of certain   Conformis assets concerning Patient-Specific Instrumentation (\"Asset Purchase Agreement\"), and a License Agreement, a   Distribution Agreement and a Quality Agreement, as defined in and attached to the Asset Purchase Agreement (collectively, such   agreements are referred to herein as the \"Other Agreements\")"
        ]
    },
    {
        "user_input":"Consider the Development Agreement between Howmedica Osteonics Corp. (Stryker) and Conformis, Inc. for Patient-Specific Instrumentation; Are there any exceptions to competitive restrictions in this contract?",
        "response":"Yes, there are exceptions to the competitive restrictions in the Development Agreement between Howmedica Osteonics Corp. (Stryker) and Conformis, Inc. Specifically, the clause states that Conformis is prohibited from developing or assisting others in developing Patient-Specific Instrumentation for Off-The-Shelf Knee Implants for any Third Party in the field of orthopedics until January 1, 2032. However, there is an exception for Conformis and any entity involved in a Change of Control of Conformis (referred to as an \"Acquirer\"). These entities may develop Patient-Specific Instrumentation for any Off-The-Shelf Implants of Conformis, an Acquirer, or any of their Affiliates. \n\nIn summary, while there are competitive restrictions in place, the exceptions allow for development by Conformis and Acquirers for specific Off-The-Shelf Implants.",
        "retrieved_contexts":[
            ".5 of the Distribution Agreement), with the exception that Conformis (including any entity involved in a   Change of Control of Conformis, any such entity an \"Acquirer\"), may develop Patient-Specific Instrumentation for any Off-The-   Shelf Implants of Conformis, an Acquirer or any of their Affiliates",
            ". Except as specifically provided in the Distribution Agreement, Conformis shall be prohibited from   developing or assisting another in developing, or causing another to develop, Patient-Specific Instrumentation for Off-The-Shelf   Knee Implants for any Third Party in the field of orthopedics until January 1, 2032 (or earlier, to the extent set forth in Section   2.3.3.4 or Section 2.3",
            ". Stryker shall pay to Conformis the following milestone payments for the development   work to be conducted hereunder if and when the following milestones are met, as follows:   (a) Milestone #1 - Within thirty (30) days following the date on which Stryker receives the first prototype of the Patient-   Specific Instrumentation delivered to it by Conformis in accordance with the R&D Work Plan, Stryker shall pay to Conformis a   total of two million U.S"
        ]
    },
    {
        "user_input":"Consider the Development Agreement between Howmedica Osteonics Corp. (Stryker) and Conformis, Inc. for Patient-Specific Instrumentation; Does this contract include an exclusivity agreement?",
        "response":"The provided clause does not explicitly state that there is an exclusivity agreement between Howmedica Osteonics Corp. (Stryker) and Conformis, Inc. for Patient-Specific Instrumentation. It mentions that Conformis may develop Patient-Specific Instrumentation for Off-The-Shelf Implants, including those of any Acquirer, which suggests that there may be some level of freedom for Conformis to engage with other entities in this area.\n\nAdditionally, the clause indicates that Conformis is not restricted from granting licenses or other immunities to third parties regarding the manufacture, use, or sale of Patient-Specific Instrumentation for Off-The-Shelf Knee Implants outside the Buyer Field. This further implies that there is no exclusivity in the sense that Conformis can still engage with other parties.\n\nTherefore, based on the information in the clause, it does not appear that the contract includes an exclusivity agreement.",
        "retrieved_contexts":[
            ".5 of the Distribution Agreement), with the exception that Conformis (including any entity involved in a   Change of Control of Conformis, any such entity an \"Acquirer\"), may develop Patient-Specific Instrumentation for any Off-The-   Shelf Implants of Conformis, an Acquirer or any of their Affiliates",
            ".\"   WHEREAS, the Parties are concurrently entering into an asset purchase agreement for Stryker's purchase of certain   Conformis assets concerning Patient-Specific Instrumentation (\"Asset Purchase Agreement\"), and a License Agreement, a   Distribution Agreement and a Quality Agreement, as defined in and attached to the Asset Purchase Agreement (collectively, such   agreements are referred to herein as the \"Other Agreements\")",
            ". For purposes of clarity, the foregoing does not prevent   Conformis from granting any license, release, covenant not to sue or other immunity to any third party under any Patents, including   any such immunity that would authorize manufacture, use or sale of Patient-Specific Instrumentation for Off-The-Shelf Knee   Implants outside the Buyer Field.   ARTICLE V   INTELLECTUAL PROPERTY   5.1 Inventions"
        ]
    },
    {
        "user_input":"Consider the Development Agreement between Howmedica Osteonics Corp. (Stryker) and Conformis, Inc. for Patient-Specific Instrumentation; Does this contract include any right of first refusal, right of first offer, or right of first negotiation?",
        "response":"Yes, the Development Agreement includes provisions related to rights of first refusal and rights of first negotiation. Specifically, it states that any material contract with any person may involve \"rights of first refusal, right of first negotiation.\" This implies that such rights could be part of the agreements made under this Development Agreement, although the specific details of those rights are not provided in the retrieved chunk.",
        "retrieved_contexts":[
            "(xii) any stockholders agreements, voting agreements, registrations rights agreements, co-sale agreements and any other similar Contracts between the Company and any holder of Company capital stock\u037e \n\n\n(xiii) the Joint Venture Agreements for the Material Clinic Joint Ventures\u037e \n\n\n(xiv) any Contract between the Company or any of its Subsidiaries and any Governmental Entity and that is material to the Company and its Subsidiaries, taken as a whole\u037e",
            "IN WITNESS WHEREOF, the parties have caused this Development Agreement to be duly executed as of the respective   dates written below.   HOWMEDICA OSTEONICS CORP. CONFORMIS, INC.   By: \/s\/ Spencer Stiles By: \/s\/ Mark A. Augusti Name: Spencer Stiles Name: Mark A. Augusti Title: President Title: President and CEO Date: September 26, 2019 Date: 9-30-2019   [Signature Page to Development Agreement]   Source: CONFORMIS INC, 10-Q, 11\/1\/2019",
            "(viii)          any material Contract with any Person (A) pursuant to which Parent or any of its Subsidiaries may be required to pay milestones, royalties or other contingent payments based on any research, testing, development, regulatory filings or approval, sale, distribution, commercial manufacture or other similar occurrences, developments, activities or events, or (B) under which Parent or any of its Subsidiaries grants to any Person any right of first refusal, right of first negotiation"
        ]
    },
    {
        "user_input":"Consider the Development Agreement between Howmedica Osteonics Corp. (Stryker) and Conformis, Inc. for Patient-Specific Instrumentation; Does this contract provide for joint intellectual property ownership?",
        "response":"The provided clause does not indicate that there is joint intellectual property ownership between Stryker and Conformis. Instead, it clearly states that each party retains ownership of their respective intellectual property rights. \n\nSpecifically, the clause states that \"Conformis owns all right, title and interest, including all Intellectual Property rights, in and to Conformis Background IP and Conformis' Confidential Information,\" while Stryker owns \"all right, title and interest, including all Intellectual Property rights, within the Stryker Background IP and Stryker's Confidential Information.\" Furthermore, it mentions that \"under this Agreement, Stryker shall acquire no right, title, or interest\" in Conformis' intellectual property, and vice versa.\n\nTherefore, there is no provision for joint ownership of intellectual property in this contract.",
        "retrieved_contexts":[
            ".   (b) Stryker acknowledges and agrees that, as between the Parties, Conformis owns all right, title and interest, including all   Intellectual Property rights, in and to Conformis Background IP and Conformis' Confidential Information, including any Conformis   Confidential Information underlying the Joint IP, and that, under this Agreement, Stryker shall acquire no right, title",
            ".   (a) Conformis acknowledges and agrees that, as between the Parties, Stryker owns all right, title and interest, including all   Intellectual Property rights, within the Stryker Background IP and Stryker's Confidential Information, including any Stryker   Confidential Information underlying the Joint IP, and that, under this Agreement, except as expressly set forth herein, Conformis   shall acquire no right, title, or interest in or to any of the foregoing",
            ".5 of the Distribution Agreement), with the exception that Conformis (including any entity involved in a   Change of Control of Conformis, any such entity an \"Acquirer\"), may develop Patient-Specific Instrumentation for any Off-The-   Shelf Implants of Conformis, an Acquirer or any of their Affiliates"
        ]
    },
    {
        "user_input":"Consider the Development Agreement between Howmedica Osteonics Corp. (Stryker) and Conformis, Inc. for Patient-Specific Instrumentation; What licenses are granted under this contract?",
        "response":"The retrieved chunk does not provide specific information regarding the licenses granted under the Development Agreement between Howmedica Osteonics Corp. (Stryker) and Conformis, Inc. for Patient-Specific Instrumentation. It mentions related agreements such as an Asset Purchase Agreement, License Agreement, Distribution Agreement, and Quality Agreement, but does not detail the licenses themselves. Therefore, I cannot provide an answer regarding the specific licenses granted under this contract based on the provided text.",
        "retrieved_contexts":[
            ".5 of the Distribution Agreement), with the exception that Conformis (including any entity involved in a   Change of Control of Conformis, any such entity an \"Acquirer\"), may develop Patient-Specific Instrumentation for any Off-The-   Shelf Implants of Conformis, an Acquirer or any of their Affiliates",
            ".\"   WHEREAS, the Parties are concurrently entering into an asset purchase agreement for Stryker's purchase of certain   Conformis assets concerning Patient-Specific Instrumentation (\"Asset Purchase Agreement\"), and a License Agreement, a   Distribution Agreement and a Quality Agreement, as defined in and attached to the Asset Purchase Agreement (collectively, such   agreements are referred to herein as the \"Other Agreements\")",
            ".2 of the License Agreement,   constitutes as Stryker's sole remedy and Conformis' exclusive liability in the event of any such rejection or failure by Conformis to   deliver materially conforming Deliverables hereunder so long as such rejection or failure does not arise from Conformis' fraud,   willful misconduct, gross negligence or bad faith"
        ]
    },
    {
        "user_input":"Consider the Development Agreement between Howmedica Osteonics Corp. (Stryker) and Conformis, Inc. for Patient-Specific Instrumentation; Does the licensee's affiliates have any licensing rights under this contract?",
        "response":"The retrieved chunk does not explicitly state whether the licensee's affiliates have any licensing rights under the Development Agreement between Howmedica Osteonics Corp. (Stryker) and Conformis, Inc. It mentions that \"Conformis (including any entity involved in a Change of Control of Conformis, any such entity an 'Acquirer')\" may develop Patient-Specific Instrumentation for Off-The-Shelf Implants, but it does not clarify the licensing rights of the licensee's affiliates specifically.\n\nAdditionally, it states that Conformis can grant licenses or other immunities to third parties under any Patents, which could imply some level of rights for affiliates, but this is not directly addressed in the context of the licensee's affiliates. Therefore, based on the provided clause, there is no clear answer regarding the licensing rights of the licensee's affiliates.",
        "retrieved_contexts":[
            ".5 of the Distribution Agreement), with the exception that Conformis (including any entity involved in a   Change of Control of Conformis, any such entity an \"Acquirer\"), may develop Patient-Specific Instrumentation for any Off-The-   Shelf Implants of Conformis, an Acquirer or any of their Affiliates",
            ". For purposes of clarity, the foregoing does not prevent   Conformis from granting any license, release, covenant not to sue or other immunity to any third party under any Patents, including   any such immunity that would authorize manufacture, use or sale of Patient-Specific Instrumentation for Off-The-Shelf Knee   Implants outside the Buyer Field.   ARTICLE V   INTELLECTUAL PROPERTY   5.1 Inventions",
            ".2 of the License Agreement,   constitutes as Stryker's sole remedy and Conformis' exclusive liability in the event of any such rejection or failure by Conformis to   deliver materially conforming Deliverables hereunder so long as such rejection or failure does not arise from Conformis' fraud,   willful misconduct, gross negligence or bad faith"
        ]
    },
    {
        "user_input":"Consider the Development Agreement between Howmedica Osteonics Corp. (Stryker) and Conformis, Inc. for Patient-Specific Instrumentation; Is there uncapped liability under this contract?",
        "response":"The retrieved chunk does not provide a direct answer regarding whether there is uncapped liability under the Development Agreement between Howmedica Osteonics Corp. (Stryker) and Conformis, Inc. It mentions that \"Stryker's sole remedy and Conformis' exclusive liability for breach of Section 3.2... shall be as set forth in Section 10.1(i) of the Distribution Agreement.\" However, it does not specify the nature of the liability or whether it is capped or uncapped.\n\nAdditionally, the clause discusses indemnification obligations and contribution to damages in the event of a claim, but it does not clarify if there are limits to liability. Therefore, based on the provided information, it cannot be determined if there is uncapped liability under the contract.",
        "retrieved_contexts":[
            ". Notwithstanding   anything to the contrary, Stryker's sole remedy and Conformis' exclusive liability for breach of Section 3.2 with respect to a   Product or a Stryker Product shall be as set forth in Section 10.1(i) of the Distribution Agreement.   (b) Indemnification by Stryker. Stryker shall indemnify and hold harmless Conformis, its directors, officers, employees, Agents   and   20   Source: CONFORMIS INC, 10-Q, 11\/1\/2019",
            ".5 of the Distribution Agreement), with the exception that Conformis (including any entity involved in a   Change of Control of Conformis, any such entity an \"Acquirer\"), may develop Patient-Specific Instrumentation for any Off-The-   Shelf Implants of Conformis, an Acquirer or any of their Affiliates",
            ". To the extent that Stryker, on the one hand, and Conformis, on the other hand, each has indemnification   obligations to the other in connection with a single Claim, they will contribute to the aggregate damages, liabilities, costs and   expenses arising from such Claim in a proportion reflecting the relative and comparative responsibilities and determined liability of   the Parties for such damages, liabilities, costs and expenses, as well as any other relevant equitable considerations"
        ]
    },
    {
        "user_input":"Consider the Development Agreement between Howmedica Osteonics Corp. (Stryker) and Conformis, Inc. for Patient-Specific Instrumentation; Is there a cap on liability under this contract?",
        "response":"The retrieved chunk does not explicitly mention a cap on liability under the Development Agreement between Howmedica Osteonics Corp. (Stryker) and Conformis, Inc. However, it does state that \"Stryker's sole remedy and Conformis' exclusive liability for breach of Section 3.2 with respect to a Product or a Stryker Product shall be as set forth in Section 10.1(i) of the Distribution Agreement.\" This implies that any limitations or caps on liability would be detailed in Section 10.1(i) of the Distribution Agreement, which is not provided in the retrieved chunk.\n\nTherefore, based on the information available, I cannot confirm whether there is a cap on liability without reviewing Section 10.1(i) of the Distribution Agreement.",
        "retrieved_contexts":[
            ".5 of the Distribution Agreement), with the exception that Conformis (including any entity involved in a   Change of Control of Conformis, any such entity an \"Acquirer\"), may develop Patient-Specific Instrumentation for any Off-The-   Shelf Implants of Conformis, an Acquirer or any of their Affiliates",
            ". Stryker shall pay to Conformis the following milestone payments for the development   work to be conducted hereunder if and when the following milestones are met, as follows:   (a) Milestone #1 - Within thirty (30) days following the date on which Stryker receives the first prototype of the Patient-   Specific Instrumentation delivered to it by Conformis in accordance with the R&D Work Plan, Stryker shall pay to Conformis a   total of two million U.S",
            ". Notwithstanding   anything to the contrary, Stryker's sole remedy and Conformis' exclusive liability for breach of Section 3.2 with respect to a   Product or a Stryker Product shall be as set forth in Section 10.1(i) of the Distribution Agreement.   (b) Indemnification by Stryker. Stryker shall indemnify and hold harmless Conformis, its directors, officers, employees, Agents   and   20   Source: CONFORMIS INC, 10-Q, 11\/1\/2019"
        ]
    },
    {
        "user_input":"Consider the Exclusive License and Product Development Agreement between Eton Pharmaceuticals, Inc. and Aucta Pharmaceuticals, Inc.; What is the expiration date of this contract?",
        "response":"The provided clause does not specify an expiration date for the Exclusive License and Product Development Agreement between Eton Pharmaceuticals, Inc. and Aucta Pharmaceuticals, Inc. It only mentions the \"Execution Date\" as June 12, 2019, but does not provide any details regarding the duration or expiration of the contract. Therefore, based on the information in the clause, there is no direct answer to your question regarding the expiration date of the contract.",
        "retrieved_contexts":[
            "Source: ETON PHARMACEUTICALS, INC., 10-Q, 11\/14\/2019\n\n\n\n\n\nCONFIDENTIAL IN WITNESS WHEREOF, the Parties hereto have executed this Agreement as of the date first above written, to be effective upon the Effective Date. ETON PHARMACEUTICALS, INC. By: Name: Title: AUCTA PHARMACEUTICALS, INC. By: Name: Title:\n\nSource: ETON PHARMACEUTICALS, INC., 10-Q, 11\/14\/2019\n\n\n\n\n\nSource: ETON PHARMACEUTICALS, INC., 10-Q, 11\/14\/2019",
            "Exhibit 10.1 Certain information identified by bracketed asterisks ([ * * * ]) has been omitted from this exhibit because it is both not material and would be competitively harmful if publicly disclosed. EXCLUSIVE LICENSE AND PRODUCT DEVELOPMENT AGREEMENT THIS EXCLUSIVE LICENSE AND PRODUCT DEVELOPMENT AGREEMENT (this \"Agreement\") is entered into as of June 12, 2019 (the \"Execution Date\") by and between Eton Pharmaceuticals, Inc., a Delaware corporation with offices at 21925 W",
            ".1 ETON shall enter into a commercial supply agreement with a contract manufacturing organization and Aucta shall enter into a commercial supply agreement with an active pharmaceutical ingredient supplier within ninety (90) days from the Execution Date unless otherwise agreed to by the parties in writing. 4.2 If the terms of Aucta's commercial supply agreement with the active pharmaceutical ingredient supplier in Section 4"
        ]
    },
    {
        "user_input":"Consider the Exclusive License and Product Development Agreement between Eton Pharmaceuticals, Inc. and Aucta Pharmaceuticals, Inc.; What is the governing law for this contract?",
        "response":"The provided clause does not specify the governing law for the Exclusive License and Product Development Agreement between Eton Pharmaceuticals, Inc. and Aucta Pharmaceuticals, Inc. Therefore, I cannot provide an answer regarding the governing law based on the information in the retrieved chunk.",
        "retrieved_contexts":[
            ".3, then (a) ETON shall have the right to, and Aucta shall hereby grant ETON a license to, Market or otherwise dispose of any existing inventory of any Products then in ETON's possession subject to paying all Royalties and other amounts due hereunder for such sales",
            ", (b) Aucta may keep all the payments under Section 6 paid by ETON up to the point of termination and for ETON's disposal of remaining inventory and Aucta is free to commercialize or relicense the Product with no further obligations owed to ETON, (c) ETON shall refrain from holding itself out as Aucta's distributor, in particular, eliminate any reference to the Product and Aucta from its business, trade style and promotional material, and (d) ETON shall transfer all rights",
            ".1 Aucta, for itself and its Affiliates, hereby grants to ETON in accordance with the terms and conditions of this Agreement, an exclusive (even as to and against Aucta in the Territory) right and license, including the right to sublicense, to the Products (or any components thereof), Dossiers, and all current and future Aucta Background Intellectual Property that is owned or controlled by Aucta or its Affiliates for ETON to develop, manufacture, import, use, promote, distribute, market"
        ]
    },
    {
        "user_input":"Consider the Exclusive License and Product Development Agreement between Eton Pharmaceuticals, Inc. and Aucta Pharmaceuticals, Inc.; Is there a non-compete clause in this contract?",
        "response":"Yes, there is a non-compete clause in the Exclusive License and Product Development Agreement between Eton Pharmaceuticals, Inc. and Aucta Pharmaceuticals, Inc. Specifically, the clause states that \"during the Term of this Agreement, and for a period of two (2) years thereafter, Aucta shall not research, develop, manufacture, file, sell, market, or distribute more than two products containing the active ingredient Lamotrigine.\" Additionally, Aucta is prohibited from \"directly or indirectly assist[ing] any other Person or entity in carrying out any such activities.\"\n\nThis non-competition provision is described as \"an essential and material part of the total agreement,\" emphasizing its significance in the context of the contract.",
        "retrieved_contexts":[
            "(iv) other than the Joint Venture Agreements, any Contract of the Company, any of its Subsidiaries or, to the knowledge of the Company, the Clinic Joint Ventures, that limits the ability of the Company, any of its Subsidiaries or a Clinic Joint Venture to compete in any line of business or with any Person or in any geographic area or during any period of time, in each case in any respect material to the Company, its Subsidiaries and the Clinic Joint Ventures, taken as a whole. \n\n\n15",
            ". 3.5 Competitive Products. During the Term of this Agreement, and for a period of two (2) years thereafter, Aucta shall not research, develop, manufacture, file, sell, market, or distribute more than two products containing the active ingredient Lamotrigine; nor will Aucta directly or indirectly assist any other Person or entity in carrying or any such activities. [ * * * ] 4. MANUFACTURE AND SUPPLY 4",
            "The non-competition provisions of this Agreement are an essential and material part of the total agreement, by which the Parties agree they shall not use any advantages derivable from such confidential information in their own business or affairs, unless the same is done pursuant to a new agreement executed by all signatories to this document.\n5. NON-CIRCUMVENTION"
        ]
    },
    {
        "user_input":"Consider the Exclusive License and Product Development Agreement between Eton Pharmaceuticals, Inc. and Aucta Pharmaceuticals, Inc.; Does this contract include an exclusivity agreement?",
        "response":"Yes, the Exclusive License and Product Development Agreement includes an exclusivity agreement. The clause states that \"ETON desires to obtain an exclusive license to the Products,\" which indicates that Eton Pharmaceuticals, Inc. is granted exclusive rights to market the Products in the specified Territory. This exclusivity is a key component of the agreement, as it specifies that Aucta Pharmaceuticals, Inc. is willing to grant such an exclusive license under the terms and conditions set forth in the agreement.",
        "retrieved_contexts":[
            "Exhibit 10.1 Certain information identified by bracketed asterisks ([ * * * ]) has been omitted from this exhibit because it is both not material and would be competitively harmful if publicly disclosed. EXCLUSIVE LICENSE AND PRODUCT DEVELOPMENT AGREEMENT THIS EXCLUSIVE LICENSE AND PRODUCT DEVELOPMENT AGREEMENT (this \"Agreement\") is entered into as of June 12, 2019 (the \"Execution Date\") by and between Eton Pharmaceuticals, Inc., a Delaware corporation with offices at 21925 W",
            "Source: ETON PHARMACEUTICALS, INC., 10-Q, 11\/14\/2019\n\n\n\n\n\nCONFIDENTIAL IN WITNESS WHEREOF, the Parties hereto have executed this Agreement as of the date first above written, to be effective upon the Effective Date. ETON PHARMACEUTICALS, INC. By: Name: Title: AUCTA PHARMACEUTICALS, INC. By: Name: Title:\n\nSource: ETON PHARMACEUTICALS, INC., 10-Q, 11\/14\/2019\n\n\n\n\n\nSource: ETON PHARMACEUTICALS, INC., 10-Q, 11\/14\/2019",
            "; WHEREAS, ETON desires to obtain an exclusive license to the Products, the Dossiers (later defined), and Aucta Background Intellectual Property (later defined) for Marketing the Products in the Territory, and Aucta is willing to grant such an exclusive license to ETON under the terms and conditions set forth herein; WHEREAS, ETON will pay Aucta certain milestone, royalty and licensing payments based on the sale of Products in the Territory under the terms and conditions set forth herein"
        ]
    },
    {
        "user_input":"Consider the Exclusive License and Product Development Agreement between Eton Pharmaceuticals, Inc. and Aucta Pharmaceuticals, Inc.; Can this contract be terminated for convenience, and under what conditions?",
        "response":"Yes, the contract can be terminated for convenience. According to the clause, ETON has the right to terminate the Agreement \"at its sole discretion\" after the approval of the Dossier or marketing application for the Product, by providing \"one hundred eighty (180) days' written notice to Aucta.\" This indicates that ETON can terminate the contract without needing a specific reason, as long as they follow the notice period requirement.\n\nAdditionally, the clause mentions that if Aucta terminates under certain sections or if ETON terminates under Section 11.4(b), ETON will continue to market the Products and handle associated costs during the notice period. \n\nIn summary, ETON can terminate the contract for convenience with a 180-day notice, while Aucta has specific conditions under which they can terminate as well.",
        "retrieved_contexts":[
            ". (b) ETON has the right to terminate this Agreement after approval of the Dossier or marketing application for the Product (or added new product), at its sole discretion, upon providing one hundred eighty (180) days' written notice to Aucta. (c) If Aucta terminates under Section 11.2 or 11.3, or if ETON terminates under Section 11",
            ".4(b), ETON shall continue to market the Products as before notice of termination, receive revenue and pay associated costs for selling the Product(s) during any notice period. After termination is effective and Aucta assumes control of the Product, ETON will provide, to the extent practicable, transition services to Aucta to include assistance with Product distribution, processing of rebates, drug safety, etc",
            ". This Agreement may be terminated, in the case of clauses (a), (b), (e), (f) or (g) below, at any time prior to the Effective Time, whether before or after receipt of the Company Stockholder Approval or, in the case of clauses (c) or (d) below, at any time prior to receipt of the Company Stockholder Approval, as follows:   (a)            by mutual written consent of Parent and the Company;   (b)            by either Parent or the Company:"
        ]
    },
    {
        "user_input":"Consider the Exclusive License and Product Development Agreement between Eton Pharmaceuticals, Inc. and Aucta Pharmaceuticals, Inc.; What happens in the event of a change of control of one of the parties in this contract?",
        "response":"In the event of a change of control of one of the parties in the Exclusive License and Product Development Agreement, the clause states that either party may assign its rights and obligations under the Agreement to its Affiliates or subsidiaries. Additionally, either party may assign the Agreement in its entirety to any purchaser of all or substantially all of its business or assets related to the line of business to which the Agreement pertains, or to any Affiliate of the party, without the other party's approval. \n\nThis means that a change of control does not require consent from the other party for the assignment of rights and obligations, as long as it meets the specified conditions.",
        "retrieved_contexts":[
            ".4(b), ETON shall continue to market the Products as before notice of termination, receive revenue and pay associated costs for selling the Product(s) during any notice period. After termination is effective and Aucta assumes control of the Product, ETON will provide, to the extent practicable, transition services to Aucta to include assistance with Product distribution, processing of rebates, drug safety, etc",
            ". (b) ETON has the right to terminate this Agreement after approval of the Dossier or marketing application for the Product (or added new product), at its sole discretion, upon providing one hundred eighty (180) days' written notice to Aucta. (c) If Aucta terminates under Section 11.2 or 11.3, or if ETON terminates under Section 11",
            ", and (ii) Licensor may assign its rights and obligations in this Agreement to its Affiliates or subsidiaries and either party may assign this Agreement in its entirety to any purchaser of all or substantially all of its business or assets pertaining to the line of business to which this Agreement relates or to any Affiliate of the party without the other party's approval"
        ]
    },
    {
        "user_input":"Consider the Exclusive License and Product Development Agreement between Eton Pharmaceuticals, Inc. and Aucta Pharmaceuticals, Inc.; Is there an anti-assignment clause in this contract?",
        "response":"Yes, there is an anti-assignment clause in the Exclusive License and Product Development Agreement. The clause explicitly states that \"neither this Agreement nor any of the rights, interests or obligations under this Agreement may be assigned by any of the parties... without the prior written consent of the other parties.\" Additionally, it specifies that any assignment not made in accordance with this provision will be considered void. This means that both parties must obtain written consent before assigning their rights or obligations under the Agreement.",
        "retrieved_contexts":[
            ".9 No Assignment. Neither this Agreement nor any of the rights, interests or obligations under this Agreement may be assigned by any of the parties (whether by operation of Law or otherwise) without the prior written consent of the other parties. Subject to the preceding sentence, this Agreement will be binding upon, inure to the benefit of and be enforceable by the parties and their respective successors and assigns",
            "Exhibit 10.1 Certain information identified by bracketed asterisks ([ * * * ]) has been omitted from this exhibit because it is both not material and would be competitively harmful if publicly disclosed. EXCLUSIVE LICENSE AND PRODUCT DEVELOPMENT AGREEMENT THIS EXCLUSIVE LICENSE AND PRODUCT DEVELOPMENT AGREEMENT (this \"Agreement\") is entered into as of June 12, 2019 (the \"Execution Date\") by and between Eton Pharmaceuticals, Inc., a Delaware corporation with offices at 21925 W",
            "14.01 Assignment. The Agreement is not assignable, including any assignment by operation of law (including but not limited to as a result of a merger or other corporate action), by either Party without the prior written consent of the other Party. Any and all assignments of this Agreement or of any part thereof not made in accordance with this Article will be void"
        ]
    },
    {
        "user_input":"Consider the Exclusive License and Product Development Agreement between Eton Pharmaceuticals, Inc. and Aucta Pharmaceuticals, Inc.; Does this contract include any revenue or profit-sharing arrangements?",
        "response":"The provided clause does not mention any revenue or profit-sharing arrangements between Eton Pharmaceuticals, Inc. and Aucta Pharmaceuticals, Inc. Instead, it specifies that Eton has the \"sole and exclusive right to determine all terms and conditions of sale of the Products\" and outlines licensing fees that Eton is obligated to pay to Aucta, which are based on a specific payment schedule. \n\nThe relevant section states, \"ETON shall pay to Aucta licensing fees of up to an amount of five million dollars ($5,000,000) based on the following payment schedule,\" indicating a licensing fee structure rather than a revenue or profit-sharing model. Therefore, the contract does not include any revenue or profit-sharing arrangements.",
        "retrieved_contexts":[
            "Exhibit 10.1 Certain information identified by bracketed asterisks ([ * * * ]) has been omitted from this exhibit because it is both not material and would be competitively harmful if publicly disclosed. EXCLUSIVE LICENSE AND PRODUCT DEVELOPMENT AGREEMENT THIS EXCLUSIVE LICENSE AND PRODUCT DEVELOPMENT AGREEMENT (this \"Agreement\") is entered into as of June 12, 2019 (the \"Execution Date\") by and between Eton Pharmaceuticals, Inc., a Delaware corporation with offices at 21925 W",
            "Source: ETON PHARMACEUTICALS, INC., 10-Q, 11\/14\/2019\n\n\n\n\n\nCONFIDENTIAL IN WITNESS WHEREOF, the Parties hereto have executed this Agreement as of the date first above written, to be effective upon the Effective Date. ETON PHARMACEUTICALS, INC. By: Name: Title: AUCTA PHARMACEUTICALS, INC. By: Name: Title:\n\nSource: ETON PHARMACEUTICALS, INC., 10-Q, 11\/14\/2019\n\n\n\n\n\nSource: ETON PHARMACEUTICALS, INC., 10-Q, 11\/14\/2019",
            ".3 ETON shall have the sole and exclusive right to determine all terms and conditions of sale of the Products to its or its prospective consumers. 5.4 [ * * * ] 6. MILESTONES AND OTHER PAYMENTS 6.1 Licensing Fees. ETON shall pay to Aucta licensing fees of up to an amount of five million dollars ($5,000,000) based on the following payment schedule: (a) An amount of two million dollars ($2,000,000) within five (5) days of the Effective Date of this Agreement"
        ]
    },
    {
        "user_input":"Consider the Exclusive License and Product Development Agreement between Eton Pharmaceuticals, Inc. and Aucta Pharmaceuticals, Inc.; Is there a minimum commitment required under this contract?",
        "response":"Yes, there is a minimum commitment required under the Exclusive License and Product Development Agreement. Specifically, Section 4.1 states that \"ETON shall enter into a commercial supply agreement with a contract manufacturing organization and Aucta shall enter into a commercial supply agreement with an active pharmaceutical ingredient supplier within ninety (90) days from the Execution Date unless otherwise agreed to by the parties in writing.\" This indicates that both parties are obligated to enter into these agreements within the specified timeframe, establishing a minimum commitment related to supply agreements.",
        "retrieved_contexts":[
            "Exhibit 10.1 Certain information identified by bracketed asterisks ([ * * * ]) has been omitted from this exhibit because it is both not material and would be competitively harmful if publicly disclosed. EXCLUSIVE LICENSE AND PRODUCT DEVELOPMENT AGREEMENT THIS EXCLUSIVE LICENSE AND PRODUCT DEVELOPMENT AGREEMENT (this \"Agreement\") is entered into as of June 12, 2019 (the \"Execution Date\") by and between Eton Pharmaceuticals, Inc., a Delaware corporation with offices at 21925 W",
            ".1 ETON shall enter into a commercial supply agreement with a contract manufacturing organization and Aucta shall enter into a commercial supply agreement with an active pharmaceutical ingredient supplier within ninety (90) days from the Execution Date unless otherwise agreed to by the parties in writing. 4.2 If the terms of Aucta's commercial supply agreement with the active pharmaceutical ingredient supplier in Section 4",
            "(f) Except as contained in a Joint Venture Agreement or as would not be material to the Company and its Subsidiaries and Clinic Joint Ventures, taken as a whole, neither the Company nor any Subsidiary of the Company nor any Clinic Joint Venture may be required, by reason of (i) the execution, delivery and performance of this Agreement or the anticipated consummation of the transactions contemplated hereby or (ii) the passage of time, to purchase or redeem or to offer to purchase or redeem"
        ]
    },
    {
        "user_input":"Consider the Exclusive License and Product Development Agreement between Eton Pharmaceuticals, Inc. and Aucta Pharmaceuticals, Inc.; Does this contract include any volume restrictions?",
        "response":"The Exclusive License and Product Development Agreement does not explicitly mention any volume restrictions. However, it does impose a limitation on the number of products that Aucta can engage with regarding the active ingredient Lamotrigine. Specifically, Section 3.5 states that \"Aucta shall not research, develop, manufacture, file, sell, market, or distribute more than two products containing the active ingredient Lamotrigine.\" \n\nThis indicates a restriction on the number of products rather than a volume restriction per se. Additionally, Aucta is prohibited from assisting any other person or entity in these activities related to Lamotrigine during the term of the agreement and for two years thereafter. \n\nIn summary, while there are no direct volume restrictions mentioned, there is a clear limitation on the number of products Aucta can work with concerning Lamotrigine.",
        "retrieved_contexts":[
            "Exhibit 10.1 Certain information identified by bracketed asterisks ([ * * * ]) has been omitted from this exhibit because it is both not material and would be competitively harmful if publicly disclosed. EXCLUSIVE LICENSE AND PRODUCT DEVELOPMENT AGREEMENT THIS EXCLUSIVE LICENSE AND PRODUCT DEVELOPMENT AGREEMENT (this \"Agreement\") is entered into as of June 12, 2019 (the \"Execution Date\") by and between Eton Pharmaceuticals, Inc., a Delaware corporation with offices at 21925 W",
            ".1 ETON shall enter into a commercial supply agreement with a contract manufacturing organization and Aucta shall enter into a commercial supply agreement with an active pharmaceutical ingredient supplier within ninety (90) days from the Execution Date unless otherwise agreed to by the parties in writing. 4.2 If the terms of Aucta's commercial supply agreement with the active pharmaceutical ingredient supplier in Section 4",
            ". 3.5 Competitive Products. During the Term of this Agreement, and for a period of two (2) years thereafter, Aucta shall not research, develop, manufacture, file, sell, market, or distribute more than two products containing the active ingredient Lamotrigine; nor will Aucta directly or indirectly assist any other Person or entity in carrying or any such activities. [ * * * ] 4. MANUFACTURE AND SUPPLY 4"
        ]
    },
    {
        "user_input":"Consider the Exclusive License and Product Development Agreement between Eton Pharmaceuticals, Inc. and Aucta Pharmaceuticals, Inc.; What licenses are granted under this contract?",
        "response":"Under the Exclusive License and Product Development Agreement, Aucta Pharmaceuticals, Inc. grants Eton Pharmaceuticals, Inc. an exclusive right and license to the following:\n\n1. **Products**: This includes any components of the Products.\n2. **Dossiers**: These are documents related to the Products.\n3. **Aucta Background Intellectual Property**: This refers to all current and future intellectual property owned or controlled by Aucta or its Affiliates.\n\nThe license is exclusive, meaning it is granted even against Aucta itself within the defined Territory. Additionally, Eton has the right to sublicense these rights. The agreement outlines that Eton will also make certain milestone, royalty, and licensing payments to Aucta based on the sale of the Products in the Territory.",
        "retrieved_contexts":[
            "Exhibit 10.1 Certain information identified by bracketed asterisks ([ * * * ]) has been omitted from this exhibit because it is both not material and would be competitively harmful if publicly disclosed. EXCLUSIVE LICENSE AND PRODUCT DEVELOPMENT AGREEMENT THIS EXCLUSIVE LICENSE AND PRODUCT DEVELOPMENT AGREEMENT (this \"Agreement\") is entered into as of June 12, 2019 (the \"Execution Date\") by and between Eton Pharmaceuticals, Inc., a Delaware corporation with offices at 21925 W",
            ".1 Aucta, for itself and its Affiliates, hereby grants to ETON in accordance with the terms and conditions of this Agreement, an exclusive (even as to and against Aucta in the Territory) right and license, including the right to sublicense, to the Products (or any components thereof), Dossiers, and all current and future Aucta Background Intellectual Property that is owned or controlled by Aucta or its Affiliates for ETON to develop, manufacture, import, use, promote, distribute, market",
            "; WHEREAS, ETON desires to obtain an exclusive license to the Products, the Dossiers (later defined), and Aucta Background Intellectual Property (later defined) for Marketing the Products in the Territory, and Aucta is willing to grant such an exclusive license to ETON under the terms and conditions set forth herein; WHEREAS, ETON will pay Aucta certain milestone, royalty and licensing payments based on the sale of Products in the Territory under the terms and conditions set forth herein"
        ]
    },
    {
        "user_input":"Consider the Exclusive License and Product Development Agreement between Eton Pharmaceuticals, Inc. and Aucta Pharmaceuticals, Inc.; Are there any services to be provided after the termination of this contract?",
        "response":"Yes, there are services to be provided after the termination of the contract. According to the clause, after termination is effective and Aucta assumes control of the Product, ETON will provide transition services to Aucta \"to the extent practicable.\" These services include assistance with Product distribution, processing of rebates, drug safety, and other related activities. This indicates that ETON has an obligation to assist Aucta during the transition period following termination.",
        "retrieved_contexts":[
            ".4(b), ETON shall continue to market the Products as before notice of termination, receive revenue and pay associated costs for selling the Product(s) during any notice period. After termination is effective and Aucta assumes control of the Product, ETON will provide, to the extent practicable, transition services to Aucta to include assistance with Product distribution, processing of rebates, drug safety, etc",
            ". (b) ETON has the right to terminate this Agreement after approval of the Dossier or marketing application for the Product (or added new product), at its sole discretion, upon providing one hundred eighty (180) days' written notice to Aucta. (c) If Aucta terminates under Section 11.2 or 11.3, or if ETON terminates under Section 11",
            "Source: ETON PHARMACEUTICALS, INC., 10-Q, 11\/14\/2019\n\n\n\n\n\nCONFIDENTIAL IN WITNESS WHEREOF, the Parties hereto have executed this Agreement as of the date first above written, to be effective upon the Effective Date. ETON PHARMACEUTICALS, INC. By: Name: Title: AUCTA PHARMACEUTICALS, INC. By: Name: Title:\n\nSource: ETON PHARMACEUTICALS, INC., 10-Q, 11\/14\/2019\n\n\n\n\n\nSource: ETON PHARMACEUTICALS, INC., 10-Q, 11\/14\/2019"
        ]
    },
    {
        "user_input":"Consider the Exclusive License and Product Development Agreement between Eton Pharmaceuticals, Inc. and Aucta Pharmaceuticals, Inc.; What are the audit rights under this contract?",
        "response":"The audit rights under the Exclusive License and Product Development Agreement between Eton Pharmaceuticals, Inc. and Aucta Pharmaceuticals, Inc. are outlined as follows:\n\n1. **Inspection Right**: The AS Parties (which likely refers to Eton Pharmaceuticals and Aucta Pharmaceuticals) have the right to inspect MusclePharm's books and records.\n\n2. **Notice Requirement**: The AS Parties must provide at least five (5) days written notice before the inspection.\n\n3. **Frequency**: The inspection can occur no more than once each Contract Year of the Term.\n\n4. **Scope of Inspection**: The inspection covers all documents and materials in the possession of or under the control of MusclePharm that pertain to the Licensed Products.\n\n5. **Location**: The inspection takes place at the locations where such records are normally retained by MusclePharm.\n\nThese conditions ensure that the AS Parties can verify compliance and performance related to the Licensed Products while adhering to specific procedural requirements.",
        "retrieved_contexts":[
            "Source: ETON PHARMACEUTICALS, INC., 10-Q, 11\/14\/2019\n\n\n\n\n\nCONFIDENTIAL IN WITNESS WHEREOF, the Parties hereto have executed this Agreement as of the date first above written, to be effective upon the Effective Date. ETON PHARMACEUTICALS, INC. By: Name: Title: AUCTA PHARMACEUTICALS, INC. By: Name: Title:\n\nSource: ETON PHARMACEUTICALS, INC., 10-Q, 11\/14\/2019\n\n\n\n\n\nSource: ETON PHARMACEUTICALS, INC., 10-Q, 11\/14\/2019",
            ". Audit Rights:   (a) The AS Parties shall have the right, upon at least five (5) days written notice and no more than once each Contract Year of the Term to inspect MusclePharm's books and records and all other documents and material in the possession of or under the control of MusclePharm with respect to the Licensed Products at the place or places where such records are normally retained by MusclePharm",
            "Exhibit 10.1 Certain information identified by bracketed asterisks ([ * * * ]) has been omitted from this exhibit because it is both not material and would be competitively harmful if publicly disclosed. EXCLUSIVE LICENSE AND PRODUCT DEVELOPMENT AGREEMENT THIS EXCLUSIVE LICENSE AND PRODUCT DEVELOPMENT AGREEMENT (this \"Agreement\") is entered into as of June 12, 2019 (the \"Execution Date\") by and between Eton Pharmaceuticals, Inc., a Delaware corporation with offices at 21925 W"
        ]
    },
    {
        "user_input":"Consider the Exclusive License and Product Development Agreement between Eton Pharmaceuticals, Inc. and Aucta Pharmaceuticals, Inc.; Is there a cap on liability under this contract?",
        "response":"The provided clause does not explicitly mention a cap on liability under the Exclusive License and Product Development Agreement between Eton Pharmaceuticals, Inc. and Aucta Pharmaceuticals, Inc. Instead, it specifies that Aucta is \"solely responsible and liable for any litigation in connection with the Product's development\" and that Eton is \"solely responsible and liable for any non-patent litigation in connection with its sales and marketing activities.\" \n\nThis indicates that each party has its own responsibilities and liabilities, but there is no indication of a limit or cap on those liabilities. Therefore, based on the clause provided, there is no cap on liability stated in the contract.",
        "retrieved_contexts":[
            ".1 At its sole cost and expense, Aucta shall be solely responsible and liable for any litigation in connection with the Product's development, and the Aucta Background Intellectual Property other than ANDA Litigation covered below in Section 7.5. 7.2 At its sole cost and expense, ETON shall be solely responsible and liable for any non-patent litigation in connection with its sales and marketing activities. 9",
            "; (ii) ETON's marketing, distribution, or sale of any Product on or after the Effective Date, including, without limitation, any Claim for personal injury or death, to the extent such Third Party Claims arise from the period time commencing on or after the Effective Date and to the extent such is not attributable to Aucta's breach of this Agreement or any Applicable Law",
            ".3 ETON shall have the sole and exclusive right to determine all terms and conditions of sale of the Products to its or its prospective consumers. 5.4 [ * * * ] 6. MILESTONES AND OTHER PAYMENTS 6.1 Licensing Fees. ETON shall pay to Aucta licensing fees of up to an amount of five million dollars ($5,000,000) based on the following payment schedule: (a) An amount of two million dollars ($2,000,000) within five (5) days of the Effective Date of this Agreement"
        ]
    },
    {
        "user_input":"Consider the Exclusive License and Product Development Agreement between Eton Pharmaceuticals, Inc. and Aucta Pharmaceuticals, Inc.; What are the insurance requirements under this contract?",
        "response":"The insurance requirements under the Exclusive License and Product Development Agreement between Eton Pharmaceuticals, Inc. and Aucta Pharmaceuticals, Inc. are as follows:\n\n1. **Duration of Coverage**: The parties must maintain general liability insurance from the first commercial sale of any product or after the Effective Date, continuing through five years after the final sale of such products.\n\n2. **Insurance Amounts**: The general liability insurance must be in amounts that are \"reasonable and customary in the pharmaceutical industry,\" but it must not be less than:\n   - **$5,000,000** per occurrence\n   - **$10,000,000** in total.\n\n3. **Scope of Coverage**: The insurance must cover claims related to Eton's marketing, distribution, or sale of any product on or after the Effective Date, specifically for claims of personal injury or death that arise from this period, provided these claims are not attributable to Aucta's breach of the agreement or any applicable law.\n\nThese requirements ensure that both parties are adequately protected against potential liabilities arising from their activities related to the products.",
        "retrieved_contexts":[
            ". INSURANCE At all times from the first commercial sale of any Product(s) or after the Effective Date through the date which is five (5) years after the final sale of such Product(s), the Parties will maintain general liability insurance in amounts that are reasonable and customary in the pharmaceutical industry, provided in no event shall the general liability insurance amounts be less than five million dollars ($5,000,000) per occurrence and ten million dollars ($10,000",
            "; (ii) ETON's marketing, distribution, or sale of any Product on or after the Effective Date, including, without limitation, any Claim for personal injury or death, to the extent such Third Party Claims arise from the period time commencing on or after the Effective Date and to the extent such is not attributable to Aucta's breach of this Agreement or any Applicable Law",
            "Source: ETON PHARMACEUTICALS, INC., 10-Q, 11\/14\/2019\n\n\n\n\n\nCONFIDENTIAL IN WITNESS WHEREOF, the Parties hereto have executed this Agreement as of the date first above written, to be effective upon the Effective Date. ETON PHARMACEUTICALS, INC. By: Name: Title: AUCTA PHARMACEUTICALS, INC. By: Name: Title:\n\nSource: ETON PHARMACEUTICALS, INC., 10-Q, 11\/14\/2019\n\n\n\n\n\nSource: ETON PHARMACEUTICALS, INC., 10-Q, 11\/14\/2019"
        ]
    },
    {
        "user_input":"Consider the Joint Development Agreement between FuelCell Energy, Inc. and ExxonMobil Research and Engineering Company for Molten Carbonate Fuel Cells; What is the expiration date of this contract?",
        "response":"The retrieved chunk does not provide a specific expiration date for the Joint Development Agreement between FuelCell Energy, Inc. and ExxonMobil Research and Engineering Company. It mentions the \"Term of the Agreement\" but does not specify the actual dates or duration of that term. Therefore, based on the provided information, I cannot determine the expiration date of the contract.",
        "retrieved_contexts":[
            "i. By the fifteenth (15th) day of the last month of the Term of the Agreement, ExxonMobil will have been invoiced for the actual charges incurred in all of the prior months of the Term of the Agreement, but the most recently issued invoice will not be due. Therefore, at such time ExxonMobil will not have yet paid for the last two (2) months of the Term of the Agreement",
            "c) Subsequent Monthly Invoices. Within fifteen (15) days after the end of each calendar month that occurs during the remainder of the Term of the Agreement, subject to Paragraph 10.01(e), FCE will calculate and invoice ExxonMobil for the actual amounts incurred (for charges permitted in accordance with the respective Project Description(s)) during the immediately preceding calendar month.\n\nPage 11 of 31\n\nSource: FUELCELL ENERGY INC, 8-K, 11\/6\/2019\n\n\n\n\n\nd) End of Term of the Program.",
            "ii. Within fifteen (15) days after the end of the Term of the Agreement, FCE will issue an invoice (\"9th Inning Invoice\") for the actual charges incurred during the last month of the Term of the Agreement, subject to Paragraph 10.01(a). FCE will apply any balance of the Initial Payment remaining after the 8th Inning Invoice as a credit towards the amount due on the 9th Inning Invoice"
        ]
    },
    {
        "user_input":"Consider the Joint Development Agreement between FuelCell Energy, Inc. and ExxonMobil Research and Engineering Company for Molten Carbonate Fuel Cells; What is the governing law for this contract?",
        "response":"The governing law for the Joint Development Agreement between FuelCell Energy, Inc. and ExxonMobil Research and Engineering Company is the laws of the State of New York. This is explicitly stated in the clause: \"The validity and interpretation of this Agreement and the legal relations of the Parties to it will be governed by the laws of the State of New York without recourse to its conflicts of law rules.\"",
        "retrieved_contexts":[
            "13.01 Governing Law. The validity and interpretation of this Agreement and the legal relations of the Parties to it will be governed by the laws of the State of New York without recourse to its conflicts of law rules.",
            "o Paragraphs 20.02 (Independent Contractors), 20.03 (Independent Entities), 20.06 (No Third-Party Beneficiaries), 20.07 (Internal Conflict), 20.08 (Severability), 20.09 (Amendments; Modification; Waiver), 20.10 (Integration), and 20.11 (Execution); and\n\no any rights and obligations contained in this Agreement which by their nature should continue.",
            "(ii) its legal obligations to third parties wherein nothing in this Agreement is intended to impair a party's contribution and indemnity rights under law with respect to third party claims.\n\nARTICLE 12 - TERM AND TERMINATION\n\n12.01 Term. Unless sooner terminated in accordance with this Article, this Agreement will continue in full force beginning on the Effective Date and ending two (2) years thereafter (\"Term\")."
        ]
    },
    {
        "user_input":"Consider the Joint Development Agreement between FuelCell Energy, Inc. and ExxonMobil Research and Engineering Company for Molten Carbonate Fuel Cells; Are there any exceptions to competitive restrictions in this contract?",
        "response":"Yes, there are exceptions to the competitive restrictions in the Joint Development Agreement between FuelCell Energy, Inc. and ExxonMobil Research and Engineering Company. According to clause 4.05, the obligations of confidentiality and restricted use do not apply if the Receiving Party can establish, through documentary evidence, that certain exceptions exist.\n\nSpecifically, two exceptions mentioned are:\n\n1. If a Major Competitor becomes the beneficial owner of ten percent (10%) or more of the voting securities of FuelCell Energy, Inc. by purchasing directly from them.\n2. If there is a sale to any Major Competitor of all or substantially all of the business of FuelCell Energy, Inc. related to this Agreement, whether through merger, consolidation, sale of stock, sale of assets, or similar transactions.\n\nAdditionally, it is important to note that the later occurrence of any of these exceptions does not excuse any prior failure to protect Confidential Information under this Agreement. Furthermore, more specific Confidential Information will not be considered within these exceptions just because it is part of more general information that is publicly available or possessed by the Receiving Party under one of the exceptions.",
        "retrieved_contexts":[
            "4.05 Exceptions. For the purposes of this Agreement, the obligations of confidentiality and restricted use herein shall not apply to any information or materials to the extent the Receiving Party can establish by documentary evidence that one or more of the following exceptions apply:",
            "The later occurrence of any one of the aforementioned exceptions will not excuse any failure to adequately protect Confidential Information pursuant to this Agreement prior to the existence of the exception. More specific Confidential Information will not be deemed to be within the foregoing exceptions merely because it is embraced by more general information that is publicly available or in the possession of Receiving Party pursuant to one of the exceptions",
            "b) any Major Competitor is or becomes the beneficial owner by purchasing directly from FCE, voting securities representing ten percent (10%) or greater than the actual voting power of any such entity;\n\nc) the sale to any Major Competitor of all or substantially all of the business of FCE to which this Agreement relates (whether by merger, consolidation, sale of stock, sale of assets or other similar transaction);"
        ]
    },
    {
        "user_input":"Consider the Joint Development Agreement between FuelCell Energy, Inc. and ExxonMobil Research and Engineering Company for Molten Carbonate Fuel Cells; Is there a non-compete clause in this contract?",
        "response":"The provided clause does not mention a non-compete clause. It primarily addresses the relationship between the parties as independent contractors (Clause 20.02) and the conditions regarding assignment of the agreement (Clause 14.01). \n\nSince there is no reference to any restrictions on competition or a non-compete agreement in the retrieved chunk, it can be concluded that the information regarding a non-compete clause is not present in this section of the contract.",
        "retrieved_contexts":[
            "20.02 Independent Contractors. The relationship between the Parties is that of independent contractors. Nothing contained in this Agreement, or any course of action by either Party pursuant to this Agreement, will be construed or deemed to constitute or create a joint venture, partnership, agency or employment relationship between the Parties or between either Party and the employees or other representatives of the other Party.",
            "14.01 Assignment. The Agreement is not assignable, including any assignment by operation of law (including but not limited to as a result of a merger or other corporate action), by either Party without the prior written consent of the other Party. Any and all assignments of this Agreement or of any part thereof not made in accordance with this Article will be void",
            ". In no event will either Party be liable to the other Party under this Agreement for any consequential, indirect, special, incidental, punitive or exemplary loss or damage, including, without limitation, business interruption, cost of capital, loss of anticipated revenues and profits, loss of goodwill or increased operating costs, whether arising from contract, warranty, tort"
        ]
    },
    {
        "user_input":"Consider the Joint Development Agreement between FuelCell Energy, Inc. and ExxonMobil Research and Engineering Company for Molten Carbonate Fuel Cells; Can this contract be terminated for convenience, and under what conditions?",
        "response":"Yes, the Joint Development Agreement can be terminated for convenience. According to clause 12.02, either Party may terminate the Agreement or any part of a Project for any reason at any time by providing the other Party with sixty (60) days prior written notice. \n\nAdditionally, ExxonMobil has specific rights to terminate the Agreement under certain conditions. For instance, ExxonMobil may terminate the Agreement with fifteen (15) days written notice without penalty if FCE commences a voluntary bankruptcy case or undergoes a Change in Control, as stated in clauses 12.02(B) and 12.04, respectively. \n\nIn summary, termination for convenience is allowed with a 60-day notice, while ExxonMobil has the right to terminate with a shorter notice under specific circumstances.",
        "retrieved_contexts":[
            "12.02 Early Termination. The Parties recognize that circumstances may arise where this Agreement's early termination would be desirable. Accordingly, either Party may terminate this Agreement or all\/part of a Project for any reason and at any time upon giving the other Party sixty (60) days prior written notice. In the event of early termination of a Project or this Agreement",
            "(B) To the maximum extent permitted under law, ExxonMobil may terminate this Agreement upon fifteen (15) days written notice, without penalty, payment or prejudice to claims and obligations then accrued, if FCE commences a voluntary case under the Bankruptcy Code or a similar voluntary bankruptcy or insolvency proceeding in a non- U.S",
            "12.04 Other Termination. ExxonMobil may terminate this Agreement upon fifteen (15) days written notice, without penalty, payment or prejudice to claims and obligations then accrued, if FCE undergoes a Change in Control"
        ]
    },
    {
        "user_input":"Consider the Joint Development Agreement between FuelCell Energy, Inc. and ExxonMobil Research and Engineering Company for Molten Carbonate Fuel Cells; Does this contract include any right of first refusal, right of first offer, or right of first negotiation?",
        "response":"The provided clause does not mention any right of first refusal, right of first offer, or right of first negotiation. It primarily outlines various articles and paragraphs related to the agreement, such as independent contractors, termination, arbitration, and execution, but does not specify any rights pertaining to first refusal or negotiation. Therefore, based on the information in the clause, there is no indication that such rights are included in the Joint Development Agreement between FuelCell Energy, Inc. and ExxonMobil Research and Engineering Company.",
        "retrieved_contexts":[
            "o Paragraphs 20.02 (Independent Contractors), 20.03 (Independent Entities), 20.06 (No Third-Party Beneficiaries), 20.07 (Internal Conflict), 20.08 (Severability), 20.09 (Amendments; Modification; Waiver), 20.10 (Integration), and 20.11 (Execution); and\n\no any rights and obligations contained in this Agreement which by their nature should continue.",
            "o Article 12 (Term and Termination) to the extent any clause therein speaks to post termination rights and obligations;\n\no Article 13 (Arbitration and Governing Law);\n\no Article 14 (Assignment);\n\no Article 16 (Addresses and Notices);\n\nPage 16 of 31\n\nSource: FUELCELL ENERGY INC, 8-K, 11\/6\/2019\n\n\n\n\n\no Paragraph 17.03 (Export Controls and Trade Sanctions);\n\no Article 18 (Records and Audit);\n\no Article 19 (Taxes);",
            "1. the execution, delivery and performance of this Agreement by such Party does not conflict with any agreement, instrument or undertaking, oral or written, to which it is a party or by which it may be bound, and\n\n2. all necessary consents, approvals and authorizations of all governmental authorities and third parties required to be obtained by such Party in connection with the execution, delivery, and performance of this Agreement have been or will be obtained;"
        ]
    },
    {
        "user_input":"Consider the Joint Development Agreement between FuelCell Energy, Inc. and ExxonMobil Research and Engineering Company for Molten Carbonate Fuel Cells; What happens in the event of a change of control of one of the parties in this contract?",
        "response":"The clause does not provide a direct answer regarding the specific consequences of a change of control of one of the parties in the Joint Development Agreement between FuelCell Energy, Inc. and ExxonMobil Research and Engineering Company. However, it does state that \"the occurrence or non-occurrence of a Change in Control does not alter or limit section 14.01 of this Agreement.\" This implies that section 14.01 remains unaffected by any change in control, but the specific implications or actions that follow a change in control are not detailed in the provided text. Therefore, you would need to refer to section 14.01 of the Agreement for more information on how a change in control is handled.",
        "retrieved_contexts":[
            "Any rights and obligations that have accrued to either Party against the other prior to the effective date of termination or expiration of this Agreement in any respect will survive such termination or expiration, and rights that have accrued to an Affiliate of a Party will continue regardless of any change in Affiliate status during the Term of this Agreement or thereafter.\n\nARTICLE 13 - ARBITRATION AND GOVERNING LAW",
            "e) the approval by such entity's board of directors or shareholders of any reorganization or transaction that would cause any of the situations described in clauses (a) through (d) to occur; or\n\nf) the approval by the board of directors or other governing body or the shareholders or other equity holders of FCE of any plan or proposal for its liquidation or dissolution.\n\nThe occurrence or non-occurrence of a Change in Control does not alter or limit section 14.01 of this Agreement.",
            ". Except as otherwise set forth in this Agreement, no failure to exercise, or delay in exercising, any rights, remedy, power, or privilege arising from this Agreement will operate or be construed as a waiver thereof; nor will any single or partial exercise of any right, remedy, power, or privilege hereunder preclude any other or further exercise thereof or the exercise of any other right, remedy, power, or privilege."
        ]
    },
    {
        "user_input":"Consider the Joint Development Agreement between FuelCell Energy, Inc. and ExxonMobil Research and Engineering Company for Molten Carbonate Fuel Cells; Is there an anti-assignment clause in this contract?",
        "response":"Yes, there is an anti-assignment clause in the Joint Development Agreement between FuelCell Energy, Inc. and ExxonMobil Research and Engineering Company. According to Clause 14.01 (Assignment), the Agreement is not assignable by either Party without the prior written consent of the other Party. It specifically states, \"Any and all assignments of this Agreement or of any part thereof not made in accordance with this Article will be void.\" This means that any attempt to assign the Agreement without consent would not be valid. Additionally, the clause outlines that any permitted assignee must agree in writing to be bound by all obligations of the assigning Party under the Agreement.",
        "retrieved_contexts":[
            "14.01 Assignment. The Agreement is not assignable, including any assignment by operation of law (including but not limited to as a result of a merger or other corporate action), by either Party without the prior written consent of the other Party. Any and all assignments of this Agreement or of any part thereof not made in accordance with this Article will be void",
            ".05, shall be applicable to both FCE and any Affiliate assignee of FCE, and (iii) no assignment pursuant to this sentence will relieve the Parties of their obligations under this Agreement.",
            "14.02 Assignees Bound. Any assignee permitted in Paragraph 14.01 (Assignment) will agree in writing to be bound by all the obligations of the assigning Party under this Agreement, and a copy of such written agreement will be promptly provided to the other Party. Any Party making an assignment of this Agreement as permitted in Paragraph 14.01 (Assignment) will remain bound by the continuing obligations of confidentiality and nonuse applicable to such Party prior to the assignment."
        ]
    },
    {
        "user_input":"Consider the Joint Development Agreement between FuelCell Energy, Inc. and ExxonMobil Research and Engineering Company for Molten Carbonate Fuel Cells; How is intellectual property ownership assigned in this contract?",
        "response":"In the Joint Development Agreement between FuelCell Energy, Inc. (FCE) and ExxonMobil Research and Engineering Company, intellectual property ownership is assigned as follows:\n\nExxonMobil will solely own all \"Program Results,\" which include Program Information, Program Patents, and copyrightable works resulting from the Program. This ownership applies regardless of whether these results are conceived, created, developed, or acquired by employees or representatives of either FCE or ExxonMobil. Furthermore, FCE is required to assign, and has hereby assigned, ownership of these Program Results to ExxonMobil.\n\nThis is explicitly stated in the clause: \"ExxonMobil will solely own Program Information, Program Patents, and copyrightable works resulting from the Program... FCE will assign, and hereby assigns, to ExxonMobil ownership of Program Results.\" \n\nThus, the contract clearly establishes that ExxonMobil holds exclusive rights to the intellectual property generated from the collaboration.",
        "retrieved_contexts":[
            "(i) All rights and licenses granted to ExxonMobil and its Affiliates under or pursuant to this Agreement are, and will otherwise be deemed to be, for all purposes of Section 365(n) of the Bankruptcy Code, licenses of rights to \"intellectual property\" as defined in section 101 of the Bankruptcy Code.",
            "ARTICLE 6 - OWNERSHIP \/ PROCUREMENT OF PROGRAM RESULTS\n\n6.01 Ownership of Program Results. ExxonMobil will solely own Program Information, Program Patents, and copyrightable works resulting from the Program (collectively, \"Program Results\"), irrespective of whether the Program Results are conceived, created, developed or acquired by employees or other representatives of FCE, ExxonMobil, or both. FCE will assign, and hereby assigns, to ExxonMobil ownership of Program Results.",
            "6.06 Joint Research Agreement. The Parties acknowledge and agree that this Agreement is a \"joint research agreement\" as defined in 35 U.S.C. \u00a7100(h). The specification of any patent application filed pursuant to this Agreement may contain (or may be amended to contain) language required to invoke 35 U.S.C. \u00a7102(b)(2)(C) and \u00a7102(c) as applicable. Notwithstanding anything to the contrary in Paragraph 5"
        ]
    },
    {
        "user_input":"Consider the Joint Development Agreement between FuelCell Energy, Inc. and ExxonMobil Research and Engineering Company for Molten Carbonate Fuel Cells; What licenses are granted under this contract?",
        "response":"The clause outlines specific licenses granted under the agreement. The rights and licenses include:\n\n1. **Right to Use**: The designated Party and its Affiliates have the right to use, reproduce, and create derivative works of the Program Information under applicable copyrights.\n\n2. **Right to Make, Use, and Import**: They are also granted the right to make, use, and import under the claims of Program Patents, but this is limited to research and development for the Program.\n\n3. **Extension to Contractors**: The right and license may be extended to contractors performing work on behalf of FuelCell Energy, Inc. (FCE), but it is explicitly stated that it is \"not otherwise sub-licensable.\"\n\nAdditionally, the clause emphasizes that the confidentiality and limited use obligations must be no less protective of the Disclosing Party's Confidential Information than the terms contained in the agreement.\n\nIn summary, the licenses granted include the right to use and create derivative works of Program Information and to make, use, and import under Program Patents, specifically for research and development purposes, with certain restrictions on sublicensing.",
        "retrieved_contexts":[
            "(a) owned or controlled by the designated Party or its Affiliates (in the sense of having the right to license without accounting to others); and\n\n(b) conceived, created, developed, or acquired by the designated Party or its Affiliates:\n\n(1) prior to the Effective Date of this Agreement; or\n\n(2) at any time, but independently of any Project prior to the termination of this Agreement.\n\nBackground Information includes Background Samples but does not include Program Information.",
            ", and sub-licensees have agreed to be bound by confidentiality and limited use obligations no less protective of Disclosing Party's Confidential Information than the terms contained herein",
            ". More particularly, said right and license to practice includes the right to use, reproduce, and create derivative works of Program Information under applicable copyrights and to make, use, and import (but not sell or offer to sell) under the claims of Program Patents, in each case solely for research and development for the Program. Said right and license may be extended to contractors performing work on behalf of FCE but is not otherwise sub-licensable."
        ]
    },
    {
        "user_input":"Consider the Joint Development Agreement between FuelCell Energy, Inc. and ExxonMobil Research and Engineering Company for Molten Carbonate Fuel Cells; Are the licenses granted under this contract non-transferable?",
        "response":"Yes, the licenses granted under this contract are non-transferable. The clause explicitly states that the rights and licenses may be extended to contractors performing work on behalf of FuelCell Energy, Inc. (FCE) but are \"not otherwise sub-licensable.\" This indicates that the licenses cannot be transferred or sublicensed to any other parties beyond those contractors.",
        "retrieved_contexts":[
            ", and sub-licensees have agreed to be bound by confidentiality and limited use obligations no less protective of Disclosing Party's Confidential Information than the terms contained herein",
            ". More particularly, said right and license to practice includes the right to use, reproduce, and create derivative works of Program Information under applicable copyrights and to make, use, and import (but not sell or offer to sell) under the claims of Program Patents, in each case solely for research and development for the Program. Said right and license may be extended to contractors performing work on behalf of FCE but is not otherwise sub-licensable.",
            ". All rights and licenses in this Paragraph (b)(1)(i) may be extended to contractors performing work on behalf of FCE but are not otherwise sub-licensable."
        ]
    },
    {
        "user_input":"Consider the Joint Development Agreement between FuelCell Energy, Inc. and ExxonMobil Research and Engineering Company for Molten Carbonate Fuel Cells; Does the licensee's affiliates have any licensing rights under this contract?",
        "response":"The clause specifies that rights and licenses may be extended to \"contractors performing work on behalf of FCE\" but states that they are \"not otherwise sub-licensable.\" This implies that while contractors can have certain rights, the clause does not explicitly mention that affiliates of the licensee (in this case, ExxonMobil Research and Engineering Company) have any licensing rights under this contract. Therefore, based on the provided clause, the licensee's affiliates do not have any licensing rights unless specifically stated elsewhere in the agreement.",
        "retrieved_contexts":[
            "4.06 Disclosure to Affiliates, Contractors, and Sub-licensees",
            "\"Affiliate(s)\" means any legal entity which, directly or indirectly, at the time in question, controls, is controlled by, or is under common control with the designated Party",
            ". All rights and licenses in this Paragraph (b)(1)(ii) may be extended to contractors performing work on behalf of FCE but are not otherwise sub-licensable."
        ]
    },
    {
        "user_input":"Consider the Joint Development Agreement between FuelCell Energy, Inc. and ExxonMobil Research and Engineering Company for Molten Carbonate Fuel Cells; Are any of the licenses granted under this contract irrevocable or perpetual?",
        "response":"The retrieved chunk does not explicitly state that any licenses granted under the Joint Development Agreement are irrevocable or perpetual. Instead, it outlines conditions under which licenses may convert or terminate. \n\nSpecifically, it mentions that if FCE is the defaulting party, certain royalty-free licenses will convert to royalty-bearing licenses upon termination (Paragraph 12.03). Additionally, under Paragraph 12.05, any licenses granted to FCE that would otherwise survive termination will automatically terminate unless waived by ExxonMobil, while licenses granted to ExxonMobil will continue to survive termination.\n\nTherefore, based on the provided information, the licenses are not described as irrevocable or perpetual, and their status depends on specific conditions related to termination and default.",
        "retrieved_contexts":[
            ". In the event of termination under this Paragraph 12.03 where FCE is the defaulting Party, FCE's royalty-free licenses described in Paragraph 7.01(b)(1), 8.02(b)(1)(i), 8.02 (b)(1)(ii), 8.02(b)(1)(iii), and 8.02(b)(2)(i) will immediately convert to royalty-bearing licenses, with the royalty rate to be negotiated by the Parties in good faith.",
            ". In the event of termination under this Paragraph 12.05 and subject to ExxonMobil's waiver (in its sole discretion), any licenses granted to FCE under this Agreement that would otherwise survive termination will automatically terminate and any licenses granted to ExxonMobil under this Agreement that would otherwise survive termination will continue to survive termination.",
            "12.06 Continuing Rights and Obligations. Except as otherwise stated in this Agreement, the following Articles and Paragraphs will survive termination of this Agreement:\n\no Article 1 (Definitions);\n\no Article 4 (Disclosure, Confidentiality and Restricted Use);\n\no Article 6 (Procurement and Ownership of Program Results)\n\no Article 7 (License to Program Results), subject to Paragraphs 12.03 (Failure to Perform), 12.04 (Other Termination), and 12.05 (Bankruptcy);"
        ]
    },
    {
        "user_input":"Consider the Joint Development Agreement between FuelCell Energy, Inc. and ExxonMobil Research and Engineering Company for Molten Carbonate Fuel Cells; Are there any services to be provided after the termination of this contract?",
        "response":"The retrieved chunk does not explicitly state whether any services will be provided after the termination of the contract. It primarily discusses the conditions for early termination and the maximum amount payable upon termination. Specifically, it mentions that either party can terminate the agreement with sixty (60) days prior written notice and that the total amount paid will not exceed the maximum authorized charge specified in the agreement.\n\nHowever, there are no details provided regarding any ongoing services or obligations that would continue after termination. Therefore, based on the information in the clause, it can be concluded that there are no specified services to be provided after the termination of the contract.",
        "retrieved_contexts":[
            "12.02 Early Termination. The Parties recognize that circumstances may arise where this Agreement's early termination would be desirable. Accordingly, either Party may terminate this Agreement or all\/part of a Project for any reason and at any time upon giving the other Party sixty (60) days prior written notice. In the event of early termination of a Project or this Agreement",
            ". The total amount paid FCE under this Agreement or for a Project, including all amounts paid following termination, will not exceed the maximum authorized charge specified in this Agreement or for a Project.",
            "(ii) its legal obligations to third parties wherein nothing in this Agreement is intended to impair a party's contribution and indemnity rights under law with respect to third party claims.\n\nARTICLE 12 - TERM AND TERMINATION\n\n12.01 Term. Unless sooner terminated in accordance with this Article, this Agreement will continue in full force beginning on the Effective Date and ending two (2) years thereafter (\"Term\")."
        ]
    },
    {
        "user_input":"Consider the Joint Development Agreement between FuelCell Energy, Inc. and ExxonMobil Research and Engineering Company for Molten Carbonate Fuel Cells; What are the audit rights under this contract?",
        "response":"Under the Joint Development Agreement between FuelCell Energy, Inc. (FCE) and ExxonMobil Research and Engineering Company, the audit rights are outlined in Clause 18.02. \n\n1. **Right to Reproduce Documents**: ExxonMobil and its representatives have the right to reproduce documents kept by FCE in accordance with Paragraph 18.01 (Recordkeeping) for internal records. These reproduced documents are subject to the confidentiality and use provisions contained in Article 4.\n\n2. **Audit Expenses**: All expenses related to the audit, including any pre-approved reasonable expenses incurred by FCE for the audit, will be borne by ExxonMobil.\n\n3. **Access to Operations and Personnel**: ExxonMobil has the right to access FCE's operations, facilities, and knowledgeable personnel as necessary to determine the completeness and accuracy of accounting and payments required under the Agreement, as well as compliance with other terms of the Agreement.\n\nThese rights ensure that ExxonMobil can verify compliance and accuracy in relation to the Agreement while also stipulating that they will cover the costs associated with the audit.",
        "retrieved_contexts":[
            "18.02 Audit Rights",
            "(a) ExxonMobil and its employees or other representatives will have the right to reproduce for its internal records any of the documents kept by FCE in accordance with Paragraph 18.01 (Recordkeeping), such reproduced documents shall be subject to the confidentiality and use provisions contained in Article 4; and\n\n(b) all expenses of each such audit, including any pre-approved reasonable expenses incurred by FCE for such audit, will be for the account of ExxonMobil.",
            ", and accounts and any part of the applicable operations and facilities of FCE relevant to this Agreement, and to have access to FCE's knowledgeable personnel, as may be necessary to determine the completeness and accuracy of any accounting and payments required to be made under this Agreement and compliance with other terms of this Agreement, subject to the following"
        ]
    },
    {
        "user_input":"Consider the Joint Development Agreement between FuelCell Energy, Inc. and ExxonMobil Research and Engineering Company for Molten Carbonate Fuel Cells; Is there uncapped liability under this contract?",
        "response":"Yes, there is uncapped liability under the contract, specifically in relation to gross negligence or willful misconduct. According to the clause, \"each Party will bear full responsibility, without limit, for... Gross Negligence or Willful Misconduct attributable to its personnel.\" This means that if either party engages in gross negligence or willful misconduct, they cannot limit their liability, and they will not be required to indemnify the other party for such actions. \n\nAdditionally, the clause states that \"in no event will either Party be liable to the other Party... for any consequential, indirect, special, incidental, punitive or exemplary loss or damage,\" but this limitation does not apply to gross negligence or willful misconduct. Therefore, while there are limitations on certain types of damages, liability for gross negligence or willful misconduct is indeed uncapped.",
        "retrieved_contexts":[
            ". In no event will either Party be liable to the other Party under this Agreement for any consequential, indirect, special, incidental, punitive or exemplary loss or damage, including, without limitation, business interruption, cost of capital, loss of anticipated revenues and profits, loss of goodwill or increased operating costs, whether arising from contract, warranty, tort",
            "11.04 Exceptions to Limitations of Liability. Notwithstanding anything to the contrary in this Agreement, each Party will bear full responsibility, without limit, for the following:\n\n(i) Gross Negligence or Willful Misconduct attributable to its personnel, and, in no event, will a Party be required to release or indemnify the other Party for Gross Negligence or Willful Misconduct attributable to the other Party; and",
            ". The arbitrators will decide all questions and settle all disputes strictly in accordance with the provisions of this Agreement, including the relevant indemnities and liability limitations. The arbitrators will have no authority to award exemplary or punitive damages, and the arbitral panel will certify in the decision that no part of the award includes such damages"
        ]
    },
    {
        "user_input":"Consider the Joint Development Agreement between FuelCell Energy, Inc. and ExxonMobil Research and Engineering Company for Molten Carbonate Fuel Cells; Is there a cap on liability under this contract?",
        "response":"Yes, there is a cap on liability under this contract. The clause states that \"the total amount paid FCE under this Agreement or for a Project, including all amounts paid following termination, will not exceed the maximum authorized charge specified in this Agreement or for a Project.\" This indicates that there is a limit to the financial liability that can be incurred under the agreement. \n\nAdditionally, the clause specifies that neither party will be liable for consequential, indirect, special, incidental, punitive, or exemplary losses or damages, which further emphasizes the limitations on liability. However, it is important to note that there are exceptions to these limitations, particularly regarding gross negligence or willful misconduct, for which each party will bear full responsibility.",
        "retrieved_contexts":[
            ". In no event will either Party be liable to the other Party under this Agreement for any consequential, indirect, special, incidental, punitive or exemplary loss or damage, including, without limitation, business interruption, cost of capital, loss of anticipated revenues and profits, loss of goodwill or increased operating costs, whether arising from contract, warranty, tort",
            "11.04 Exceptions to Limitations of Liability. Notwithstanding anything to the contrary in this Agreement, each Party will bear full responsibility, without limit, for the following:\n\n(i) Gross Negligence or Willful Misconduct attributable to its personnel, and, in no event, will a Party be required to release or indemnify the other Party for Gross Negligence or Willful Misconduct attributable to the other Party; and",
            ". The total amount paid FCE under this Agreement or for a Project, including all amounts paid following termination, will not exceed the maximum authorized charge specified in this Agreement or for a Project."
        ]
    },
    {
        "user_input":"Consider the Recipe Development Agreement between Reed's, Inc. and B C Marketing Concepts Inc. for Ginger-Based Alcohol Beverages; What is the expiration date of this contract?",
        "response":"The retrieved chunk does not specify an expiration date for the Recipe Development Agreement between Reed's, Inc. and B C Marketing Concepts Inc. It only mentions the effective date as October 11, 2019. Therefore, based on the provided information, there is no direct answer regarding the expiration date of the contract.",
        "retrieved_contexts":[
            ". Reed's is engaged in the business of developing recipes for ginger-based non- alcohol beverage products. Reed's desires to engage Company, and Company desires to be engaged, to participate and assist in the development of formulas for ginger-based flavored alcohol beverage products for Reed's (the \"Products\") as identified in Exhibit A. AGREEMENT The parties agree as follows: 1. Definitions",
            "RECIPE DEVELOPMENT AGREEMENT This Recipe Development Agreement (this \"Agreement\") is made between Reed's, Inc., a Delaware corporation (\"Reed's\") and B C Marketing Concepts Inc., dba Full Sail Brewing Company, an Oregon corporation (\"Company\"), effective as of October 11, 2019 (the \"Effective Date\"). RECITALS Company is engaged in the business of developing recipes for and manufacturing alcohol beverage products",
            ". The final Recipes, Deliverables and Specifications for the Products must be agreed to in writing by at least one member of the Development Committee from each of Reed's and Company. 4. Rights and Obligations. (a) The parties will collaborate to develop commercial production-ready Products according to the Specifications as may be developed by the Development Committee"
        ]
    },
    {
        "user_input":"Consider the Recipe Development Agreement between Reed's, Inc. and B C Marketing Concepts Inc. for Ginger-Based Alcohol Beverages; What is the governing law for this contract?",
        "response":"The provided clause does not specify the governing law for the Recipe Development Agreement between Reed's, Inc. and B C Marketing Concepts Inc. Therefore, based on the information given, I cannot provide an answer regarding the governing law for this contract.",
        "retrieved_contexts":[
            ". Reed's is engaged in the business of developing recipes for ginger-based non- alcohol beverage products. Reed's desires to engage Company, and Company desires to be engaged, to participate and assist in the development of formulas for ginger-based flavored alcohol beverage products for Reed's (the \"Products\") as identified in Exhibit A. AGREEMENT The parties agree as follows: 1. Definitions",
            ". The final Recipes, Deliverables and Specifications for the Products must be agreed to in writing by at least one member of the Development Committee from each of Reed's and Company. 4. Rights and Obligations. (a) The parties will collaborate to develop commercial production-ready Products according to the Specifications as may be developed by the Development Committee",
            "RECIPE DEVELOPMENT AGREEMENT This Recipe Development Agreement (this \"Agreement\") is made between Reed's, Inc., a Delaware corporation (\"Reed's\") and B C Marketing Concepts Inc., dba Full Sail Brewing Company, an Oregon corporation (\"Company\"), effective as of October 11, 2019 (the \"Effective Date\"). RECITALS Company is engaged in the business of developing recipes for and manufacturing alcohol beverage products"
        ]
    },
    {
        "user_input":"Consider the Recipe Development Agreement between Reed's, Inc. and B C Marketing Concepts Inc. for Ginger-Based Alcohol Beverages; Does this contract include an exclusivity agreement?",
        "response":"The provided clause does not mention any exclusivity agreement between Reed's, Inc. and B C Marketing Concepts Inc. It primarily outlines the engagement of the parties to develop recipes for ginger-based flavored alcohol beverage products and specifies that the final recipes and specifications must be agreed upon in writing by members of the Development Committee from both parties. There are no terms or conditions indicating that either party is restricted from engaging with other companies or developing similar products independently. Therefore, based on the information in the clause, there is no exclusivity agreement included in the Recipe Development Agreement.",
        "retrieved_contexts":[
            ". Reed's is engaged in the business of developing recipes for ginger-based non- alcohol beverage products. Reed's desires to engage Company, and Company desires to be engaged, to participate and assist in the development of formulas for ginger-based flavored alcohol beverage products for Reed's (the \"Products\") as identified in Exhibit A. AGREEMENT The parties agree as follows: 1. Definitions",
            "RECIPE DEVELOPMENT AGREEMENT This Recipe Development Agreement (this \"Agreement\") is made between Reed's, Inc., a Delaware corporation (\"Reed's\") and B C Marketing Concepts Inc., dba Full Sail Brewing Company, an Oregon corporation (\"Company\"), effective as of October 11, 2019 (the \"Effective Date\"). RECITALS Company is engaged in the business of developing recipes for and manufacturing alcohol beverage products",
            ". The final Recipes, Deliverables and Specifications for the Products must be agreed to in writing by at least one member of the Development Committee from each of Reed's and Company. 4. Rights and Obligations. (a) The parties will collaborate to develop commercial production-ready Products according to the Specifications as may be developed by the Development Committee"
        ]
    },
    {
        "user_input":"Consider the Recipe Development Agreement between Reed's, Inc. and B C Marketing Concepts Inc. for Ginger-Based Alcohol Beverages; Is there an anti-assignment clause in this contract?",
        "response":"Yes, there is an anti-assignment clause in the contract. The clause states, \"Neither party shall have the right to bind the other party to any obligations to third parties.\" This indicates that neither Reed's nor Company can assign their rights or obligations under the agreement to another party without the consent of the other party.",
        "retrieved_contexts":[
            ". This Agreement does not constitute and shall not be construed as constituting a partnership or joint venture or grant of a franchise between Reed's and Company. Neither party shall have the right to bind the other party to any obligations to third parties. 13. Assignment",
            ". Reed's is engaged in the business of developing recipes for ginger-based non- alcohol beverage products. Reed's desires to engage Company, and Company desires to be engaged, to participate and assist in the development of formulas for ginger-based flavored alcohol beverage products for Reed's (the \"Products\") as identified in Exhibit A. AGREEMENT The parties agree as follows: 1. Definitions",
            ". The final Recipes, Deliverables and Specifications for the Products must be agreed to in writing by at least one member of the Development Committee from each of Reed's and Company. 4. Rights and Obligations. (a) The parties will collaborate to develop commercial production-ready Products according to the Specifications as may be developed by the Development Committee"
        ]
    },
    {
        "user_input":"Consider the Recipe Development Agreement between Reed's, Inc. and B C Marketing Concepts Inc. for Ginger-Based Alcohol Beverages; How is intellectual property ownership assigned in this contract?",
        "response":"In the Recipe Development Agreement between Reed's, Inc. and B C Marketing Concepts Inc., the ownership of intellectual property is assigned as follows:\n\n1. **Company Intellectual Property** includes the Company's know-how, independently developed recipes, and alcohol beverage production processes, specifically mentioning the proprietary composition of the neutral alcohol beverage base.\n\n2. **Reed's Intellectual Property** is defined as all intellectual property that:\n   - Was owned or developed by Reed's prior to the execution of the Agreement.\n   - Was or is independently developed by Reed's without any contribution or assistance from the Company or its Intellectual Property.\n   - Specifically includes \"the Recipe.\"\n\n3. If any intellectual property rights that are subject to legal protection are created or developed jointly by the Parties as a result of the collaboration under this Agreement, those rights will be owned jointly by both parties.\n\nThus, the ownership of intellectual property is clearly delineated between Reed's prior developments and the contributions made during the collaboration, with joint ownership for any jointly developed rights.",
        "retrieved_contexts":[
            ". Company Intellectual Property includes but is not limited to Company's know-how and independently developed recipes and alcohol beverage production processes, including the Company's proprietary composition of or recipe for the neutral alcohol beverage base that contributes alcohol to the Products (\"Neutral Alcohol Beverage Base\")",
            ". (f) \"Reed's Intellectual Property\" means all Intellectual Property that: (i) was owned or developed by Reed's prior to the execution of this Agreement; (ii) was or is independently developed by Reed's without contribution or assistance from Company or Company's Intellectual Property; and (iii) the Recipe. (g) \"Specifications\" means the specifications for the Products to be developed by the Development Committee (as defined in Section 3). 2. Consideration",
            "4.2.3.2. If any intellectual property rights that are subject to legal protection are created or developed jointly by the Parties as a result of the collaboration under this Agreement, such intellectual property rights shall be owned as follows:"
        ]
    },
    {
        "user_input":"Consider the Recipe Development Agreement between Reed's, Inc. and B C Marketing Concepts Inc. for Ginger-Based Alcohol Beverages; Is there uncapped liability under this contract?",
        "response":"The provided clause does not explicitly address liability, whether capped or uncapped, under the Recipe Development Agreement between Reed's, Inc. and B C Marketing Concepts Inc. It primarily focuses on the disclosure of Intellectual Property related to the Products and does not contain any terms regarding liability.\n\nTo determine if there is uncapped liability, you would need to review other sections of the agreement that specifically address liability, indemnification, or limitations of liability. The current clause does not provide any information on this matter.",
        "retrieved_contexts":[
            "(b) Company shall promptly disclose to the Development Committee any prospective or actual new Intellectual Property related to the Products or Product-specific production processes, whether developed solely by Company or jointly by the Company and Reed's, except with regard to the Neutral Alcohol Beverage Base, and except with regard to the Company's general know-how and independently developed production processes not specifically related to the Products. 5. Representations and Warranties",
            ". Reed's is engaged in the business of developing recipes for ginger-based non- alcohol beverage products. Reed's desires to engage Company, and Company desires to be engaged, to participate and assist in the development of formulas for ginger-based flavored alcohol beverage products for Reed's (the \"Products\") as identified in Exhibit A. AGREEMENT The parties agree as follows: 1. Definitions",
            "RECIPE DEVELOPMENT AGREEMENT This Recipe Development Agreement (this \"Agreement\") is made between Reed's, Inc., a Delaware corporation (\"Reed's\") and B C Marketing Concepts Inc., dba Full Sail Brewing Company, an Oregon corporation (\"Company\"), effective as of October 11, 2019 (the \"Effective Date\"). RECITALS Company is engaged in the business of developing recipes for and manufacturing alcohol beverage products"
        ]
    },
    {
        "user_input":"Consider the Recipe Development Agreement between Reed's, Inc. and B C Marketing Concepts Inc. for Ginger-Based Alcohol Beverages; Is there a cap on liability under this contract?",
        "response":"The provided clause does not mention any terms related to liability or a cap on liability under the Recipe Development Agreement between Reed's, Inc. and B C Marketing Concepts Inc. It focuses on the disclosure of Intellectual Property related to the Products and does not address liability limitations or caps. Therefore, based on the information in the clause, there is no indication of a cap on liability in this contract.",
        "retrieved_contexts":[
            "(b) Company shall promptly disclose to the Development Committee any prospective or actual new Intellectual Property related to the Products or Product-specific production processes, whether developed solely by Company or jointly by the Company and Reed's, except with regard to the Neutral Alcohol Beverage Base, and except with regard to the Company's general know-how and independently developed production processes not specifically related to the Products. 5. Representations and Warranties",
            "RECIPE DEVELOPMENT AGREEMENT This Recipe Development Agreement (this \"Agreement\") is made between Reed's, Inc., a Delaware corporation (\"Reed's\") and B C Marketing Concepts Inc., dba Full Sail Brewing Company, an Oregon corporation (\"Company\"), effective as of October 11, 2019 (the \"Effective Date\"). RECITALS Company is engaged in the business of developing recipes for and manufacturing alcohol beverage products",
            ". Reed's is engaged in the business of developing recipes for ginger-based non- alcohol beverage products. Reed's desires to engage Company, and Company desires to be engaged, to participate and assist in the development of formulas for ginger-based flavored alcohol beverage products for Reed's (the \"Products\") as identified in Exhibit A. AGREEMENT The parties agree as follows: 1. Definitions"
        ]
    },
    {
        "user_input":"Consider the Recipe Development Agreement between Reed's, Inc. and B C Marketing Concepts Inc. for Ginger-Based Alcohol Beverages; Is there a covenant not to sue included in this contract?",
        "response":"The provided clause does not explicitly mention a covenant not to sue. It primarily outlines the engagement between Reed's and Company for the development of ginger-based flavored alcohol beverage products, detailing the collaboration process and the requirement for written agreement on final recipes and specifications. \n\nSince there is no indication of a covenant not to sue in the retrieved chunk, I can conclude that such a provision is not included in this contract based on the information provided.",
        "retrieved_contexts":[
            ". Reed's is engaged in the business of developing recipes for ginger-based non- alcohol beverage products. Reed's desires to engage Company, and Company desires to be engaged, to participate and assist in the development of formulas for ginger-based flavored alcohol beverage products for Reed's (the \"Products\") as identified in Exhibit A. AGREEMENT The parties agree as follows: 1. Definitions",
            ". The final Recipes, Deliverables and Specifications for the Products must be agreed to in writing by at least one member of the Development Committee from each of Reed's and Company. 4. Rights and Obligations. (a) The parties will collaborate to develop commercial production-ready Products according to the Specifications as may be developed by the Development Committee",
            "RECIPE DEVELOPMENT AGREEMENT This Recipe Development Agreement (this \"Agreement\") is made between Reed's, Inc., a Delaware corporation (\"Reed's\") and B C Marketing Concepts Inc., dba Full Sail Brewing Company, an Oregon corporation (\"Company\"), effective as of October 11, 2019 (the \"Effective Date\"). RECITALS Company is engaged in the business of developing recipes for and manufacturing alcohol beverage products"
        ]
    },
    {
        "user_input":"Consider the Distributorship Agreement between Signature Orthopaedics Pty Ltd and CPM Medical Consultants LLC for Medical Products; What is the expiration date of this contract?",
        "response":"The Distributorship Agreement between Signature Orthopaedics Pty Ltd and CPM Medical Consultants LLC is effective for a period of three (3) years from the date it was signed, which is dated 29\/3\/18. Therefore, the expiration date of this contract would be 29\/3\/21. \n\nAdditionally, the Distributor has the option to renew the Agreement for an additional three (3) year period by providing prior written notice within ninety (90) days of the end of the initial period.",
        "retrieved_contexts":[
            "EXHIBIT 10.43 Dated 29\/3\/18\n\nDistributorship agreement\n\nbetween\n\nSignature Orthopaedics Pty Ltd\n\nAnd\n\nCPM Medical Consultants LLC\n\nSource: FUSE MEDICAL, INC., 10-K, 3\/21\/2019\n\n\n\n\n\nEXHIBIT 10.43 THIS AGREEMENT is dated\n\nParties\n\n(1) Signature Orthopaedics Pty Ltd (ACN 106 702 416) , 7 Sirius Road, Lane Cove, NSW\n\n(2) CPM Medical Consultants, LLC of 1565N. Central Expressway, Suite 200, Dallas, TX 75080.\n\nBackground",
            "7. DURATION & TERMINATION. (a) Effective Date and Duration. This Agreement shall become effective on the date first written above and shall continue in effect for a period of Three (3) years. (b) Distributor Option to Renew. Distributor shall have the option to renew this Agreement for an additional Three (3) year period by providing prior written notice to Company within Ninety (90) days of the end of the initial period of this Agreement. (c) Termination",
            "Exhibit 6.1 DISTRIBUTOR AGREEMENT THIS DISTRIBUTOR AGREEMENT (this \"Agreement\") is made and effective as of1 August 2019, by and between, B & C General Warehouse Corporation LLC , a USA Limited Liability Company (LLC), with an address located at 7405 SW 11th CT, North Lauderdale, FL, 33068, USA, (\"Company\"), and XXXXXXXXXXXXXXXXXXXXX (\"Distributor\")"
        ]
    },
    {
        "user_input":"Consider the Distributorship Agreement between Signature Orthopaedics Pty Ltd and CPM Medical Consultants LLC for Medical Products; What is the renewal term for this contract?",
        "response":"The renewal term for the Distributorship Agreement between Signature Orthopaedics Pty Ltd and CPM Medical Consultants LLC is an additional three (3) years. The Distributor has the option to renew the Agreement by providing prior written notice to the Company within ninety (90) days of the end of the initial three-year period. This is stated in clause 7(b) of the agreement.",
        "retrieved_contexts":[
            "EXHIBIT 10.43 Dated 29\/3\/18\n\nDistributorship agreement\n\nbetween\n\nSignature Orthopaedics Pty Ltd\n\nAnd\n\nCPM Medical Consultants LLC\n\nSource: FUSE MEDICAL, INC., 10-K, 3\/21\/2019\n\n\n\n\n\nEXHIBIT 10.43 THIS AGREEMENT is dated\n\nParties\n\n(1) Signature Orthopaedics Pty Ltd (ACN 106 702 416) , 7 Sirius Road, Lane Cove, NSW\n\n(2) CPM Medical Consultants, LLC of 1565N. Central Expressway, Suite 200, Dallas, TX 75080.\n\nBackground",
            "7. DURATION & TERMINATION. (a) Effective Date and Duration. This Agreement shall become effective on the date first written above and shall continue in effect for a period of Three (3) years. (b) Distributor Option to Renew. Distributor shall have the option to renew this Agreement for an additional Three (3) year period by providing prior written notice to Company within Ninety (90) days of the end of the initial period of this Agreement. (c) Termination",
            ": (i) no additional Stock Compensation (as defined below) shall be issued in connection with the renewal Term, (ii) the Cash Compensation for the First Additional Term shall be as set forth in Section 7 and Exhibit \"C\" Section (2) attached hereto, (iii) Endorser shall only be obligated to make two (2) Appearances in each Contract Year during the First Additional Term pursuant to Section 4(a)(ii) below and (iv) the marketing budget to promote the Licensed Products shall be $5"
        ]
    },
    {
        "user_input":"Consider the Distributorship Agreement between Signature Orthopaedics Pty Ltd and CPM Medical Consultants LLC for Medical Products; What is the notice period required to terminate the renewal?",
        "response":"The clause does not specify a notice period required to terminate the renewal of the Distributorship Agreement. It only mentions that the Distributor has the option to renew the Agreement for an additional three-year period by providing prior written notice to the Company within ninety (90) days of the end of the initial period. However, it does not outline any notice period for terminating the renewal itself. Therefore, based on the provided clause, there is no information regarding a notice period for terminating the renewal.",
        "retrieved_contexts":[
            "7. DURATION & TERMINATION. (a) Effective Date and Duration. This Agreement shall become effective on the date first written above and shall continue in effect for a period of Three (3) years. (b) Distributor Option to Renew. Distributor shall have the option to renew this Agreement for an additional Three (3) year period by providing prior written notice to Company within Ninety (90) days of the end of the initial period of this Agreement. (c) Termination",
            "EXHIBIT 10.43 Dated 29\/3\/18\n\nDistributorship agreement\n\nbetween\n\nSignature Orthopaedics Pty Ltd\n\nAnd\n\nCPM Medical Consultants LLC\n\nSource: FUSE MEDICAL, INC., 10-K, 3\/21\/2019\n\n\n\n\n\nEXHIBIT 10.43 THIS AGREEMENT is dated\n\nParties\n\n(1) Signature Orthopaedics Pty Ltd (ACN 106 702 416) , 7 Sirius Road, Lane Cove, NSW\n\n(2) CPM Medical Consultants, LLC of 1565N. Central Expressway, Suite 200, Dallas, TX 75080.\n\nBackground",
            ". Either party may terminate this Agreement upon written notice if the Manufacturing and Distribution Agreement terminates prior to the first anniversary of the Effective Date. 9. Indemnification"
        ]
    },
    {
        "user_input":"Consider the Distributorship Agreement between Signature Orthopaedics Pty Ltd and CPM Medical Consultants LLC for Medical Products; What is the governing law for this contract?",
        "response":"The provided clause does not specify the governing law for the Distributorship Agreement between Signature Orthopaedics Pty Ltd and CPM Medical Consultants LLC. Therefore, based on the information in the clause, I cannot provide an answer regarding the governing law for this contract.",
        "retrieved_contexts":[
            "EXHIBIT 10.43 Dated 29\/3\/18\n\nDistributorship agreement\n\nbetween\n\nSignature Orthopaedics Pty Ltd\n\nAnd\n\nCPM Medical Consultants LLC\n\nSource: FUSE MEDICAL, INC., 10-K, 3\/21\/2019\n\n\n\n\n\nEXHIBIT 10.43 THIS AGREEMENT is dated\n\nParties\n\n(1) Signature Orthopaedics Pty Ltd (ACN 106 702 416) , 7 Sirius Road, Lane Cove, NSW\n\n(2) CPM Medical Consultants, LLC of 1565N. Central Expressway, Suite 200, Dallas, TX 75080.\n\nBackground",
            "16.1 The Distributor shall not assign, transfer, mortgage, charge, declare a trust of or deal in any other manner with this agreement or any of its rights and obligations under or arising out of this agreement, or purport to do any of the same; provided, however, the Distributor may assign or transfer this agreement to a Permitted Assignee without the consent of Supplier",
            ". (d) Company has all rights, power, and authority to enter into this Agreement. (e) Company's execution of this Distributor Agreement, and Company's performance of its obligations and duties hereunder, do not and will not violate any agreement to which Company is a party or by which it is otherwise bound, and (f) Neither Party is subject to any pending or threatened litigation or governmental action that could interfere with its performance of this Agreement"
        ]
    },
    {
        "user_input":"Consider the Distributorship Agreement between Signature Orthopaedics Pty Ltd and CPM Medical Consultants LLC for Medical Products; Is there an anti-assignment clause in this contract?",
        "response":"Yes, there is an anti-assignment clause in the Distributorship Agreement between Signature Orthopaedics Pty Ltd and CPM Medical Consultants LLC. The clause states that \"The Distributor shall not assign, transfer, mortgage, charge, declare a trust of or deal in any other manner with this agreement or any of its rights and obligations under or arising out of this agreement.\" \n\nHowever, it also provides an exception: the Distributor may assign or transfer this agreement to a \"Permitted Assignee\" without the consent of the Supplier, provided that (i) any compensation to such sub-agent or other person acting on the Distributor's behalf is solely the Distributor's responsibility, and (ii) such appointment does not deprive the Company of its essential rights under the Agreement. \n\nThis means that while there is a general restriction on assignment, there are specific conditions under which assignment is allowed.",
        "retrieved_contexts":[
            "EXHIBIT 10.43 Dated 29\/3\/18\n\nDistributorship agreement\n\nbetween\n\nSignature Orthopaedics Pty Ltd\n\nAnd\n\nCPM Medical Consultants LLC\n\nSource: FUSE MEDICAL, INC., 10-K, 3\/21\/2019\n\n\n\n\n\nEXHIBIT 10.43 THIS AGREEMENT is dated\n\nParties\n\n(1) Signature Orthopaedics Pty Ltd (ACN 106 702 416) , 7 Sirius Road, Lane Cove, NSW\n\n(2) CPM Medical Consultants, LLC of 1565N. Central Expressway, Suite 200, Dallas, TX 75080.\n\nBackground",
            "16.1 The Distributor shall not assign, transfer, mortgage, charge, declare a trust of or deal in any other manner with this agreement or any of its rights and obligations under or arising out of this agreement, or purport to do any of the same; provided, however, the Distributor may assign or transfer this agreement to a Permitted Assignee without the consent of Supplier",
            "; provided that (i) any compensation to such sub-agent, sub-distributor, sub-representative or other person to act on Distributor's behalf or to otherwise perform any of Distributor's obligations shall be solely Distributor's responsibility, and (ii) such appointment does not deprive Company of the essential rights to which it is entitled under this Agreement"
        ]
    },
    {
        "user_input":"Consider the Distributorship Agreement between Signature Orthopaedics Pty Ltd and CPM Medical Consultants LLC for Medical Products; What licenses are granted under this contract?",
        "response":"The Distributorship Agreement includes provisions regarding licenses, specifically stating that \"non-exclusive licenses [are] granted to other Persons in the Ordinary Course of Business consistent with past practice.\" This indicates that the agreement allows for the granting of non-exclusive licenses to third parties as part of normal business operations.\n\nAdditionally, it mentions that licenses may be granted \"in connection with distribution agreements entered into in the Ordinary Course of Business.\" This suggests that licenses related to distribution agreements are also permitted under the contract.\n\nHowever, the clause does not specify any particular licenses beyond these general terms. Therefore, the licenses granted under this contract are non-exclusive and tied to the ordinary course of business and distribution agreements.",
        "retrieved_contexts":[
            "EXHIBIT 10.43 Dated 29\/3\/18\n\nDistributorship agreement\n\nbetween\n\nSignature Orthopaedics Pty Ltd\n\nAnd\n\nCPM Medical Consultants LLC\n\nSource: FUSE MEDICAL, INC., 10-K, 3\/21\/2019\n\n\n\n\n\nEXHIBIT 10.43 THIS AGREEMENT is dated\n\nParties\n\n(1) Signature Orthopaedics Pty Ltd (ACN 106 702 416) , 7 Sirius Road, Lane Cove, NSW\n\n(2) CPM Medical Consultants, LLC of 1565N. Central Expressway, Suite 200, Dallas, TX 75080.\n\nBackground",
            ", and covenants not to sue (other than non-exclusive licenses granted to other Persons in the Ordinary Course of Business consistent with past practice and licenses granted in connection with distribution agreements entered into in the Ordinary Course of Business)",
            ", and (ii) Licensor may assign its rights and obligations in this Agreement to its Affiliates or subsidiaries and either party may assign this Agreement in its entirety to any purchaser of all or substantially all of its business or assets pertaining to the line of business to which this Agreement relates or to any Affiliate of the party without the other party's approval"
        ]
    },
    {
        "user_input":"Consider the Distributorship Agreement between Signature Orthopaedics Pty Ltd and CPM Medical Consultants LLC for Medical Products; Are there any services to be provided after the termination of this contract?",
        "response":"Yes, there are services to be provided after the termination of the Distributorship Agreement. According to the clause, if the Agreement is terminated for any reason other than a breach by the Distributor, the Company (Signature Orthopaedics Pty Ltd) is obligated to process orders that were accepted prior to the effective date of termination or within ninety (90) days thereafter. \n\nThis means that while the general responsibilities of the Company to the Distributor cease upon termination, there is a specific obligation to fulfill certain orders within the specified timeframe. Additionally, the clause states that termination does not affect any rights or liabilities that have accrued up to the date of termination.",
        "retrieved_contexts":[
            "EXHIBIT 10.43 Dated 29\/3\/18\n\nDistributorship agreement\n\nbetween\n\nSignature Orthopaedics Pty Ltd\n\nAnd\n\nCPM Medical Consultants LLC\n\nSource: FUSE MEDICAL, INC., 10-K, 3\/21\/2019\n\n\n\n\n\nEXHIBIT 10.43 THIS AGREEMENT is dated\n\nParties\n\n(1) Signature Orthopaedics Pty Ltd (ACN 106 702 416) , 7 Sirius Road, Lane Cove, NSW\n\n(2) CPM Medical Consultants, LLC of 1565N. Central Expressway, Suite 200, Dallas, TX 75080.\n\nBackground",
            ". 8. RIGHTS OF PARTIES AT TERMINATION. (a) Obligations After Termination. In the event that this Agreement is terminated or expires on its own terms, Company shall have no further responsibilities to Distributor except that in the event the Agreement terminates for any reason other than a breach hereof by Distributor, Company shall be obligated to process orders accepted by Company prior to the effective date of such termination or expiration or within Ninety (90) days thereafter. (b) Survival",
            "12.1 Termination of this agreement for any reason shall not affect any rights or liabilities accrued at the date of termination.\n\n10\n\nSource: FUSE MEDICAL, INC., 10-K, 3\/21\/2019\n\n\n\n\n\n12.2 At the Supplier's option, on termination of this agreement:"
        ]
    },
    {
        "user_input":"Consider the Distributorship Agreement between Signature Orthopaedics Pty Ltd and CPM Medical Consultants LLC for Medical Products; What are the insurance requirements under this contract?",
        "response":"Under the Distributorship Agreement, the insurance requirements are as follows:\n\n1. **Product Liability Insurance**: The Supplier (Signature Orthopaedics Pty Ltd) is required to maintain product liability insurance with a reputable insurer.\n   \n2. **Coverage Amount**: The insurance must cover no less than AU$10 million for any one occurrence.\n\n3. **Scope of Liability**: This insurance is for any and all liability arising from claims that the Products are faulty or defective.\n\n4. **Documentation**: The Supplier must provide a copy of the insurance policy to the Distributor (CPM Medical Consultants LLC) upon request.\n\nThese requirements ensure that there is adequate coverage for potential claims related to the products distributed under this agreement.",
        "retrieved_contexts":[
            "EXHIBIT 10.43 Dated 29\/3\/18\n\nDistributorship agreement\n\nbetween\n\nSignature Orthopaedics Pty Ltd\n\nAnd\n\nCPM Medical Consultants LLC\n\nSource: FUSE MEDICAL, INC., 10-K, 3\/21\/2019\n\n\n\n\n\nEXHIBIT 10.43 THIS AGREEMENT is dated\n\nParties\n\n(1) Signature Orthopaedics Pty Ltd (ACN 106 702 416) , 7 Sirius Road, Lane Cove, NSW\n\n(2) CPM Medical Consultants, LLC of 1565N. Central Expressway, Suite 200, Dallas, TX 75080.\n\nBackground",
            ". The Supplier shall add the distributor to their current insurance certificate.",
            "10.3 During the Term, the Supplier shall maintain product liability insurance with a reputable insurer of no less than AU$10 million for any one occurrence for any and all liability (however arising) for a claim that the Products are faulty or defective. The Supplier shall provide a copy of the insurance policy to the Distributor on request.\n\n8\n\nSource: FUSE MEDICAL, INC., 10-K, 3\/21\/2019"
        ]
    },
    {
        "user_input":"Consider the Distributorship Agreement between Signature Orthopaedics Pty Ltd and CPM Medical Consultants LLC for Medical Products; Is there a covenant not to sue included in this contract?",
        "response":"Yes, the Distributorship Agreement includes a covenant not to sue. The clause explicitly states that there is a \"covenant not to sue\" related to the rights under any Company IP, with specific exceptions for non-exclusive licenses granted in the ordinary course of business. This means that while the parties agree not to sue each other regarding certain intellectual property rights, there are allowances for non-exclusive outbound licenses and other agreements that are standard in the course of business.",
        "retrieved_contexts":[
            "EXHIBIT 10.43 Dated 29\/3\/18\n\nDistributorship agreement\n\nbetween\n\nSignature Orthopaedics Pty Ltd\n\nAnd\n\nCPM Medical Consultants LLC\n\nSource: FUSE MEDICAL, INC., 10-K, 3\/21\/2019\n\n\n\n\n\nEXHIBIT 10.43 THIS AGREEMENT is dated\n\nParties\n\n(1) Signature Orthopaedics Pty Ltd (ACN 106 702 416) , 7 Sirius Road, Lane Cove, NSW\n\n(2) CPM Medical Consultants, LLC of 1565N. Central Expressway, Suite 200, Dallas, TX 75080.\n\nBackground",
            ", and covenants not to sue (other than non-exclusive licenses granted to other Persons in the Ordinary Course of Business consistent with past practice and licenses granted in connection with distribution agreements entered into in the Ordinary Course of Business)",
            ", covenant not to sue or other rights under any Company IP, other than any non-exclusive outbound license entered into in the ordinary course of business, in the case of each of the foregoing clauses (A) and (B), in each case, that could not be replaced on commercially reasonable terms, excluding any standard non- disclosure, end-user, customer, confidentiality or consulting agreements, in each case as entered into in the ordinary course of business"
        ]
    },
    {
        "user_input":"Consider the Distributor Agreement between B & C General Warehouse Corporation LLC and Distributor for Coffee Products; What is the expiration date of this contract?",
        "response":"The Distributor Agreement between B & C General Warehouse Corporation LLC and the Distributor is effective as of August 1, 2019, and it continues for a period of three (3) years. Therefore, the expiration date of this contract would be August 1, 2022. \n\nAdditionally, the Distributor has the option to renew the Agreement for an additional three (3) year period by providing written notice within ninety (90) days of the end of the initial period.",
        "retrieved_contexts":[
            "Exhibit 6.1 DISTRIBUTOR AGREEMENT THIS DISTRIBUTOR AGREEMENT (this \"Agreement\") is made and effective as of1 August 2019, by and between, B & C General Warehouse Corporation LLC , a USA Limited Liability Company (LLC), with an address located at 7405 SW 11th CT, North Lauderdale, FL, 33068, USA, (\"Company\"), and XXXXXXXXXXXXXXXXXXXXX (\"Distributor\")",
            "7. DURATION & TERMINATION. (a) Effective Date and Duration. This Agreement shall become effective on the date first written above and shall continue in effect for a period of Three (3) years. (b) Distributor Option to Renew. Distributor shall have the option to renew this Agreement for an additional Three (3) year period by providing prior written notice to Company within Ninety (90) days of the end of the initial period of this Agreement. (c) Termination",
            "12\n\nSource: GENTECH HOLDINGS, INC., 1-A, 8\/8\/2019\n\n\n\n\n\nIN WITNESS WHEREOF, this Agreement was signed by the Parties under the hands of their duly authorised officers and made effective as of the date first written above. Luiz Augusto Matavelli Bacetti B & C General Warehouse Corporation LLC Date: 04th, August, 2019. xxxxxxxx xxxxxxxx Date:\n\nSource: GENTECH HOLDINGS, INC., 1-A, 8\/8\/2019"
        ]
    },
    {
        "user_input":"Consider the Distributor Agreement between B & C General Warehouse Corporation LLC and Distributor for Coffee Products; What is the renewal term for this contract?",
        "response":"The renewal term for the Distributor Agreement is an additional three (3) years. According to the clause, the Distributor has the option to renew the Agreement for this period by providing prior written notice to the Company within ninety (90) days of the end of the initial three-year period. Additionally, the Agreement will automatically renew for one (1) additional three (3) year period unless either party gives written notice of non-renewal at least ninety (90) days before the expiration of the initial term.",
        "retrieved_contexts":[
            "7. DURATION & TERMINATION. (a) Effective Date and Duration. This Agreement shall become effective on the date first written above and shall continue in effect for a period of Three (3) years. (b) Distributor Option to Renew. Distributor shall have the option to renew this Agreement for an additional Three (3) year period by providing prior written notice to Company within Ninety (90) days of the end of the initial period of this Agreement. (c) Termination",
            "Exhibit 6.1 DISTRIBUTOR AGREEMENT THIS DISTRIBUTOR AGREEMENT (this \"Agreement\") is made and effective as of1 August 2019, by and between, B & C General Warehouse Corporation LLC , a USA Limited Liability Company (LLC), with an address located at 7405 SW 11th CT, North Lauderdale, FL, 33068, USA, (\"Company\"), and XXXXXXXXXXXXXXXXXXXXX (\"Distributor\")",
            ". Thereafter, this Agreement shall renew automatically for one (1) additional three (3) year period (the \"Renewal Term\" and collectively, together with the Initial Term, the \"Term\") unless either party provides the other with written notice of non-renewal at least ninety (90) days before the expiration of the Initial Term].   6.2 Termination"
        ]
    },
    {
        "user_input":"Consider the Distributor Agreement between B & C General Warehouse Corporation LLC and Distributor for Coffee Products; What is the governing law for this contract?",
        "response":"The provided clause does not specify the governing law for the Distributor Agreement between B & C General Warehouse Corporation LLC and the Distributor. Therefore, based on the information in the retrieved chunk, there is no direct answer regarding the governing law for this contract.",
        "retrieved_contexts":[
            ". (d) Company has all rights, power, and authority to enter into this Agreement. (e) Company's execution of this Distributor Agreement, and Company's performance of its obligations and duties hereunder, do not and will not violate any agreement to which Company is a party or by which it is otherwise bound, and (f) Neither Party is subject to any pending or threatened litigation or governmental action that could interfere with its performance of this Agreement",
            "Exhibit 6.1 DISTRIBUTOR AGREEMENT THIS DISTRIBUTOR AGREEMENT (this \"Agreement\") is made and effective as of1 August 2019, by and between, B & C General Warehouse Corporation LLC , a USA Limited Liability Company (LLC), with an address located at 7405 SW 11th CT, North Lauderdale, FL, 33068, USA, (\"Company\"), and XXXXXXXXXXXXXXXXXXXXX (\"Distributor\")",
            "16.1 The Distributor shall not assign, transfer, mortgage, charge, declare a trust of or deal in any other manner with this agreement or any of its rights and obligations under or arising out of this agreement, or purport to do any of the same; provided, however, the Distributor may assign or transfer this agreement to a Permitted Assignee without the consent of Supplier"
        ]
    },
    {
        "user_input":"Consider the Distributor Agreement between B & C General Warehouse Corporation LLC and Distributor for Coffee Products; Is there a most favored nation clause in this contract?",
        "response":"The retrieved chunk does mention \"most favored nation\" rights in relation to contracts. Specifically, it states that a contract may not grant \"most favored nation\" rights, except for rights and provisions that are \"not material to the Company and its Subsidiaries, taken as a whole.\" \n\nHowever, the clause does not provide a direct answer regarding whether the Distributor Agreement between B & C General Warehouse Corporation LLC and Distributor for Coffee Products specifically contains a most favored nation clause. Therefore, based on the provided information, I cannot confirm the presence of such a clause in that specific contract.",
        "retrieved_contexts":[
            ", (C) contains any provision that requires the purchase of all or any portion of the Company\u2019s or any of its Subsidiaries\u2019 requirements from any Third Party or (D) grants \u201cmost favored nation\u201d rights, except in the case of each of clauses (A), (B), (C) and (D) for such rights and provisions that are not material to the Company and its Subsidiaries, taken as a whole",
            ":   (i)                 a Contract granting a \u201cmost favored nation\u201d or most favored customer pricing to any Person, or any Contract providing for the grant of exclusive material sales, distribution, marketing or other exclusive rights, rights of first refusal, rights of first negotiation or similar rights and\/or terms to any Person, or materially limiting the right of the Company or any of its Subsidiaries to engage in any line of business or in any geographic area",
            ", (B) contains material exclusivity or \u201cmost favored nation\u201d obligations or restrictions or (C) contains any other provisions that restrict the ability of the Company or any of its Subsidiaries to sell, market, distribute, promote, manufacture, develop, commercialize, or test or research any Company Product, directly or indirectly through third parties, in any material respect, or that would so limit or purport to limit the ability of Parent or any of its Affiliates to sell, market, distribute"
        ]
    },
    {
        "user_input":"Consider the Distributor Agreement between B & C General Warehouse Corporation LLC and Distributor for Coffee Products; Does this contract include an exclusivity agreement?",
        "response":"Yes, the contract includes an exclusivity agreement. The clause states that the Company \"hereby appoints and grants Distributor the exclusive right to sell and distribute the Products to customers that Distributor introduce and confirmed by Company.\" This indicates that the Distributor has exclusive rights within the specified territory of the United States of America (USA) for the sale and distribution of the Products.",
        "retrieved_contexts":[
            ". Subject to the terms and conditions of this Distributor Agreement, Company hereby appoints and grants Distributor the exclusive right to sell and distribute the Products to customers that Distributor introduce and confirmed by Company, (in all territory of United State of America (USA) and to render other services as a distributor for Company as set forth herein",
            ". (d) Company has all rights, power, and authority to enter into this Agreement. (e) Company's execution of this Distributor Agreement, and Company's performance of its obligations and duties hereunder, do not and will not violate any agreement to which Company is a party or by which it is otherwise bound, and (f) Neither Party is subject to any pending or threatened litigation or governmental action that could interfere with its performance of this Agreement",
            "The Supplier wishes to appoint the Distributor as its non-exclusive distributor for the promotion and sale of the Products within the Territory (both as defined below), and the Distributor wishes to promote and sell the Products within the Territory on the terms of this agreement.\n\nAgreed terms\n\n1. Definitions and interpretation\n\n1.1 The definitions and rules of interpretation in this clause apply in this agreement."
        ]
    },
    {
        "user_input":"Consider the Distributor Agreement between B & C General Warehouse Corporation LLC and Distributor for Coffee Products; Is there a clause preventing the solicitation of customers in this contract?",
        "response":"Yes, there is a clause preventing the solicitation of customers in the Distributor Agreement. Specifically, the clause states, \"The Company shall not contact any of Distributor's Customer's for any reason, without the prior written approval of Distributor.\" This means that the Company is prohibited from reaching out to the Distributor's customers unless they obtain prior written consent from the Distributor.",
        "retrieved_contexts":[
            ". The Company shall not contact any of Distributor's Customer's for any reason, without the prior written approval of Distributor.",
            ". Subject to the terms and conditions of this Distributor Agreement, Company hereby appoints and grants Distributor the exclusive right to sell and distribute the Products to customers that Distributor introduce and confirmed by Company, (in all territory of United State of America (USA) and to render other services as a distributor for Company as set forth herein",
            "16.2 If the Distributor seeks the Supplier's consent to any proposed dealing under clause 16.1, the Distributor must: -\n\n(a) disclose fully in writing all material facts relating to the dealing\n\n(b) comply fully with any conditions or requirements set down by the Supplier which attach to any Suppliers consent that is given.\n\n16.3 Each party that has rights under this agreement is acting on its own behalf and not for the benefit of another person.\n\n17. Freedom to contract"
        ]
    },
    {
        "user_input":"Consider the Distributor Agreement between B & C General Warehouse Corporation LLC and Distributor for Coffee Products; Is there an anti-assignment clause in this contract?",
        "response":"Yes, there is an anti-assignment clause in the contract. Clause 16.1 explicitly states that \"The Distributor shall not assign, transfer, mortgage, charge, declare a trust of or deal in any other manner with this agreement or any of its rights and obligations under or arising out of this agreement.\" \n\nHowever, it does provide an exception where the Distributor may assign or transfer the agreement to a \"Permitted Assignee\" without the consent of the Supplier. This means that while general assignments are prohibited, there is a specific allowance for assignments to certain approved parties. \n\nAdditionally, the clause includes conditions stating that any compensation to sub-agents or representatives is the sole responsibility of the Distributor, and such appointments must not deprive the Company of its essential rights under the agreement. Furthermore, the Distributor is not allowed to sub-contract or delegate any of its obligations to third parties or agents.",
        "retrieved_contexts":[
            "16.1 The Distributor shall not assign, transfer, mortgage, charge, declare a trust of or deal in any other manner with this agreement or any of its rights and obligations under or arising out of this agreement, or purport to do any of the same; provided, however, the Distributor may assign or transfer this agreement to a Permitted Assignee without the consent of Supplier",
            "; provided that (i) any compensation to such sub-agent, sub-distributor, sub-representative or other person to act on Distributor's behalf or to otherwise perform any of Distributor's obligations shall be solely Distributor's responsibility, and (ii) such appointment does not deprive Company of the essential rights to which it is entitled under this Agreement",
            ". The Distributor shall not sub-contract or delegate in any manner any or all of its obligations under this agreement to any third party or agent."
        ]
    },
    {
        "user_input":"Consider the Distributor Agreement between B & C General Warehouse Corporation LLC and Distributor for Coffee Products; Are there any price restrictions or controls specified in this contract?",
        "response":"The Distributor Agreement specifies that the Distributor is \"free to resell the Products for such prices and upon such terms and conditions as Distributor may see fit in its sole discretion.\" This means there are no price restrictions or controls imposed by the Company on the Distributor regarding the resale of the Products. Additionally, the Company \"shall have no control over or any liability in connection with the price at which Distributor resells the Products.\" Therefore, the Distributor has complete discretion over pricing without any restrictions from the Company.",
        "retrieved_contexts":[
            ". Distributor shall be free to resell the Products for such prices and upon such terms and conditions as Distributor may see fit in its sole discretion. Company shall have no control over or any liability in connection with the price at which Distributor resells the Products, and Distributor shall hold Company harmless and indemnify and defend Company from and against any liability resulting therefrom. 3. REPRESENTATIONS",
            "Exhibit 6.1 DISTRIBUTOR AGREEMENT THIS DISTRIBUTOR AGREEMENT (this \"Agreement\") is made and effective as of1 August 2019, by and between, B & C General Warehouse Corporation LLC , a USA Limited Liability Company (LLC), with an address located at 7405 SW 11th CT, North Lauderdale, FL, 33068, USA, (\"Company\"), and XXXXXXXXXXXXXXXXXXXXX (\"Distributor\")",
            ". Subject to the terms and conditions of this Distributor Agreement, Company hereby appoints and grants Distributor the exclusive right to sell and distribute the Products to customers that Distributor introduce and confirmed by Company, (in all territory of United State of America (USA) and to render other services as a distributor for Company as set forth herein"
        ]
    },
    {
        "user_input":"Consider the Distributor Agreement between B & C General Warehouse Corporation LLC and Distributor for Coffee Products; Does this contract include any volume restrictions?",
        "response":"The provided clause does not mention any volume restrictions related to the Distributor Agreement between B & C General Warehouse Corporation LLC and the Distributor for Coffee Products. The clause primarily addresses the assignment and transfer of the agreement and does not contain any terms regarding volume limitations or restrictions on the quantity of products to be distributed. Therefore, based on the information in the clause, there are no volume restrictions specified in the contract.",
        "retrieved_contexts":[
            "Exhibit 6.1 DISTRIBUTOR AGREEMENT THIS DISTRIBUTOR AGREEMENT (this \"Agreement\") is made and effective as of1 August 2019, by and between, B & C General Warehouse Corporation LLC , a USA Limited Liability Company (LLC), with an address located at 7405 SW 11th CT, North Lauderdale, FL, 33068, USA, (\"Company\"), and XXXXXXXXXXXXXXXXXXXXX (\"Distributor\")",
            "16.1 The Distributor shall not assign, transfer, mortgage, charge, declare a trust of or deal in any other manner with this agreement or any of its rights and obligations under or arising out of this agreement, or purport to do any of the same; provided, however, the Distributor may assign or transfer this agreement to a Permitted Assignee without the consent of Supplier",
            ". (d) Company has all rights, power, and authority to enter into this Agreement. (e) Company's execution of this Distributor Agreement, and Company's performance of its obligations and duties hereunder, do not and will not violate any agreement to which Company is a party or by which it is otherwise bound, and (f) Neither Party is subject to any pending or threatened litigation or governmental action that could interfere with its performance of this Agreement"
        ]
    },
    {
        "user_input":"Consider the Distributor Agreement between B & C General Warehouse Corporation LLC and Distributor for Coffee Products; How is intellectual property ownership assigned in this contract?",
        "response":"In the Distributor Agreement, the ownership of intellectual property, specifically trademarks, is addressed in the following way: \n\nThe Distributor is prohibited from initiating any legal proceedings regarding the trademarks of the Company, either in their own name or on behalf of the Company, without obtaining \"express written permission of Company.\" Furthermore, the Distributor is required to assign to the Company, without charge, any rights in the trademarks that may benefit the Distributor under this Agreement or otherwise. The Distributor must also execute any necessary documents or actions to fulfill the intent of this section.\n\nThis means that the Company retains ownership of its trademarks, and the Distributor must comply with the Company's directives regarding those trademarks. The clause emphasizes that any rights or benefits related to the trademarks that might accrue to the Distributor must be assigned to the Company, reinforcing the Company's ownership of its intellectual property.",
        "retrieved_contexts":[
            ". Distributor will not institute any proceedings with respect to the trademarks of Company either in Distributor's own name or on behalf of Company without express written permission of Company. Distributor shall assign to Company, without charge, any rights in the trademarks of Company that may inure to the benefit of Distributor pursuant to this Agreement or otherwise. Distributor shall execute any documents or do any acts that may be required to accomplish the intent of this Section. 12",
            "(f) This Agreement shall be binding upon and inure to the benefit of each party\u2019s respective successors and lawful assigns; provided, however, that Vendor may not assign this Agreement (whether by operation of law, sale of securities or assets, merger or otherwise), in whole or in part, without the prior written approval of IBC. Any purported assignment in violation of this Section shall be void",
            "(b) Territory. The rights granted Distributor hereunder are granted for the following geographical areas and markets. USA. (c) Products. The Products manufactured and sold by Company to Distributor for distribution hereunder are as follows: \u25cf Arte Caf\u00e9 Especial \u25cf Arte Caf\u00e9 Gourmet \u25cf Arte Caf\u00e9 Laurina \u25cf Arte Caf\u00e9 Organico \u25cf And all another new brand and or kind of coffee. (d) Subagents"
        ]
    },
    {
        "user_input":"Consider the Distributor Agreement between B & C General Warehouse Corporation LLC and Distributor for Coffee Products; Are there any services to be provided after the termination of this contract?",
        "response":"Yes, there are specific services to be provided after the termination of the Distributor Agreement. According to the clause, if the Agreement is terminated for any reason other than a breach by the Distributor, the Company is obligated to process orders that were accepted prior to the effective date of termination or within ninety (90) days thereafter. This means that while the Company will have no further responsibilities to the Distributor after termination, it must still fulfill those accepted orders during the specified timeframe.",
        "retrieved_contexts":[
            ". 8. RIGHTS OF PARTIES AT TERMINATION. (a) Obligations After Termination. In the event that this Agreement is terminated or expires on its own terms, Company shall have no further responsibilities to Distributor except that in the event the Agreement terminates for any reason other than a breach hereof by Distributor, Company shall be obligated to process orders accepted by Company prior to the effective date of such termination or expiration or within Ninety (90) days thereafter. (b) Survival",
            "Exhibit 6.1 DISTRIBUTOR AGREEMENT THIS DISTRIBUTOR AGREEMENT (this \"Agreement\") is made and effective as of1 August 2019, by and between, B & C General Warehouse Corporation LLC , a USA Limited Liability Company (LLC), with an address located at 7405 SW 11th CT, North Lauderdale, FL, 33068, USA, (\"Company\"), and XXXXXXXXXXXXXXXXXXXXX (\"Distributor\")",
            "(n) Without affecting any other rights that it may be entitled to, the Supplier may give notice in writing to the Distributor terminating this agreement immediately if the Distributor purports to assign its rights or obligations under this agreement to an entity that is not (1) affiliated with, (2) related to, or (3) sharing common ownership with the Distributor (a Permitted Assignee).\n\n12. Effectsof termination"
        ]
    },
    {
        "user_input":"Consider the Distributor Agreement between B & C General Warehouse Corporation LLC and Distributor for Coffee Products; Is there a cap on liability under this contract?",
        "response":"Yes, there is a cap on liability under the contract. According to clause 13.1, \"IN NO EVENT SHALL JRVS'S LIABILITY ARISING OUT OF THIS AGREEMENT EXCEED THE AMOUNT RECEIVED BY JRVS FROM THE DISTRIBUTOR HEREUNDER FOR THE PRODUCT GIVING RISE TO THE LIABILITY.\" This means that JRVS's liability is limited to the amount it received from the Distributor for the specific product that caused the liability.",
        "retrieved_contexts":[
            ", except to the extent the liability arises as a result of the wilful misconduct of the Distributor",
            "13. LIMITATION OF LIABILITIES 13.1 Limitation of Liabilities. IN NO EVENT SHALL JRVS'S LIABILITY ARISING OUT OF THIS AGREEMENT EXCEED THE AMOUNT RECEIVED BY JRVS FROM THE DISTRIBUTOR HEREUNDER FOR THE PRODUCT GIVING RISE TO THE LIABILITY",
            "16.1 The Distributor shall not assign, transfer, mortgage, charge, declare a trust of or deal in any other manner with this agreement or any of its rights and obligations under or arising out of this agreement, or purport to do any of the same; provided, however, the Distributor may assign or transfer this agreement to a Permitted Assignee without the consent of Supplier"
        ]
    },
    {
        "user_input":"Consider the Distributor Agreement between B & C General Warehouse Corporation LLC and Distributor for Coffee Products; What is the duration of any warranties provided in this contract?",
        "response":"The retrieved chunk does not provide any information regarding the duration of warranties in the Distributor Agreement between B & C General Warehouse Corporation LLC and the Distributor. The section provided focuses on the effective date, duration of the agreement, the option to renew, and termination conditions, but does not mention any warranties or their duration. Therefore, I cannot answer your question based on the provided clause.",
        "retrieved_contexts":[
            "Exhibit 6.1 DISTRIBUTOR AGREEMENT THIS DISTRIBUTOR AGREEMENT (this \"Agreement\") is made and effective as of1 August 2019, by and between, B & C General Warehouse Corporation LLC , a USA Limited Liability Company (LLC), with an address located at 7405 SW 11th CT, North Lauderdale, FL, 33068, USA, (\"Company\"), and XXXXXXXXXXXXXXXXXXXXX (\"Distributor\")",
            "7. DURATION & TERMINATION. (a) Effective Date and Duration. This Agreement shall become effective on the date first written above and shall continue in effect for a period of Three (3) years. (b) Distributor Option to Renew. Distributor shall have the option to renew this Agreement for an additional Three (3) year period by providing prior written notice to Company within Ninety (90) days of the end of the initial period of this Agreement. (c) Termination",
            "(a) the Supplier may buy from the Distributor all or any stocks of Products for the current market value for those Products. The Distributor must deliver such Products to the Supplier within 14 days of receiving the Supplier's notice, and the Supplier must pay for the Products in full within 30 days of their delivery. The Supplier shall be responsible for the costs of packaging, insurance and carriage of the Products; or"
        ]
    },
    {
        "user_input":"Consider the Distributor Agreement between B & C General Warehouse Corporation LLC and Distributor for Coffee Products; Is there a covenant not to sue included in this contract?",
        "response":"The provided clause does not explicitly mention a covenant not to sue. It primarily addresses the rights and authority of the Company to enter into the Agreement, the compliance of the Company's execution with other agreements, and the absence of pending litigation that could interfere with the Agreement's performance. \n\nThe clause states, \"Neither Party is subject to any pending or threatened litigation or governmental action that could interfere with its performance of this Agreement,\" but it does not include any terms or conditions that would constitute a covenant not to sue. Therefore, based on the information in the clause, there is no indication of a covenant not to sue in the Distributor Agreement.",
        "retrieved_contexts":[
            ". (d) Company has all rights, power, and authority to enter into this Agreement. (e) Company's execution of this Distributor Agreement, and Company's performance of its obligations and duties hereunder, do not and will not violate any agreement to which Company is a party or by which it is otherwise bound, and (f) Neither Party is subject to any pending or threatened litigation or governmental action that could interfere with its performance of this Agreement",
            ", except to the extent the liability arises as a result of the wilful misconduct of the Distributor",
            "Exhibit 6.1 DISTRIBUTOR AGREEMENT THIS DISTRIBUTOR AGREEMENT (this \"Agreement\") is made and effective as of1 August 2019, by and between, B & C General Warehouse Corporation LLC , a USA Limited Liability Company (LLC), with an address located at 7405 SW 11th CT, North Lauderdale, FL, 33068, USA, (\"Company\"), and XXXXXXXXXXXXXXXXXXXXX (\"Distributor\")"
        ]
    },
    {
        "user_input":"Consider the Non-Exclusive Distributor Agreement between iMine Corporation and Sunwai Technology for Cryptocurrency Mining Rigs; What is the expiration date of this contract?",
        "response":"The provided clause does not specify an expiration date for the Non-Exclusive Distributor Agreement between iMine Corporation and Sunwai Technology. It only states the date the agreement was made, which is July 19, 2018. Without additional information or clauses regarding the duration or termination of the agreement, I cannot provide an expiration date.",
        "retrieved_contexts":[
            "EXHIBIT 10.5 NON-EXCLUSIVE DISTRIBUTOR AGREEMENT This Non-Exclusive Distributor Agreement (the \"Agreement\") is made and entered into as of this 19th day of July 2018, by and between iMine Corporation, (hereinafter referred to as \"JRVS\") and SUNWAI Technology, a Taiwanese company, with its principal office at 6th Floor, No. 258, Section 3, Nanjing East Road, Songshan District, Taipei 10051 (hereinafter referred to as the \"Distributor\")",
            "Source: IMINE CORP, S-1, 7\/25\/2018\n\n\n\n\n\nIN WITNESS WHEREOF, THE PARTIES HERETO HAVE EXECUTED THIS AGREEMENT AS OF THE DATE FIRST WRITTEN ABOVE. Sunwai Technology iMine Corporation\n\n\/s\/ Sei-Peng Tu \/s\/ Daniel Tsai By: Sei-Peng Tu By: Daniel Tsai Title: President Title: Chief Executive Officer 9\n\nSource: IMINE CORP, S-1, 7\/25\/2018",
            ". RECITAL WHEREAS, Distributor desires to be, a nonexclusive distributor of JRVS for certain cryptocurrency mining rig products; JRVS wishes to sell its products through Distributor on a continuing basis on the terms and conditions set forth below. AGREEMENT NOW, THEREFORE, in consideration of the mutual agreements and covenants, JRVS and the Distributor agree as follows: 1. DEFINITIONS 1"
        ]
    },
    {
        "user_input":"Consider the Non-Exclusive Distributor Agreement between iMine Corporation and Sunwai Technology for Cryptocurrency Mining Rigs; What is the governing law for this contract?",
        "response":"The provided clause does not specify the governing law for the Non-Exclusive Distributor Agreement between iMine Corporation and Sunwai Technology. Therefore, based on the information given, I cannot provide a direct answer regarding the governing law for this contract.",
        "retrieved_contexts":[
            ". RECITAL WHEREAS, Distributor desires to be, a nonexclusive distributor of JRVS for certain cryptocurrency mining rig products; JRVS wishes to sell its products through Distributor on a continuing basis on the terms and conditions set forth below. AGREEMENT NOW, THEREFORE, in consideration of the mutual agreements and covenants, JRVS and the Distributor agree as follows: 1. DEFINITIONS 1",
            ". or international intellectual property, unfair competition or trade secret laws. 1.7 \"Products\" shall mean the products offered by JRVS for sale to the Distributor; the Products shall include iMine cryptocurrency mining rigs and its parts and components. 1.8 \"Territory\" shall mean the geographic area of Taiwan. 2. APPOINTMENT 2.1 Appointment of Nonexclusive Distributor",
            "EXHIBIT 10.5 NON-EXCLUSIVE DISTRIBUTOR AGREEMENT This Non-Exclusive Distributor Agreement (the \"Agreement\") is made and entered into as of this 19th day of July 2018, by and between iMine Corporation, (hereinafter referred to as \"JRVS\") and SUNWAI Technology, a Taiwanese company, with its principal office at 6th Floor, No. 258, Section 3, Nanjing East Road, Songshan District, Taipei 10051 (hereinafter referred to as the \"Distributor\")"
        ]
    }
]